EP2655587B1 - Liquid surfactant preparation containing lipase and phosphonate - Google Patents

Liquid surfactant preparation containing lipase and phosphonate Download PDF

Info

Publication number
EP2655587B1
EP2655587B1 EP11805804.9A EP11805804A EP2655587B1 EP 2655587 B1 EP2655587 B1 EP 2655587B1 EP 11805804 A EP11805804 A EP 11805804A EP 2655587 B1 EP2655587 B1 EP 2655587B1
Authority
EP
European Patent Office
Prior art keywords
lipase
acid
surfactant preparation
phosphonate
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP11805804.9A
Other languages
German (de)
French (fr)
Other versions
EP2655587A1 (en
Inventor
Karl-Heinz Maurer
Timothy O'connell
Petra Siegert
Thomas Weber
Susanne Tondera
Hendrik Hellmuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to PL11805804T priority Critical patent/PL2655587T3/en
Publication of EP2655587A1 publication Critical patent/EP2655587A1/en
Application granted granted Critical
Publication of EP2655587B1 publication Critical patent/EP2655587B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06LDRY-CLEANING, WASHING OR BLEACHING FIBRES, FILAMENTS, THREADS, YARNS, FABRICS, FEATHERS OR MADE-UP FIBROUS GOODS; BLEACHING LEATHER OR FURS
    • D06L4/00Bleaching fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods; Bleaching leather or furs
    • D06L4/40Bleaching fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods; Bleaching leather or furs using enzymes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38627Preparations containing enzymes, e.g. protease or amylase containing lipase
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/66Non-ionic compounds
    • C11D1/78Neutral esters of acids of phosphorus
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/36Organic compounds containing phosphorus
    • C11D3/361Phosphonates, phosphinates or phosphonites
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/36Organic compounds containing phosphorus
    • C11D3/364Organic compounds containing phosphorus containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/36Organic compounds containing phosphorus
    • C11D3/365Organic compounds containing phosphorus containing carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase

Definitions

  • the invention is in the field of liquid enzyme-containing surfactant preparations, as used for example in washing, cleaning or disinfecting. More particularly, the invention relates to liquid enzyme-containing surfactant formulations containing defined lipases in combination with a phosphonate, and further proposes uses and methods in which such formulations are employed. The invention further relates to uses of defined lipases in liquid surfactant formulations containing a phosphonate.
  • Surfactant preparations in particular in modern liquid detergents, but also in detergents or disinfectants, often contain phosphonates. They are used, for example, as complexing agents, to prevent precipitation or as a bleach stabilizer. As complexing agents they serve, for example, as water softeners. They can encase cations such as Ca 2+ in the solution and thus alter the chemical behavior of the cation. In the case of calcium, the property of water hardness disappears. Other cations can be complexed and thus protected against chemical reactions. They can also participate as corrosion inhibitors or serve as a stabilizer for peroxides, especially in bleaching agents.
  • complexing agents serve, for example, as water softeners. They can encase cations such as Ca 2+ in the solution and thus alter the chemical behavior of the cation. In the case of calcium, the property of water hardness disappears. Other cations can be complexed and thus protected against chemical reactions. They can also participate as corrosion inhibitors or serve as a stabilizer for peroxides, especially in bleach
  • lipase is increasingly used in surfactant preparations, in particular in detergents or cleaners.
  • a lipase is an enzyme that catalyzes the hydrolysis of ester bonds in lipid substrates, especially in fats and oils. Lipases are therefore a group of esterases. Lipases are generally versatile enzymes that accept a variety of substrates, for example, aliphatic, alicyclic, bicyclic and aromatic esters, thioesters and activated amines. Lipases act against fat residues in the laundry to catalyze their hydrolysis (lipolysis).
  • Lipases with broad substrate spectra are used in particular where inhomogeneous raw materials or substrate mixtures have to be reacted, for example in detergents and cleaners, since soiling may consist of differently structured fats and oils.
  • the lipases used in the washing or cleaning agents known from the prior art are usually of microbial origin and are usually derived from bacteria or fungi, for example the genera Bacillus, Pseudomonas, Acinetobacter, Micrococcus, Humicola, Trichoderma or Trichosporon. Lipases are usually produced by biotechnological methods known per se by suitable microorganisms, for example by transgenic expression hosts of the genera Bacillus or by filamentous fungi.
  • EP 443063 is, for example, intended for detergents and cleaners lipase from Pseudomonas sp. ATCC 21808, but not explicitly for use in a phosphonate-containing liquid formulation.
  • JP 1225490 is a lipase from Rhizopus oryzae disclosed.
  • this document also does not disclose a specific liquid surfactant preparation which necessarily contains a phosphonate in combination with a Rhizopus oryzae lipase.
  • WO037097780 discloses combinations of certain lipases with transition metal bleach catalysts to increase cleaning performance.
  • WO2005 / 124012 discloses an enzymatic bleaching system containing phosphonate, at least one oxidase and at least one perhydrolase, and their use in various care and cleaning agents.
  • lipases from Rhizopus oryzae or Mucor javanicus are not mentioned in either document.
  • WO2004 / 053039 discloses detergent compositions containing a combination of an endoglucanase and a Rhizopus oryzae lipase. However, these detergent compositions do not contain phosphonates.
  • DE 102007003143 discloses alkaline proteases from Bacillus gibsonii, and their use in detergents and cleaners, as well as their combination with lipases.
  • a liquid surfactant preparation containing a phosphonate in combination with a lipase from Rhizopus oryzae or Mucor javanicus is also not apparent from this document.
  • lipases are suitable for use in liquid surfactant preparations. Many lipases do not show sufficient catalytic performance or stability in such formulations. In phosphonate-containing liquid surfactant preparations, this problem is even more serious, for example due to the complex-forming properties of the phosphonates or due to unfavorable interactions between the phosphonate and the lipase.
  • lipase-containing liquid surfactant preparations of the prior art in particular those containing phosphonates, have the disadvantage that they often do not have satisfactory lipolytic activity and therefore the surfactant preparation does not show optimal cleaning performance on lipase-sensitive soils.
  • the object of the present invention is to overcome the mentioned disadvantage and to provide a phosphonate-containing liquid surfactant preparation which has a beneficial lipolytic activity.
  • An object of the invention is a liquid surfactant preparation comprising a phosphonate and a lipase which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus.
  • a liquid surfactant preparation which contains the combination of such a lipase with a phosphonate has advantageous cleaning performance on lipase-sensitive soiling.
  • a surfactant preparation exhibits an improved cleaning performance on at least one, preferably on several lipase-sensitive stains, in particular on textiles and / or hard surfaces.
  • a surfactant preparation according to the invention is also advantageously storage-stable.
  • inventive surfactant formulations show an advantageous cleaning performance with respect to at least one lipase-sensitive soiling at temperatures between 10 Ā° C and 80 Ā° C, preferably also at low temperatures, for example between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C or between 20 Ā° C and 40 Ā° C.
  • the present invention is therefore a particularly advantageous selection of a lipase for a phosphonate-containing liquid surfactant preparation.
  • cleaning performance is understood to mean the whitening performance of one or more soiling, in particular laundry soiling or scrape dirt, which are sensitive to degradation by the lipase.
  • soiling in particular laundry soiling or scrape dirt
  • examples of such stains are carbon black / mineral oil, carbon black / olive oil, pigment / oil or skin fat (sebum) / carbon black, in each case for example on cotton fabric, in particular as indicated below.
  • both the surfactant preparation which comprises the lipase or the washing or cleaning liquor formed by this surfactant preparation, and the lipase itself have a respective cleaning performance.
  • the cleaning performance of the lipase thus contributes to the cleaning performance of the surfactant preparation or the washing or cleaning liquor formed by the surfactant preparation.
  • the cleaning performance is preferably determined as indicated below.
  • Washing or cleaning liquor is understood as meaning the use solution containing the surfactant preparation which acts on textiles or fabrics (wash liquor) or hard surfaces (cleaning liquor) and thus comes into contact with the soiling present on textiles or fabrics or hard surfaces.
  • the washing or cleaning liquor arises when the washing or cleaning process begins and the surfactant preparation, in particular the detergent or cleaning agent, for example, in a washing machine, dishwasher or other suitable container is diluted with water.
  • a lipase contained in a surfactant preparation according to the invention has a lipolytic activity, that is, it is capable of hydrolysis (lipolysis) of lipids such as glycerides or cholesterol esters.
  • the lipase contained in a surfactant preparation according to the invention is naturally present in a microorganism of the species Rhizopus oryzae or Mucor javanicus. Naturally present in this context means that the lipase is a separate enzyme of the microorganism.
  • the lipase can thus be expressed in the microorganism from a nucleic acid sequence which is part of the chromosomal DNA of the microorganism in its wild-type form.
  • nucleic acid sequence is therefore present in the wild-type form of the microorganism and / or can be isolated from the wild-type form of the microorganism from this.
  • a lipase or the nucleic acid sequence coding for it in the microorganism would be incorporated into the microorganism by means of genetic engineering have been deliberately introduced so that the microorganism would have been enriched to the lipase or the coding for them nucleic acid sequence.
  • a lipase naturally present in a microorganism of the genus Rhizopus oryzae or Mucor javanicus may well have been produced recombinantly from another organism.
  • the fungus Rhizopus oryzae belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae and the genus Rhizopus.
  • the fungus Mucorjavanicus also belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae, then herein to the genus Mucor.
  • the names Rhizopus oryzae and Mucorjavanicus are the biological species names within the respective genus.
  • Phosphonates are salts and organic compounds, especially esters, of phosphonic acid.
  • M' stands for a monovalent metal.
  • inorganic phosphonates are also referred to as primary and secondary phosphites, respectively.
  • Inorganic phosphonates are formed, for example, by reaction of phosphonic acid HP (O) (OH) 2 , in particular the stable tautomeric form of phosphorous acid with a (primary) or two (secondary) equivalents of base, for example alkali metal hydroxide.
  • organic P-substituted phosphonates which have a phosphorus-carbon bond (phosphorus-organic compounds).
  • Organic P-substituted phosphonates are formed, for example, by the Michaelis-Arbusov reaction. Many of these phosphonates are soluble in water. Some technically important phosphonates also carry amino group (s). Some of these aminophosphonates have structural similarities to complexing agents such as EDTA, NTA or DTPA and have a similar function.
  • Particularly preferred phosphonates in the context of the present invention are 1-hydroxyethane-1,1-diphosphonic acid (HEDP), aminotrimethylenephosphonic acid (ATMP), nitrilotrimethylenephosphonic acid (NTMP), diethylenetriaminepentamethylenephosphonic acid (DTPMP, DETPMP or DTPNT), ethylenediamine tetramethylenephosphonic acid (EDTMP) and 2-phosphonobutane.
  • HEDP 1-hydroxyethane-1,1-diphosphonic acid
  • ATMP aminotrimethylenephosphonic acid
  • NTMP nitrilotrimethylenephosphonic acid
  • DTPMP diethylenetriaminepentamethylenephosphonic acid
  • DETPMP DETPMP or DTPNT
  • ETMP ethylenediamine tetramethylenephosphonic acid
  • 2-phosphonobutane 2-phosphonobutane.
  • 1,2,4-tricarboxylic acid PBS-AM, also referred to as 3-carboxy-3-phosphonoadipic acid
  • DTPMP diethylenetriaminepentamethylenephosphonic acid sodium
  • HEDP 1-hydroxyethane-1,1-diphosphonic acid
  • Such phosphonates are available, for example, under the trade names DequestĀ® 2066 and DequestĀ® 2010 (each from Thermphos).
  • the surfactant preparation is characterized in that the lipase has an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 amino acid sequence is at least 80% identical. More preferably, the amino acid sequence is at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95% %, 96%, 97%, 98%, 99% and most preferably 100% identical to that shown in SEQ ID NO. 1 indicated amino acid sequence.
  • SEQ ID NO. 1 is the sequence of a mature (mature) lipase from Rhizopus oryzae.
  • Lipases which are very particularly preferred according to the invention are the lipase enzymes obtainable from the company Amano Pharmaceuticals under the names Lipase M-AP10Ā®, Lipase LEĀ® and Lipase FĀ® (also Lipase JVĀ®).
  • the Lipase FĀ® is naturally present in Rhizopus oryzae.
  • the lipase M-AP10Ā® is naturally present in Mucor javanicus.
  • a lipase to a liquid surfactant preparation which comprises a phosphonate, in particular one as described above, provides a particularly advantageous lipolytic activity in this preparation.
  • surfactant preparations are sufficiently stable on storage, in particular with regard to their remaining lipolytic activity after storage, in particular after a storage period of 1 to 5 weeks, 1 to 4 weeks, 1.5 to 3 weeks and particularly preferably after 2 weeks.
  • nucleic acid or amino acid sequences is determined by a sequence comparison. Such a comparison is made by assigning similar sequences in the nucleotide sequences or amino acid sequences to each other. This sequence comparison is preferably carried out based on the BLAST algorithm established and commonly used in the prior art (cf., for example, US Pat Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ (1990) "Basic local alignment search tool.ā€ J. Mol. Biol. 215: 403-410 , and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J.
  • T-Coffee cf., for example Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217 ) or programs based on these programs or algorithms.
  • Clustal cf., for example, Chenna et al. (2003): Multiple sequence alignment with the Clustal series of programs.
  • T-Coffee cf., for example Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol.
  • sequence comparisons and alignments are preferably created with the computer program Vector NTIĀ® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the default parameters specified.
  • nucleic acid or amino acid sequence can be small and comprise only a few nucleotides or amino acids. Often, such small regions exert essential functions for the overall activity of the protein. It may therefore be useful to relate sequence matches only to individual, possibly small areas. Unless stated otherwise, identity or homology information in the present application, however, refers to the total length of the respectively indicated nucleic acid or amino acid sequence.
  • the detergent for the washing system is a liquid detergent composed as follows (all figures in weight percent): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0.3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda , 14-16% coconut fatty acids, 0.5% HEDP (1-hydroxyethane-1,1-diphosphonic acid), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% Dye, remainder demineralized water.
  • the lipase is used in this regard in a concentration of 0.0001-0.06 wt .-%, preferably from 0.001 to 0.006 wt .-%, in the detergent, based on active protein.
  • the dosage of the liquid detergent is between 2.0 and 9.0, preferably between 2.5 and 8.0, between 3.0 and 7.0 and more preferably 3.5 grams per liter of wash liquor. Washing takes place in a pH range between pH 8 and pH 10.5, preferably between pH 8 and pH 9.
  • the lipase activity in the wash liquor is not equal to zero at the start of washing.
  • the degree of whiteness i. the brightening of the stains, as a measure of the cleaning performance is determined by optical measurement methods, preferably photometrically.
  • a suitable device for this purpose is for example the spectrometer Minolta CM508d.
  • the devices used for the measurement are previously calibrated with a white standard, preferably a supplied white standard.
  • the activity-like use of the respective lipase ensures that even if the ratio of active substance to total protein (the values of the specific activity) diverge, the respective enzymatic properties, for example the cleaning performance of certain soils, are compared. In general, a low specific activity can be compensated by adding a larger amount of protein.
  • the lipase activity is determined in a customary manner, preferably as described in Bruno Stellmach, "Methods of determination enzymes for pharmacy, food chemistry, engineering, biochemistry, biology, medicineā€ (Steinkopff Verlag Darmstadt, 1988, p 172ff).
  • lipase-containing samples are added to an olive oil emulsion in emulsifier-containing water and incubated at 30 Ā° C and pH 9.0. This fatty acids are released. These will be with an autotitrator over 20min. titrated continuously with 0.01 N sodium hydroxide solution so that the pH remains constant (ā€œpH-stat titration"). Based on the sodium hydroxide consumption, the determination of the lipase activity takes place by reference to a reference lipase sample.
  • lipases are formed as so-called pre-proteins, ie together with a propeptide and / or a signal peptide. Often the prodrug and / or signal peptide are N-terminal sequences. In the course of the folding and / or secretion process of the protein Cleaved signal and / or propeptide, so that after the cleavage of the pro- and / or signal peptide, the then mature lipase exerts its catalytic activity without the originally present N-terminal amino acids.
  • the mature (mature) lipases ie the enzymes processed after their preparation, are preferred over the preproteins.
  • the lipases may also be modified by the cells producing them after production of the polypeptide chain, for example, by attachment of sugar molecules, formylations, aminations, etc. Such modifications are post-translational modifications and may, but do not, have an effect on the function of the lipase.
  • the lipase contained in a surfactant preparation according to the invention may be adsorbed to carriers and / or embedded in encapsulating substances in order to protect them against premature inactivation. In the washing or cleaning liquor, ie under conditions of use, the lipase is then released and can develop their lipolytic action.
  • the surfactant preparation is characterized in that the phosphonate is contained in an amount of 0.01 to 4 wt .-%. Further preferred amounts of the phosphonate contained in the surfactant preparation are from 0.01 to 3% by weight, from 0.01 to 2.5% by weight, from 0.02 to 2.4% by weight, from 0, 02 to 2 wt .-%, from 0.03 to 1.5 wt .-% or from 0.05 to 1 wt .-%.
  • the lipase is preferably contained in a surfactant preparation according to the invention in each case in an amount of from 1 ā‡ 10 -8 to 5% by weight, based on active protein. More preferably, the lipase is in an amount of 1 x 10 -7 -3 wt .-%, from 0.00001 to 1 wt .-%, from 0.0002 to 0.8% wt .-% and particularly preferably from 0 , 0008-0.4% wt .-% in a surfactant preparations according to the invention, based on active protein.
  • the protein concentration can be determined by known methods, for example the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method ( Gornall AG, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766 ).
  • the Aktivenzymproteinehalt can by means of "Active Siteā€ titration of the lipase preparation according to Rotticci et al .: "An active-site titration method for lipasesā€ (Biochim Biophys Acta 1483 (1), pages 132-140 ).
  • a surfactant preparation is to be understood as meaning any type of composition which comprises at least one surfactant.
  • a composition contains a surfactant as described below.
  • liquid or flowable administration forms can serve as liquid surfactant preparations.
  • "Flowable" in the context of the present application are preparations which are pourable and can have viscosities of up to several tens of thousands of mPas. The viscosity can be measured by conventional standard methods (for example, Brookfield LVT-II viscosimeter at 20 rpm and 20 Ā° C., spindle 3) and is preferably in the range from 5 to 10,000 mPas.
  • Preferred surfactant formulations have viscosities of 10 to 8000 mPas, with values between 120 to 3000 mPas being particularly preferred.
  • a liquid surfactant preparation in the context of the present invention can therefore also be gelatinous or paste-like, it can be in the form of a homogeneous solution or suspension, and can be sprayed or packaged in other conventional dosage forms, for example.
  • a liquid surfactant preparation according to the invention can be used as such or after dilution with water, in particular for the cleaning of textiles and / or hard surfaces.
  • Such dilution can be readily made by diluting a measured amount of the surfactant preparation in a further amount of water in certain weight ratios of surfactant preparation: water and optionally shaking this dilution to ensure uniform distribution of the surfactant formulation in the water.
  • Possible weight or volume ratios of the dilutions are from 1: 0 surfactant preparation: water to 1: 10,000 or 1: 20000 surfactant preparation: water, preferably from 1:10 to 1: 2000 surfactant preparation: water.
  • a surfactant preparation in the sense of the present invention can therefore also be the washing or cleaning liquor itself.
  • the surfactant preparation is a washing, cleaning or disinfecting agent.
  • the detergents include all conceivable types of detergents, in particular detergents for textiles, carpets or natural fibers. They can be provided for manual and / or machine application.
  • the detergents also include washing aids, which are added to the actual detergent in the manual or machine textile washing, in order to achieve a further effect.
  • Detergents include all agents for cleaning and / or disinfecting hard surfaces also found in all of the above dosage forms, manual and automatic dishwashing detergents, carpet cleaners, abrasives, glass cleaners, toilet scavengers, etc.
  • Textile pre- and post-treatment agent Finally, on the one hand are such means with which the laundry is brought into contact before the actual laundry, for example, for solving stubborn dirt, on the other hand, those in one of the actual textile laundry downstream step the laundry further desirable properties such as pleasant handle , Give crease-free or low static charge.
  • the fabric softeners are calculated. Disinfectants are, for example, hand disinfectants, surface disinfectants and instrument disinfectants, which may also occur in the mentioned dosage forms.
  • a disinfectant preferably causes a germ reduction by a factor of at least 10 4 , that is to say that of originally 10,000 proliferating germs (so-called colony-forming units - CFU) survived no more than a single, with viruses in this regard are not considered as germs, since they have no cytoplasm and have no own metabolism.
  • Preferred disinfectants cause a germ reduction by a factor of at least 10 5 .
  • surfactant (s) it is possible to use anionic, nonionic, zwitterionic and / or amphoteric surfactants. From an application point of view, preference is given to mixtures of anionic and nonionic surfactants.
  • the total surfactant content of the liquid surfactant preparation is preferably below 60% by weight, and more preferably below 45% by weight, based on the total liquid surfactant formulation.
  • Suitable nonionic surfactants include alkoxylated fatty alcohols, alkoxylated fatty acid alkyl esters, fatty acid amides, alkoxylated fatty acid amides, polyhydroxy fatty acid amides, alkylphenol polyglycol ethers, amine oxides, alkyl polyglucosides, and mixtures thereof.
  • the nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary, alcohols having preferably 8 to 18 carbon atoms and on average 1 to 12 moles of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical can be linear or preferably methyl-branched in the 2-position or linear and methyl-branched radicals in the mixture can contain, as they are usually present in Oxoalkoholresten.
  • alcohol ethoxylates with linear radicals of alcohols of native origin having 12 to 18 carbon atoms, for example of coconut, palm, tallow or oleyl alcohol, and on average 2 to 8 EO per mole of alcohol are preferred.
  • Preferred ethoxylated alcohols include, for example, C12-14 alcohols containing 3 EO, 7 EO or 4 EO, C9-11 alcohol containing 7 EO, C 13-5 alcohols containing 3 EO, 5 EO, 7 EO or 8 EO, C 12-18 -alcohols with 3 EO, 5 EO or 7 EO and mixtures of these, such as mixtures of C 12-14 -alcohol with 3 EO and C 12-18 -alcohol with 7 EO.
  • the degrees of ethoxylation given represent statistical means which, for a particular product, may be an integer or a fractional number.
  • Preferred alcohol ethoxylates have a narrowed Homolog distribution (narrow range ethoxylates, NRE).
  • fatty alcohols with more than 12 EO can also be used. Examples include tallow fatty alcohol with 14 EO, 25 EO, 30 EO or 40 EO.
  • Nonionic surfactants containing EO and PO groups together in the molecule can also be used according to the invention. Also suitable are also a mixture of a (more) branched ethoxylated fatty alcohol and an unbranched ethoxylated fatty alcohol, such as a mixture of a C 16-18 fatty alcohol with 7 EO and 2-propylheptanol with 7 EO.
  • the surfactant preparation contains a C 12-18 fatty alcohol with 7 EO or a C 13-15 oxo alcohol with 7 EO as nonionic surfactant.
  • the content of nonionic surfactants is preferably 3 to 40 wt .-%, preferably 5 to 30 wt .-% and in particular 7 to 20 wt .-%, each based on the total surfactant.
  • the surfactant preparation may also contain anionic surfactants.
  • the anionic surfactant used is preferably sulfonates, sulfates, soaps, alkyl phosphates, anionic silicone surfactants and mixtures thereof.
  • the surfactants of the sulfonate type are preferably C 9-13 -alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, as are obtained, for example, from C 12-18 -monoolefins having terminal or internal double bonds by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation products into consideration.
  • esters of ā‡ -sulfo fatty acids for example the ā‡ -sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids.
  • Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C 12 -C 18 fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C 10 -C 20 oxo alcohols and those half-esters of secondary alcohols of these chain lengths are preferred.
  • the C 12 -C 16 alkyl sulfates and C 12 -C 15 alkyl sulfates and C 14 -C 15 alkyl sulfates are preferred.
  • 2,3-alkyl sulfates are also suitable anionic surfactants.
  • EO ethylene oxide
  • Fatty alcohols with 1 to 4 EO are suitable.
  • anionic surfactants are soaps.
  • Suitable are saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid and, in particular, soap mixtures derived from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acids.
  • the anionic surfactants including the soaps may be in the form of their sodium, potassium or magnesium or ammonium salts.
  • the anionic surfactants are in the form of their sodium salts.
  • Further preferred counterions for the anionic surfactants are also the protonated forms of choline, triethylamine or methylethylamine.
  • the content of a surfactant preparation of anionic surfactants can be from 1 to 40% by weight, preferably from 5 to 30% by weight and very particularly preferably from 10 to 25% by weight, based in each case on the total surfactant preparation.
  • surfactant preparations in particular of liquid detergents or cleaners containing a lipase, in particular such as described above, in particular at a temperature between 10 Ā° C and 80 Ā° C and preferably at comparatively low temperatures, in particular between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C, between 10 Ā° C and 30 Ā° C and / or between 20 Ā° C and 40 Ā° C.
  • the substances indicated are anionic or polyanionic substances, ie these substances carry at least one and preferably several negative charges. It is preferably a polymer having at least one negatively charged monomer, preferably having a plurality of negatively charged monomers. According to the invention, this polymer is therefore a negatively charged polymer.
  • polymers of organic acids or their salts in particular polyacrylates and / or poly-sugar acids and / or polyarcylate copolymers and / or poly-sugar copolymers, are preferred.
  • further preferred compounds are polyacrylic sulfonates or polycarboxylates and their salts, copolymers or salts of the copolymers.
  • Acusol 587D polyacrylic sulfonate, Rohm & Haas / Dow Chemical Company
  • Acusol 445N polycarboxylate sodium salt, Rohm & Haas / Dow Chemical Company
  • Acusol 590 polyacrylate copolymer; Rohm & Haas / Dow Chemical
  • Acusol 916 polyarcrylate sodium salt, Rohm & Haas / Dow Chemical Company
  • Sokalan CP42 modified polycarboxylate sodium salt, BASF Company
  • Sokalan PA 30CL polycarboxylate sodium salt, BASF Company
  • Dequest P 9000 polymaleic acid, Thermphos Company
  • alginic acid Poly-2-acrylamido-2-methyl-1-propane-sulfonic acid, poly-4-styrene sulfonic acid-co-maleic acid sodium salt, poly-acrylamido-co-acrylic acid sodium salt, poly-me
  • the substances indicated are cationic or polycationic substances, i. these substances carry at least one and preferably several positive charges. It is preferably a polymer having at least one positively charged monomer, preferably having a plurality of positively charged monomers. According to the invention, this polymer is therefore a positively charged polymer.
  • preferred compounds in this regard are salts of polyamines, polyethylene imines or their copolymers, salts of polyallylamines, salts of Polydiallyldimethylammonium compounds or poly (acrylamide-co-diallyldimethylammonium compounds.
  • under iii. specified substances are substances which have at least one hydroxyl and / or polyhydroxyl group and preferably more hydroxyl and / or polyhydroxyl groups.
  • Preferred in this regard are, for example, polyvinyl alcohols, for example those which are available under the trade name Mowiol (Kremer Pigmente GmbH & Co. KG).
  • a specific substance to one or more of the above groups i. to iii. may be associated.
  • it may be an anionic polymer having one or more hydroxyl and / or polyhydroxyl group (s).
  • Such a substance is then associated with the groups i. and iii.
  • the surfactant preparation is characterized by further comprising at least one other ingredient selected from the group consisting of builder, peroxygen compound, bleach activator, nonaqueous solvent, acid, water soluble salt, thickener, disinfecting ingredient, and the like Combinations thereof.
  • the addition of one or more of the further ingredient (s) proves to be advantageous, as this further improved cleaning performance and / or disinfection is achieved.
  • the improved cleaning performance and / or disinfection is based on a synergistic interaction of at least two ingredients.
  • Builders which may be present in the surfactant preparation include, in particular, silicates, aluminum silicates (in particular zeolites), carbonates, salts of organic di- and polycarboxylic acids and mixtures of these substances.
  • Organic builders which may be present in the surfactant preparation are, for example, the polycarboxylic acids which can be used in the form of their sodium salts, polycarboxylic acids meaning those carboxylic acids which carry more than one acid function. These are, for example, citric acid, adipic acid, succinic acid, glutaric acid, malic acid, tartaric acid, maleic acid, fumaric acid, sugar acids, aminocarboxylic acids, nitrilotriacetic acid (NTA), methylglycine diacetic acid (MGDA) and derivatives thereof and mixtures thereof.
  • Preferred salts are the salts of polycarboxylic acids such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof.
  • polymeric polycarboxylates are suitable. These are, for example, the alkali metal salts of polyacrylic acid or polymethacrylic acid, for example, those having a molecular weight of 600 to 750,000 g / mol.
  • Suitable polymers are in particular polyacrylates, which preferably have a molecular weight of from 1,000 to 15,000 g / mol. Because of their superior solubility, the short-chain polyacrylates, which have molecular weights of from 1,000 to 10,000 g / mol, and particularly preferably from 1,000 to 5,000 g / mol, may again be preferred from this group.
  • copolymeric polycarboxylates in particular those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid.
  • the polymers may also contain allylsulfonic acids, such as allyloxybenzenesulfonic acid and methallylsulfonic acid, as a monomer.
  • soluble builders such as, for example, citric acid, or acrylic polymers having a molar mass of from 1,000 to 5,000 g / mol, preferably in the liquid surfactant preparation.
  • the molecular weights stated for polymeric polycarboxylates are weight-average molecular weights M w of the particular acid form, which were determined in principle by means of gel permeation chromatography (GPC), a UV detector being used. The measurement was carried out against an external polyacrylic acid standard, which provides realistic molecular weight values due to its structural relationship with the polymers investigated. These data differ significantly from the molecular weight data in which Polystyrene sulfonic acids are used as standard. The molar masses measured against polystyrenesulfonic acids are generally significantly higher than the molecular weights specified in this document.
  • organic builder substances may be present in amounts of up to 40% by weight, in particular up to 25% by weight and preferably from 1% by weight to 8% by weight. Amounts close to the stated upper limit are preferably used in paste-form or liquid, in particular water-containing, surfactant preparations.
  • Peroxygen compounds which are suitable for use in surfactant preparations according to the invention are, in particular, organic peracids or persalts of organic acids, such as phthalimidopercaproic acid, perbenzoic acid or salts of diperdodecanedioic acid, hydrogen peroxide and inorganic salts which release hydrogen peroxide under the washing conditions, such as perborate, percarbonate, persilicate and / or persulphate Caroat belong into consideration. If a preparation contains peroxygen compounds, they are present in amounts of preferably up to 50% by weight, especially from 5% to 30% by weight. The addition of small amounts of known bleach stabilizers such as phosphonates, borates or metaborates and metasilicates and magnesium salts such as magnesium sulfate may be useful.
  • organic peracids or persalts of organic acids such as phthalimidopercaproic acid, perbenzoic acid or salts of diperdodecanedioic acid, hydrogen
  • bleach activators it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid.
  • Suitable substances are those which carry O- and / or N-acyl groups of the stated C atom number and / or optionally substituted benzoyl groups.
  • polyacylated alkylenediamines in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N- Acylimides, in particular N-nonanoylsuccinimide (NOSI), acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate, 2,5-diacetoxy- 2,5-dihydrofuran and enol esters
  • TAED
  • the hydrophilic substituted acyl acetals and the acyl lactams are also preferably used.
  • combinations of conventional bleach activators can be used.
  • Such bleach activators can, in particular in the presence of the abovementioned hydrogen peroxide-producing bleach, in the usual amount range, preferably in amounts of from 0.5 wt .-% to 10 wt .-%, in particular 1 wt .-% to 8 wt .-%, based on However, the total surfactant preparation, be contained when using percarboxylic acid as the sole bleach, but preferably completely.
  • sulfone imines and / or bleach-enhancing transition metal salts or transition metal complexes may also be present as so-called bleach catalysts.
  • the surfactant preparations according to the invention are liquid and preferably contain water as the main solvent.
  • non-aqueous solvents may be added to the surfactant preparation. Suitable non-aqueous solvents include mono- or polyhydric alcohols, alkanolamines or glycol ethers, provided that they are miscible with water in the specified concentration range.
  • the solvents are selected from ethanol, n-propanol, i-propanol, butanols, glycol, propanediol, butanediol, glycerol, diglycol, propyldiglycol, butyldiglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, ethylene glycol mono-n-butyl ether, diethylene glycol methyl ether, diethylene glycol ethyl ether, Propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, diisopropylene glycol monomethyl ether, di-isopropylene glycol monoethyl ether, methoxytriglycol, ethoxytriglycol
  • the surfactant formulation contain a polyol as a nonaqueous solvent.
  • the polyol may in particular comprise glycerol, 1,2-propanediol, 1,3-propanediol, ethylene glycol, diethylene glycol and / or dipropylene glycol.
  • the surfactant formulation contains a mixture of a polyol and a monohydric alcohol.
  • Non-aqueous solvents may be used in the surfactant preparation in amounts of between 0.5 and 15% by weight, but preferably below 12% by weight.
  • the surfactant formulation s systemic and environmentally acceptable acids, especially citric acid, acetic acid, tartaric acid, malic acid, lactic acid, glycolic acid, succinic acid, glutaric acid and / or adipic acid, but also, mineral acids, in particular sulfuric acid, or bases, in particular ammonium or alkali metal hydroxides.
  • Such pH regulators are present in the surfactant preparations in amounts of preferably not more than 20% by weight, in particular from 1.2% by weight to 17% by weight.
  • a surfactant preparation according to the invention may further contain one or more water-soluble salts which serve, for example, for adjusting the viscosity.
  • These may be inorganic and / or organic salts.
  • Useful inorganic salts are preferably selected from the group consisting of colorless water-soluble halides, sulfates, sulfites, carbonates, bicarbonates, nitrates, nitrites, phosphates and / or oxides of the alkali metals, alkaline earth metals, aluminum and / or transition metals; Furthermore, ammonium salts can be used.
  • the inorganic salt is selected from the group comprising sodium chloride, potassium chloride, sodium sulfate, potassium sulfate and mixtures thereof.
  • Useful organic salts are, for example, colorless water-soluble alkali metal, alkaline earth metal, ammonium, aluminum and / or transition metal salts of the carboxylic acids.
  • the salts are selected from the group comprising formate, acetate, propionate, citrate, malate, tartrate, succinate, malonate, oxalate, lactate and mixtures thereof.
  • a surfactant preparation according to the invention may contain one or more thickeners.
  • the thickener is selected from the group comprising xanthan, guar, carrageenan, agar-agar, gellan, pectin, locust bean gum and mixtures thereof. These compounds are effective thickeners even in the presence of inorganic salts.
  • the surfactant formulation contains xanthan gum as a thickener because xanthan effectively thickened even in the presence of high salt concentrations and prevents macroscopic separation of the continuous phase.
  • the thickener stabilizes the continuous, low surfactant phase and prevents macroscopic phase separation.
  • acrylic and methacrylic (co) polymers include, for example, the high molecular weight homopolymers of acrylic acid crosslinked with a polyalkenyl polyether, in particular an allyl ether of sucrose, pentaerythritol or propylene (INCI name according to "International Dictionary of Cosmetic Ingredientsā€ of "The Cosmetic, Toiletry and Fragrance Association (CTFA) ": carbomer), also referred to as carboxyvinyl polymers.
  • CFA Cosmetic, Toiletry and Fragrance Association
  • Such polyacrylic acids are available, inter alia, under the trade names PolygelĀ® and CarbopolĀ®.
  • acrylic acid copolymers are suitable: (i) copolymers of two or more monomers from the group of acrylic acid, methacrylic acid and their simple, preferably formed with C 1-4 alkanols, esters (INCI acrylates copolymer), for example, among the Trade names AculynĀ®, AcusolĀ® or TegoĀ® Polymer are available; (ii) crosslinked high molecular weight acrylic acid copolymers, such as those crosslinked with an allyl ether of sucrose or pentaerythritol copolymers of C 10-30 alkyl acrylates with one or more Monomers from the group of acrylic acid, methacrylic acid and their simple, preferably with C 1-4 alkanols formed ester (INCI acrylates / C 10-30 alkyl acrylate crosspolymer) include and are available, for example, under the trade name CarbopolĀ®.
  • Other suitable polymers are (meth) acrylic acid (co) polymers of the SokalanĀ® type.
  • the surfactant preparation according to the invention contains a (meth) acrylic acid (co) polymer in combination with a further thickener, preferably xanthan.
  • the surfactant preparation can contain from 0.05 to 1.5% by weight and preferably from 0.1 to 1% by weight, based in each case on the total surfactant preparation, of thickening agent.
  • the amount of thickener used depends on the type of thickener and the desired degree of thickening.
  • ingredients which have an antimicrobial or antiviral activity are understood to be a disinfectant ingredient.
  • the germicidal effect is dependent on the content of the disinfecting ingredient in the surfactant preparation, wherein the germicidal effect decreases with decreasing content of disinfecting ingredient or increasing dilution of the surfactant preparation.
  • a preferred disinfecting ingredient is ethanol or propanol. These monohydric alcohols are commonly used in disinfectants and detergents because of their solvent properties and their germicidal activity.
  • the term "propanolā€ includes both the 1-propanol (n-propanol) and the 2-propanol ("isopropanolā€).
  • Ethanol and / or propanol for example, in an amount of from 10 to 65 wt .-%, preferably 25 to 55 wt .-% in the surfactant preparation.
  • Another preferred disinfecting ingredient is tea tree oil.
  • the tea tree oil is obtained by steam distillation from the leaves and branch tips of these trees and is a mixture of about 100 substances; its main constituents include (+) - terpinene-4-ol, ā‡ -terpinene, terpinolene, terpineol, pinene, myrcene, phellandrene, p-cymene, limonene and 1,8-cineole.
  • Tea tree oil is contained, for example, in an amount of 0.05 to 10% by weight, preferably 0.1 to 5.0% by weight, in the virucidal treatment solution.
  • Another preferred disinfecting ingredient is lactic acid.
  • the lactic acid or 2-hydroxypropionic acid is a fermentation product produced by various microorganisms. She is weakly active in antibiotics. Lactic acid is for example, in amounts of up to 10 wt .-%, preferably 0.2 to 5.0 wt .-% in the surfactant preparation.
  • disinfectant ingredients are, for example, active compounds from the groups of alcohols, aldehydes, antimicrobial acids or their salts, carboxylic esters, acid amides, phenols, phenol derivatives, diphenyls, diphenylalkanes, urea derivatives, oxygen, nitrogen acetals and formals, benzamidines, isothiazoles and derivatives thereof such as isothiazolines and isothiazolinones, phthalimide derivatives, pyridine derivatives, antimicrobial surface active compounds, guanidines, antimicrobial amphoteric compounds, quinolines, 1,2-dibromo-2,4-dicyanobutane, iodo-2-propynyl-butyl-carbamate, iodine, iodophores and peroxides.
  • active compounds from the groups of alcohols, aldehydes, antimicrobial acids or their salts, carboxylic esters, acid amides, phenols,
  • preferred active ingredients are selected from the group comprising 1,3-butanediol, phenoxyethanol, 1,2-propylene glycol, glycerol, undecylenic acid, citric acid, lactic acid, benzoic acid, salicylic acid, thymol, 2-benzyl-4-chlorophenol, 2,2 '.
  • Preferred quaternary surface active compounds contain an ammonium, sulfonium, phosphonium, iodonium or arsonium group.
  • disinfectant essential oils can be used, which at the same time provide for a scenting of the virucidal treatment solution.
  • particularly preferred active compounds are selected from the group comprising salicylic acid, quaternary surfactants, in particular benzalkonium chloride, peroxo compounds, in particular hydrogen peroxide, alkali metal hypochlorite and mixtures thereof.
  • Such another disinfecting ingredient is, for example, in an amount of 0.01 to 1 wt .-%, preferably 0.02 to 0.8 wt .-%, in particular 0.05 to 0.5 wt .-%, particularly preferably 0 , 1 to 0.3 wt .-%, most preferably 0.2 wt .-% in the surfactant preparation.
  • Liquid surfactant preparations according to the invention in the form of customary solvent-containing solutions are generally prepared by simply mixing the ingredients, which can be added in bulk or as a solution in an automatic mixer.
  • Surfactant preparations according to the invention may contain as enzymatic constituents exclusively a lipase as described. Alternatively, they may also contain other hydrolytic enzymes or other enzymes in a concentration useful for the effectiveness of the surfactant formulation. In a further embodiment of the invention, therefore, the surfactant preparation comprises at least one further enzyme. In principle, all the enzymes established in the prior art for this purpose can be used in this regard.
  • Preferred as further enzymes all enzymes which can develop a catalytic activity in a surfactant preparation according to the invention can be used, in particular a protease, amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, .beta.-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreductase or another Lipase, as well as their mixtures.
  • a protease amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, .beta.-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreducta
  • each further enzyme is in an amount of 1 x 10 -7 -3 wt%, from 0.00001 to 1 wt%, from 0.00005 to 0.5 wt%, from 0.0001 to 0.1 wt .-% and particularly preferably from 0.0001 to 0.05 wt .-% in inventive surfactant preparations, based on active protein.
  • the enzymes show synergistic cleaning performance against certain stains or stains, ie the enzymes contained in the surfactant preparation support each other in their cleaning performance.
  • subtilisin type those of the subtilisin type are preferable.
  • subtilisins BPN 'and Carlsberg the protease PB92, the subtilisins 147 and 309, the alkaline protease from Bacillus lentus, subtilisin DY and the enzymes thermitase, proteinase K and the subtilases, but not the subtilisins in the narrower sense Proteases TW3 and TW7.
  • Subtilisin Carlsberg is available in a further developed form under the trade name AlcalaseĀ® from Novozymes A / S, Bagsvaard, Denmark.
  • subtilisins 147 and 309 are sold under the trade names EsperaseĀ®, and SavinaseĀ® by the company Novozymes. From the protease from Bacillus lentus DSM 5483 derived under the name BLAPĀ® protease variants derived.
  • proteases are, for example, those under the trade names DurazymĀ®, RelaseĀ®, EverlaseĀ®, NafizymĀ®, NatalaseĀ®, KannaseĀ® and OvozymeĀ® from Novozymes, which are available under the trade names, PurafectĀ®, PurafectĀ® OxP, PurafectĀ® Prime, ExcellaseĀ® and ProperaseĀ® from Genencor, sold under the trade name ProtosolĀ® by Advanced Biochemicals Ltd., Thane, India, under the trade name WuxiĀ® by Wuxi Snyder Bioproducts Ltd., China, under the trade names Proleather Ā® and Protease PĀ® from Amano Pharmaceuticals Ltd., Nagoya, Japan, and the enzyme available under the name Proteinase K-16 from Kao Corp., Tokyo, Japan.
  • the proteases are also used with particular preference Bacillus gibsonii and Bacillus pumilus disclosed in international patent applications WO2008 / 086916 and WO2007 / 131656 ,
  • Amylases which can be synthesized according to the invention are, for example, the ā‡ -amylases from Bacillus licheniformis, from Bacillus amyloliquefaciens or from Bacillus stearothermophilus, and in particular also their further developments improved for use in detergents or cleaners.
  • the enzyme from Bacillus licheniformis is available from the company Novozymes under the name TermamylĀ® and from the company Danisco / Genencor under the name PurastarĀ®ST.
  • this ā‡ -amylase is available from the company Novozymes under the trade name DuramylĀ® and TermamylĀ®ultra, from the company Danisco / Genencor under the name PurastarĀ®OxAm and from the company Daiwa Seiko Inc., Tokyo, Japan, as KeistaseĀ®.
  • the Bacillus amyloliquefaciens ā‡ -amylase is sold by the company Novozymes under the name BANĀ®, and variants derived from the Bacillus stearothermophilus ā‡ -amylase under the names BSGĀ® and NovamylĀ®, also from the company Novozymes. Furthermore, for this purpose, the ā‡ -amylase from Bacillus sp.
  • a 7-7 (DSM 12368) and cyclodextrin glucanotransferase (CGTase) from Bacillus agaradherens (DSM 9948).
  • CCTase cyclodextrin glucanotransferase
  • fusion products of all the molecules mentioned can be used.
  • the further developments of the ā‡ -amylase from Aspergillus niger and A. oryzae available under the trade name FungamylĀ® from the company Novozymes are suitable.
  • Further advantageously usable commercial products are, for example, the amylase-LTĀ® and StainzymeĀ® or Stainzyme ultraĀ® or Stainzyme plusĀ®, the latter also from the company Novozymes.
  • variants of these enzymes obtainable by point mutations can be used according to the invention.
  • amylases are disclosed in International Publications WO 00/60060 . WO 03/002711 . WO 03/054177 and WO07 / 079938 , whose disclosure is therefore expressly referred to, or whose disclosure in this regard is therefore expressly incorporated into the present patent application. Further, amylases which can be synthesized according to the invention are preferably .alpha.-amylases.
  • lipases or cutinases which can be synthesized according to the invention, which are contained in particular because of their triglyceride-cleaving activities, but also in order to generate in situ peracids from suitable precursors, are the lipases which are originally obtainable from Humicola lanuginosa (Thermomyces lanuginosus) or further developed, in particular those with the amino acid exchange D96L. They are sold for example by the company Novozymes under the trade names LipolaseĀ®, LipolaseĀ®Ultra, LipoPrimeĀ®, LipozymeĀ® and LipexĀ®. Furthermore, for example, the cutinases can be used, which were originally isolated from Fusarium solani pisi and Humicola insolens.
  • the lipases or cutinases can be used whose initial enzymes were originally isolated from Pseudomonas mendocina and Fusarium solanii.
  • Other important commercial products are the preparations M1 Lipase.RTM. And Lipomax.RTM.
  • Lipase MY-30Ā®, Lipase OFĀ® and Lipase PLĀ® to mention also the product LumafastĀ® from the company Genencor.
  • Detergents or cleaning agents according to the invention may also contain cellulases, depending on the purpose, as pure enzymes, as enzyme preparations or in the form of mixtures in which the individual components advantageously supplement each other in terms of their various performance aspects.
  • These performance aspects include, in particular, contributions to the primary washing performance, the secondary washing performance of the composition (anti-redeposition effect or graying inhibition) and softening (fabric effect), up to the exercise of a "stone washed" effect.
  • Cellulases (endoglucanases, EG) which can be synthesized according to the invention comprise, for example, the fungal cellulase preparation rich in endoglucanase (EG) or its further developments, which is offered by the company Novozymes under the trade name CelluzymeĀ®. EndolaseĀ® and CarezymeĀ®, also available from Novozymes, are based on the 50 kD EG or 43 kD EG from Humicola insolens DSM 1800. Further commercial products of this company are CellusoftĀ®, RenozymeĀ® and CellucleanĀ®.
  • cellulases available from the company AB Enzymes, Finland, under the trade names EcostoneĀ® and BiotouchĀ®, which are based, at least in part, on the 20 kD-EG of melanocarpus.
  • Other cellulases from AB Enzymes are EconaseĀ® and EcopulpĀ®.
  • Other suitable cellulases are from Bacillus sp. CBS 670.93 and CBS 669.93, those derived from Bacillus sp. CBS 670.93 is available from the company Danisco / Genencor under the trade name PuradaxĀ®.
  • Other usable commercial products of the company Danisco / Genencor are "Genencor detergent cellulase L" and IndiAgeĀ®Neutra.
  • cellulases are Thielavia terrestris cellulase variants described in International Publication WO 98/12307 Cellulases from Melanocarpus, in particular Melanocarpus albomyces, disclosed in the international publication WO 97/14804 Cellulases of the EGIII type from Trichoderma reesei disclosed in the European patent application EP 1 305 432 and variations obtainable therefrom, in particular those disclosed in the European patent applications EP 1240525 and EP 1305432 , as well as cellulases, which are disclosed in international publications WO 1992006165 .
  • WO 96/29397 and WO 02/099091 On their respective disclosure is therefore expressly referenced or their disclosure in this regard is therefore expressly included in the present patent application.
  • Suitable enzymes for this purpose are available, for example, under the name GamanaseĀ® and Pektinex ARĀ® from Novozymes, under the name RohapecĀ® B1L from AB Enzymes and under the name PyrolaseĀ® from Diversa Corp., San Diego, CA, USA ,
  • the ā‡ -glucanase obtained from Bacillus subtilis is available under the name CerefloĀ® from Novozymes.
  • Hemicellulases which are particularly preferred according to the invention are mannanases which are sold, for example, under the trade names MannawayĀ® by the company Novozymes or PurabriteĀ® by the company Genencor.
  • a surfactant preparation according to the invention may also contain oxidoreductases, for example oxidases, oxygenases, catalases (which react as peroxidase at low H 2 O 2 concentrations), peroxidases, such as halo-, chloro-, bromo-, lignin-, glucose- or manganese peroxidases, dioxygenases or laccases (phenol oxidases, polyphenol oxidases).
  • Suitable commercial products are DeniliteĀ® 1 and 2 from Novozymes.
  • advantageous systems for enzymatic perhydrolysis can be applied to the applications WO 98/45398 A1 .
  • WO 2005/056782 A2 such as WO 2004/058961 A1 directed.
  • a combined enzymatic bleaching system comprising an oxidase and a perhydrolase describes the application WO 2005/124012 .
  • organic, particularly preferably aromatic, compounds which interact with the enzymes in order to enhance the activity of the relevant oxidoreductases (enhancers) or to ensure the flow of electrons (mediators) at greatly varying redox potentials between the oxidizing enzymes and the soils.
  • the enzymes to be used according to the invention may also be formulated together with accompanying substances, for example from the fermentation, or with stabilizers and incorporated in such a formulation in a surfactant preparation according to the invention.
  • a further subject of the invention is the use of a surfactant preparation according to the invention for the removal of stains, in particular of lipase-sensitive stains, on textiles or hard surfaces, ie for the cleaning of textiles or of hard surfaces.
  • surfactant preparations according to the invention may be used, in particular because of the combination of phosphonate and lipase, advantageously in order to remove impurities from textiles or from hard surfaces.
  • Embodiments of this subject invention include, for example, hand washing, manual removal of stains from textiles or hard surfaces, or use in conjunction with a machine process.
  • a further subject of the invention is a process for the cleaning of textiles or hard surfaces or for disinfection, wherein in at least one process step a surfactant preparation according to the invention is used.
  • the invention furthermore relates to a process, in particular a washing, cleaning or disinfecting process, in which a wash liquor which comprises a phosphonate and a lipase which is naturally present in a microorganism, the microorganism being Rhizopus oryzae or Mucorjavanicus, is contacted with a lipase-sensitive soil or germ on a textile or hard surface.
  • a wash liquor which comprises a phosphonate and a lipase which is naturally present in a microorganism, the microorganism being Rhizopus oryzae or Mucorjavanicus
  • Processes for cleaning textiles are generally characterized in that one or more cleaning-active substances are applied to the items to be cleaned and washed off after the action time.
  • the cleaning product is treated with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes.
  • the germ to be killed is brought into contact with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes.
  • a method according to the invention is characterized in that the lipase is present in the wash liquor in a concentration of 0.0000003 to 0.0004 wt .-%, preferably from 0.0000005 to 0.0003 wt .-%, wherein the Details are based on active protein in the wash liquor.
  • a method according to the invention is characterized in that it is carried out at a temperature between 10 Ā° C and 80 Ā° C, preferably between 10 Ā° C and 70 Ā° C and more preferably between 20 Ā° C and 60 Ā° C.
  • Lipases provided according to the invention are advantageously usable in surfactant preparations according to the invention and processes, in particular washing, cleaning or disinfection processes. They can therefore be used advantageously to provide lipolytic activity in corresponding preparations.
  • Another object of the invention is the use of a lipase naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus, for providing a lipolytic activity in a liquid surfactant preparation further comprising a phosphonate.
  • Another object of the invention is the use of a lipase, which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus, for the removal of lipase-sensitive stains on textiles or hard surfaces or for disinfection in a wash liquor, which further comprises a phosphonate.
  • the detergent base formulation used was a phosphonate-containing liquid detergent of the following composition (all figures in percent by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0 , 3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda, 14-16% coconut oil.
  • This detergent base formulation was added to the following series of lipases for the various series of experiments in an activity-identical manner to 0.35% by weight of Lipex 100L (lipase preparation from Novozymes (batch 4 as reference): Lipase M-AP10Ā® (batch 1), Lipase LE Ā® (batch 2) and Lipase FĀ® (also Lipase JVĀ®, batch 3), all available from Amano Pharmaceuticals.

Description

Die Erfindung liegt auf dem Gebiet der flĆ¼ssigen enzymhaltigen Tensidzubereitungen, wie sie zum Beispiel beim Waschen, Reinigen oder Desinfizieren Verwendung finden. Die Erfindung betrifft insbesondere flĆ¼ssige enzymhaltige Tensidzubereitungen, die definierte Lipasen in Kombination mit einem Phosphonat enthalten, und schlƤgt ferner Verwendungen und Verfahren vor, in denen solche Zubereitungen angewendet werden. Die Erfindung betrifft ferner Verwendungen definierter Lipasen in flĆ¼ssigen Tensidzubereitungen, die ein Phosphonat enthalten.The invention is in the field of liquid enzyme-containing surfactant preparations, as used for example in washing, cleaning or disinfecting. More particularly, the invention relates to liquid enzyme-containing surfactant formulations containing defined lipases in combination with a phosphonate, and further proposes uses and methods in which such formulations are employed. The invention further relates to uses of defined lipases in liquid surfactant formulations containing a phosphonate.

In Tensidzubereitungen, insbesondere in modernen FlĆ¼ssigwaschmitteln, aber auch in Reinigungs-oder Desinfektionsmitteln, sind oftmals Phosphonate enthalten. Sie werden beispielsweise als Komplexbildner, zur Verhinderung von AusfƤllungen oder als Bleichmittelstabilisator eingesetzt. Als Komplexbildner dienen sie beispielsweise als WasserenthƤrter. Sie kƶnnen Kationen wie Ca2+ in der Lƶsung ummanteln und damit das chemische Verhalten des Kations verƤndern. Im Fall von Calcium verschwindet die Eigenschaft WasserhƤrte zu bilden. Auch andere Kationen kƶnnen komplexiert und damit vor chemischen Reaktionen geschĆ¼tzt werden. Sie kƶnnen ferner als Korrosionsinhibitoren mitwirken oder als Stabilisator fĆ¼r Peroxide, insbesondere in Bleichmitteln, dienen.Surfactant preparations, in particular in modern liquid detergents, but also in detergents or disinfectants, often contain phosphonates. They are used, for example, as complexing agents, to prevent precipitation or as a bleach stabilizer. As complexing agents they serve, for example, as water softeners. They can encase cations such as Ca 2+ in the solution and thus alter the chemical behavior of the cation. In the case of calcium, the property of water hardness disappears. Other cations can be complexed and thus protected against chemical reactions. They can also participate as corrosion inhibitors or serve as a stabilizer for peroxides, especially in bleaching agents.

Ferner werden in Tensidzubereitungen, insbesondere in Wasch- oder Reinigungsmitteln, zunehmend Lipasen eingesetzt. Eine Lipase ist ein Enzym, das die Hydrolyse von Esterbindungen in Lipid-Substraten, insbesondere in Fetten und Ɩlen, katalysiert. Lipasen stellen daher eine Gruppe der Esterasen dar. Lipasen sind im Allgemeinen vielseitige Enzyme, die eine Vielzahl an Substraten akzeptieren, beispielsweise aliphatische, alizyklische, bizyklische und aromatische Ester, Thioester und aktivierte Amine. Lipasen wirken gegen FettrĆ¼ckstƤnde in der WƤsche katalysieren deren Hydrolyse (Lipolyse). Lipasen mit breiten Substratspektren werden insbesondere dort verwendet, wo inhomogene Rohstoffe oder Substratgemische umgesetzt werden mĆ¼ssen, also beispielsweise in Wasch- und Reinigungsmitteln, da Verschmutzungen aus unterschiedlich aufgebauten Fetten und Ɩlen bestehen kƶnnen. Die in den aus dem Stand der Technik bekannten Wasch- oder Reinigungsmitteln eingesetzten Lipasen sind Ć¼blicherweise mikrobiellen Ursprungs und stammen in der Regel aus Bakterien oder Pilzen, beispielsweise der Gattungen Bacillus, Pseudomonas, Acinetobacter, Micrococcus, Humicola, Trichoderma oder Trichosporon. Lipasen werden Ć¼blicherweise nach an sich bekannten biotechnologischen Verfahren durch geeignete Mikroorganismen produziert, beispielsweise durch transgene Expressionswirte der Gattungen Bacillus oder durch filamentƶse Pilze.Furthermore, lipase is increasingly used in surfactant preparations, in particular in detergents or cleaners. A lipase is an enzyme that catalyzes the hydrolysis of ester bonds in lipid substrates, especially in fats and oils. Lipases are therefore a group of esterases. Lipases are generally versatile enzymes that accept a variety of substrates, for example, aliphatic, alicyclic, bicyclic and aromatic esters, thioesters and activated amines. Lipases act against fat residues in the laundry to catalyze their hydrolysis (lipolysis). Lipases with broad substrate spectra are used in particular where inhomogeneous raw materials or substrate mixtures have to be reacted, for example in detergents and cleaners, since soiling may consist of differently structured fats and oils. The lipases used in the washing or cleaning agents known from the prior art are usually of microbial origin and are usually derived from bacteria or fungi, for example the genera Bacillus, Pseudomonas, Acinetobacter, Micrococcus, Humicola, Trichoderma or Trichosporon. Lipases are usually produced by biotechnological methods known per se by suitable microorganisms, for example by transgenic expression hosts of the genera Bacillus or by filamentous fungi.

In der europƤischen Patentanmeldung EP 443063 ist beispielsweise eine fĆ¼r Wasch- und Reinigungsmittel vorgesehene Lipase aus Pseudomonas sp. ATCC 21808 offenbart, jedoch nicht explizit fĆ¼r den Einsatz in einer Phosphonat-haltigen FlĆ¼ssigformulierung. In der japanischen Patentanmeldung JP 1225490 ist eine Lipase aus Rhizopus oryzae offenbart. Jedoch geht auch aus dieser Schrift keine konkrete flĆ¼ssige Tensidzubereitung hervor, die zwingend ein Phosphonat in Kombination mit einer Lipase aus Rhizopus oryzae enthƤlt.In the European patent application EP 443063 is, for example, intended for detergents and cleaners lipase from Pseudomonas sp. ATCC 21808, but not explicitly for use in a phosphonate-containing liquid formulation. In the Japanese patent application JP 1225490 is a lipase from Rhizopus oryzae disclosed. However, this document also does not disclose a specific liquid surfactant preparation which necessarily contains a phosphonate in combination with a Rhizopus oryzae lipase.

WO037097780 offenbart Kombinationen bestimmter Lipasen mit Ɯbergangsmetallbleichkatalysatoren zur Erhƶhung der Reinigungsleistung. WO2005/124012 offenbart ein enzymatisches Bleichsystem enthaltend Phosphonat, mindestens eine Oxidase und mindestens eine Perhydrolase, sowie deren Verwendung in verschiedenen Pflege- und Reinigungsmitteln. Lipasen aus Rhizopus oryzae oder Mucor javanicus werden jedoch in beiden Dokumenten nicht erwƤhnt. WO2004/053039 offenbart Waschmittelzusammensetzungen enthaltend eine Kombination aus einer Endoglucanase und einer Rhizopus oryzae Lipase. Diese Waschmittelzusammensetzungen enthalten jedoch keine Phosphonate. DE 102007003143 offenbart alkalische Proteasen aus Bacillus gibsonii, und deren Verwendung in Wasch-und Reinigungsmitteln, sowie deren Kombination mit Lipasen. Eine flĆ¼ssige Tensidzubereitung die ein Phosphonat in Kombination mit einer Lipase aus Rhizopus oryzae oder Mucor javanicus enthƤlt geht jedoch ebenfalls nicht aus dieser Schrift hervor. WO037097780 discloses combinations of certain lipases with transition metal bleach catalysts to increase cleaning performance. WO2005 / 124012 discloses an enzymatic bleaching system containing phosphonate, at least one oxidase and at least one perhydrolase, and their use in various care and cleaning agents. However, lipases from Rhizopus oryzae or Mucor javanicus are not mentioned in either document. WO2004 / 053039 discloses detergent compositions containing a combination of an endoglucanase and a Rhizopus oryzae lipase. However, these detergent compositions do not contain phosphonates. DE 102007003143 discloses alkaline proteases from Bacillus gibsonii, and their use in detergents and cleaners, as well as their combination with lipases. However, a liquid surfactant preparation containing a phosphonate in combination with a lipase from Rhizopus oryzae or Mucor javanicus is also not apparent from this document.

Generell sind nur ausgewƤhlte Lipasen fĆ¼r den Einsatz in flĆ¼ssigen Tensidzubereitungen Ć¼berhaupt geeignet. Viele Lipasen zeigen in derartigen Zubereitungen keine ausreichende katalytische Leistung oder StabilitƤt. In Phosphonat-haltigen flĆ¼ssigen Tensidzubereitungen ist diese Problematik noch gravierender, beispielsweise auf Grund der komplexbildenden Eigenschaften der Phosphonate oder auf Grund von unvorteilhaften Wechselwirkungen zwischen dem Phosphonat und der Lipase.In general, only selected lipases are suitable for use in liquid surfactant preparations. Many lipases do not show sufficient catalytic performance or stability in such formulations. In phosphonate-containing liquid surfactant preparations, this problem is even more serious, for example due to the complex-forming properties of the phosphonates or due to unfavorable interactions between the phosphonate and the lipase.

Folglich haben lipasehaltige flĆ¼ssige Tensidzubereitungen aus dem Stand der Technik, insbesondere solche mit Phosphonaten, den Nachteil, dass sie oftmals keine zufriedenstellende lipolytische AktivitƤt aufweisen und die Tensidzubereitung daher keine optimale Reinigungsleistung an lipase-sensitiven Anschmutzungen zeigt.Consequently, lipase-containing liquid surfactant preparations of the prior art, in particular those containing phosphonates, have the disadvantage that they often do not have satisfactory lipolytic activity and therefore the surfactant preparation does not show optimal cleaning performance on lipase-sensitive soils.

Der vorliegenden Erfindung liegt die Aufgabe zugrunde, den genannten Nachteil zu Ć¼berwinden und eine Phosphonat-haltige flĆ¼ssige Tensidzubereitung bereitzustellen, die eine vorteilhafte lipolytische AktivitƤt aufweist.The object of the present invention is to overcome the mentioned disadvantage and to provide a phosphonate-containing liquid surfactant preparation which has a beneficial lipolytic activity.

Ein Gegenstand der Erfindung ist eine flĆ¼ssige Tensidzubereitung umfassend ein Phosphonat und eine Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucorjavanicus ist.An object of the invention is a liquid surfactant preparation comprising a phosphonate and a lipase which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus.

Ɯberraschenderweise wurde festgestellt, dass eine flĆ¼ssige Tensidzubereitung, welche die Kombination einer derartigen Lipase mit einem Phosphonat enthƤlt, vorteilhafte Reinigungsleistungen an lipase-sensitiven Anschmutzungen aufweist. Vorteilhafterweise zeigt eine derartige Tensidzubereitung eine verbesserte Reinigungsleistung an mindestens einer, vorzugsweise an mehreren lipase-sensitiven Anschmutzungen, insbesondere auf Textilien und/oder harten OberflƤchen. In einer bevorzugten Ausgestaltung ist eine erfindungsgemƤƟe Tensidzubereitung zudem vorteilhaft lagerstabil. Weitere bevorzugte AusfĆ¼hrungsformen erfindungsgemƤƟer Tensidzubereitungen zeigen eine vorteilhafte Reinigungsleistung hinsichtlich mindestens einer lipase-sensitiven Anschmutzung bei Temperaturen zwischen 10Ā°C und 80Ā°C, vorzugsweise auch bei niedrigen Temperaturen, beispielsweise zwischen 10Ā°C und 50Ā°C, zwischen 10Ā°C und 40Ā°C oder zwischen 20Ā°C und 40Ā°C. Hinsichtlich des einleitend erwƤhnten Standes der Technik handelt es bei der vorliegenden Erfindung daher um eine besonders vorteilhafte Auswahl von einer Lipase fĆ¼r eine Phosphonat-haltige flĆ¼ssige Tensidzubereitung.Surprisingly, it has been found that a liquid surfactant preparation which contains the combination of such a lipase with a phosphonate has advantageous cleaning performance on lipase-sensitive soiling. Advantageously, such a surfactant preparation exhibits an improved cleaning performance on at least one, preferably on several lipase-sensitive stains, in particular on textiles and / or hard surfaces. In a preferred embodiment, a surfactant preparation according to the invention is also advantageously storage-stable. Further preferred embodiments of inventive surfactant formulations show an advantageous cleaning performance with respect to at least one lipase-sensitive soiling at temperatures between 10 Ā° C and 80 Ā° C, preferably also at low temperatures, for example between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C or between 20 Ā° C and 40 Ā° C. With regard to the prior art mentioned in the introduction, the present invention is therefore a particularly advantageous selection of a lipase for a phosphonate-containing liquid surfactant preparation.

Unter Reinigungsleistung wird im Rahmen der Erfindung die Aufhellungsleistung an einer oder mehreren Anschmutzungen, insbesondere WƤscheanschmutzungen oder Geschirranschmutzungen, verstanden, die sensitiv sind fĆ¼r den Abbau durch die Lipase. Beispiele fĆ¼r solche Anschmutzungen sind RuƟ/Mineralƶl, RuƟ/Olivenƶl, Pigment/ƖI oder Hautfett (Sebum)/Kohlenschwarz, jeweils beispielsweise auf Baumwollgewebe, insbesondere derart wie weiter unten angegeben. Im Rahmen der Erfindung weist sowohl die Tensidzubereitung, welche die Lipase umfasst bzw. die durch diese Tensidzubereitung gebildete Wasch- bzw. Reinigungsflotte, als auch die Lipase selbst eine jeweilige Reinigungsleistung auf. Die Reinigungsleistung der Lipase trƤgt somit zur Reinigungsleistung der Tensidzubereitung bzw. der durch die Tensidzubereitung gebildeten Wasch- bzw. Reinigungsflotte bei. Die Reinigungsleistung wird bevorzugt ermittelt wie weiter unten angegeben.In the context of the invention, cleaning performance is understood to mean the whitening performance of one or more soiling, in particular laundry soiling or scrape dirt, which are sensitive to degradation by the lipase. Examples of such stains are carbon black / mineral oil, carbon black / olive oil, pigment / oil or skin fat (sebum) / carbon black, in each case for example on cotton fabric, in particular as indicated below. In the context of the invention, both the surfactant preparation, which comprises the lipase or the washing or cleaning liquor formed by this surfactant preparation, and the lipase itself have a respective cleaning performance. The cleaning performance of the lipase thus contributes to the cleaning performance of the surfactant preparation or the washing or cleaning liquor formed by the surfactant preparation. The cleaning performance is preferably determined as indicated below.

Unter Wasch- bzw. Reinigungsflotte wird diejenige die Tensidzubereitung enthaltende Gebrauchslƶsung verstanden, die auf Textilien oder Gewebe (Waschflotte) bzw. harte OberflƤchen (Reinigungsflotte) einwirkt und damit mit den auf Textilien bzw. Geweben oder harten OberflƤchen vorhandenen Anschmutzungen in Kontakt kommt. Ɯblicherweise entsteht die Wasch- bzw. Reinigungsflotte, wenn der Wasch- oder Reinigungsvorgang beginnt und die Tensidzubereitung, insbesondere das Wasch- oder Reinigungsmittel, beispielsweise in einer Waschmaschine, GeschirrspĆ¼lmaschine oder in einem anderen geeigneten BehƤltnis mit Wasser verdĆ¼nnt wird.Washing or cleaning liquor is understood as meaning the use solution containing the surfactant preparation which acts on textiles or fabrics (wash liquor) or hard surfaces (cleaning liquor) and thus comes into contact with the soiling present on textiles or fabrics or hard surfaces. Usually, the washing or cleaning liquor arises when the washing or cleaning process begins and the surfactant preparation, in particular the detergent or cleaning agent, for example, in a washing machine, dishwasher or other suitable container is diluted with water.

Eine in einer erfindungsgemƤƟen Tensidzubereitung enthaltene Lipase weist eine lipolytische AktivitƤt auf, das heiƟt, sie ist zur Hydrolyse (Lipolyse) von Lipiden wie Glyceriden oder Cholesterinestern befƤhigt. Ferner ist die in einer erfindungsgemƤƟen Tensidzubereitung enthaltene Lipase natĆ¼rlicherweise in einem Mikroorganismus der Art Rhizopus oryzae oder Mucor javanicus vorhanden. NatĆ¼rlicherweise vorhanden bedeutet in diesem Zusammenhang, dass die Lipase ein eigenes Enzym des Mikroorganismus ist. Die Lipase kann folglich in dem Mikroorganismus von einer NukleinsƤuresequenz exprimiert werden, die Teil der chromosomalen DNA des Mikroorganismus in seiner Wildtyp-Form ist. Sie bzw. die fĆ¼r sie codierende NukleinsƤuresequenz ist folglich in der Wildtyp-Form des Mikroorganismus vorhanden und/oder kann aus der Wildtyp-Form des Mikroorganismus aus diesem isoliert werden. Im Gegensatz hierzu wƤre eine nicht natĆ¼rlicherweise in dem Mikroorganismus vorhandene Lipase bzw. die fĆ¼r sie codierende NukleinsƤuresequenz mit Hilfe gentechnischer Verfahren in den Mikroorganismus gezielt eingebracht worden, so dass der Mikroorganismus um die Lipase bzw. die fĆ¼r sie codierende NukleinsƤuresequenz bereichert worden wƤre. Jedoch kann eine Lipase, die natĆ¼rlicherweise in einem Mikroorganismus der Art Rhizopus oryzae oder Mucor javanicus vorhanden ist, aber durchaus rekombinant von einem anderen Organismus hergestellt worden sein.A lipase contained in a surfactant preparation according to the invention has a lipolytic activity, that is, it is capable of hydrolysis (lipolysis) of lipids such as glycerides or cholesterol esters. Furthermore, the lipase contained in a surfactant preparation according to the invention is naturally present in a microorganism of the species Rhizopus oryzae or Mucor javanicus. Naturally present in this context means that the lipase is a separate enzyme of the microorganism. The lipase can thus be expressed in the microorganism from a nucleic acid sequence which is part of the chromosomal DNA of the microorganism in its wild-type form. It or the coding for them nucleic acid sequence is therefore present in the wild-type form of the microorganism and / or can be isolated from the wild-type form of the microorganism from this. In contrast to this, a lipase or the nucleic acid sequence coding for it in the microorganism would be incorporated into the microorganism by means of genetic engineering have been deliberately introduced so that the microorganism would have been enriched to the lipase or the coding for them nucleic acid sequence. However, a lipase naturally present in a microorganism of the genus Rhizopus oryzae or Mucor javanicus may well have been produced recombinantly from another organism.

Der Pilz Rhizopus oryzae zƤhlt zur Klasse der Zygomyceten (Unterklasse Incertae sedis), hierin zur Ordnung Mucorales und hierin wiederum zur Familie Mucoraceae und der Gattung Rhizopus. Der Pilz Mucorjavanicus zƤhlt ebenfalls zur Klasse der Zygomyceten (Unterklasse Incertae sedis), hierin zur Ordnung Mucorales und hierin wiederum zur Familie Mucoraceae, hierin dann zur Gattung Mucor. Die Bezeichnungen Rhizopus oryzae und Mucorjavanicus sind die biologischen Artbezeichnungen innerhalb der jeweiligen Gattung.The fungus Rhizopus oryzae belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae and the genus Rhizopus. The fungus Mucorjavanicus also belongs to the class of Zygomycetes (subclass Incertae sedis), herein to the order Mucorales and here again to the family Mucoraceae, then herein to the genus Mucor. The names Rhizopus oryzae and Mucorjavanicus are the biological species names within the respective genus.

Phosphonate sind Salze und organische Verbindungen, insbesondere Ester, der PhosphonsƤure. Als Salze existieren primƤre (M'H2PO3 bzw. HP(O)(OH)(OM')) und sekundƤre (M'2HPO3 bzw. HP(O)(OM')2) Phosphonate, wobei M' fĆ¼r ein einwertiges Metall steht. Diese anorganischen Phosphonate werden auch als primƤre bzw. sekundƤre Phosphite bezeichnet. Anorganische Phosphonate entstehen beispielsweise durch Umsetzung von PhosphonsƤure HP(O)(OH)2, insbesondere der stabilen tautomeren Form der PhosphorigsƤure mit einem (primƤre) oder zwei (sekundƤre) Ƅquivalenten Base, beispielsweise Alkalimetallhydroxid.Phosphonates are salts and organic compounds, especially esters, of phosphonic acid. As salts there exist primary (M'H 2 PO 3 or HP (O) (OH) (OM ')) and secondary (M' 2 HPO 3 or HP (O) (OM ') 2 ) phosphonates, where M' stands for a monovalent metal. These inorganic phosphonates are also referred to as primary and secondary phosphites, respectively. Inorganic phosphonates are formed, for example, by reaction of phosphonic acid HP (O) (OH) 2 , in particular the stable tautomeric form of phosphorous acid with a (primary) or two (secondary) equivalents of base, for example alkali metal hydroxide.

Im Rahmen der vorliegenden Erfindung bevorzugt sind organisch P-substituierte Phosphonate, die eine Phosphor-Kohlenstoff-Bindung aufweisen (Phosphor-organische Verbindungen). Ihre allgemeine Struktur ist R1 P(O)(OR2)2, mit R1 und/oder R2 = Alkyl, Aryl oder H, wobei die Alkyl- bzw. Arylreste weitere Substitutionen aufweisen oder weitere chemische Gruppen tragen kƶnnen. Organisch P-substituierte Phosphonate entstehen beispielsweise durch Michaelis-Arbusov-Reaktion. Viele dieser Phosphonate sind lƶslich in Wasser. Einige technisch wichtige Phosphonate tragen ferner Amino-Gruppe(n). Einige diese Aminophosphonate haben strukturelle Ƅhnlichkeiten mit Komplexbildnern wie EDTA, NTA oder DTPA und haben eine Ƥhnliche Funktion.In the context of the present invention, preference is given to organic P-substituted phosphonates which have a phosphorus-carbon bond (phosphorus-organic compounds). Their general structure is R1P (O) (OR2) 2 , with R1 and / or R2 = alkyl, aryl or H, where the alkyl or aryl radicals can have further substitutions or carry further chemical groups. Organic P-substituted phosphonates are formed, for example, by the Michaelis-Arbusov reaction. Many of these phosphonates are soluble in water. Some technically important phosphonates also carry amino group (s). Some of these aminophosphonates have structural similarities to complexing agents such as EDTA, NTA or DTPA and have a similar function.

Besonders bevorzugte Phosphonate im Rahmen der vorliegenden Erfindung sind 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP), AminotrimethylenphosphonsƤure (ATMP), NitrilotrimethylenphosphonsƤure (NTMP), DiethylentriaminpentamethylenphosphonsƤure (DTPMP, DETPMP oder DTPNT), EthylendiamintetramethylenphosphonsƤure (EDTMP) sowie 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM, auch bezeichnet als 3-Carboxy-3-phosphonoadipinsƤure), die zumeist in Form ihrer Ammonium- oder Alkalimetallsalze eingesetzt werden. Ferner kƶnnen Kombinationen der Phosphonate eingesetzt werden.Particularly preferred phosphonates in the context of the present invention are 1-hydroxyethane-1,1-diphosphonic acid (HEDP), aminotrimethylenephosphonic acid (ATMP), nitrilotrimethylenephosphonic acid (NTMP), diethylenetriaminepentamethylenephosphonic acid (DTPMP, DETPMP or DTPNT), ethylenediamine tetramethylenephosphonic acid (EDTMP) and 2-phosphonobutane. 1,2,4-tricarboxylic acid (PBS-AM, also referred to as 3-carboxy-3-phosphonoadipic acid), which are usually used in the form of their ammonium or alkali metal salts. Furthermore, combinations of the phosphonates can be used.

Besonders bevorzugt sind DiethylentriaminpentamethylenphosphonsƤure-Natrium (DTPMP), insbesondere fĆ¼r erfindungsgemƤƟe Tensidzubereitungen, die Waschmittel darstellen, und/oder 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP), insbesondere fĆ¼r erfindungsgemƤƟe Tensidzubereitungen, die Wasch- oder GeschirrspĆ¼lmittel, insbesondere maschinelle GeschirrspĆ¼lmittel, darstellen. Derartige Phosphonate sind beispielsweise unter den Handelsnamen DequestĀ® 2066 und DequestĀ® 2010 (jeweils Firma Thermphos) erhƤltlich.Particular preference is given to diethylenetriaminepentamethylenephosphonic acid sodium (DTPMP), in particular for surfactant preparations according to the invention which are detergents, and / or 1-hydroxyethane-1,1-diphosphonic acid (HEDP), in particular for surfactant preparations according to the invention which contain washing or dishwashing detergents, in particular automatic dishwasher detergents, represent. Such phosphonates are available, for example, under the trade names DequestĀ® 2066 and DequestĀ® 2010 (each from Thermphos).

In einerweiteren AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass die Lipase eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% identisch ist. Zunehmend bevorzugt ist die AminosƤuresequenz zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz. SEQ ID NO. 1 ist die Sequenz einer reifen (maturen) Lipase aus Rhizopus oryzae.In a further embodiment of the invention, the surfactant preparation is characterized in that the lipase has an amino acid sequence which corresponds to the amino acid sequence shown in SEQ ID NO. 1 amino acid sequence is at least 80% identical. More preferably, the amino acid sequence is at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95% %, 96%, 97%, 98%, 99% and most preferably 100% identical to that shown in SEQ ID NO. 1 indicated amino acid sequence. SEQ ID NO. 1 is the sequence of a mature (mature) lipase from Rhizopus oryzae.

ErfindungsgemƤƟ ganz besonders bevorzugte Lipasen sind die von dem Unternehmen Amano Pharmaceuticals unter den Bezeichnungen Lipase M-AP10Ā®, Lipase LEĀ® und Lipase FĀ® (auch Lipase JVĀ®) erhƤltlichen Lipaseenzyme. Die Lipase FĀ® ist beispielsweise natĆ¼rlicherweise in Rhizopus oryzae vorhanden. Die Lipase M-AP10Ā® ist beispielsweise natĆ¼rlicherweise in Mucor javanicus vorhanden.Lipases which are very particularly preferred according to the invention are the lipase enzymes obtainable from the company Amano Pharmaceuticals under the names Lipase M-AP10Ā®, Lipase LEĀ® and Lipase FĀ® (also Lipase JVĀ®). For example, the Lipase FĀ® is naturally present in Rhizopus oryzae. For example, the lipase M-AP10Ā® is naturally present in Mucor javanicus.

ErfindungsgemƤƟ hat sich gezeigt, dass durch den Zusatz einer derartigen Lipase zu einer flĆ¼ssigen Tensidzubereitung, welche ein Phosphonat enthƤlt, insbesondere eines wie vorstehend beschrieben, eine besonders vorteilhafte lipolytische AktivitƤt in dieser Zubereitung bereitgestellt wird. Ferner sind derartige Tensidzubereitungen ausreichend lagerstabil, insbesondere hinsichtlich deren verbleibender lipolytischer AktivitƤt nach Lagerung, insbesondere nach einer Lagerdauer von 1 bis 5 Wochen, 1 bis 4 Wochen, 1,5 bis 3 Wochen und besonders bevorzugt nach 2 Wochen.According to the invention, it has been found that the addition of such a lipase to a liquid surfactant preparation which comprises a phosphonate, in particular one as described above, provides a particularly advantageous lipolytic activity in this preparation. Furthermore, such surfactant preparations are sufficiently stable on storage, in particular with regard to their remaining lipolytic activity after storage, in particular after a storage period of 1 to 5 weeks, 1 to 4 weeks, 1.5 to 3 weeks and particularly preferably after 2 weeks.

Besonders bevorzugte Kombinationen von Lipase und Phosphonat in erfindungsgemƤƟen Tensidzubereitungen sind:

  • Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP);
  • Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit AminotrimethylenphosphonsƤure (ATMP);
  • Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit NitrilotrimethylenphosphonsƤure (NTMP);
  • Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit DiethylentriaminpentamethylenphosphonsƤure (DTPMP);
  • Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit EthylendiamintetramethylenphosphonsƤure (EDTMP);
  • Lipase, die eine AminosƤuresequenz aufweist, die zu der in SEQ ID NO. 1 angegebenen AminosƤuresequenz zu mindestens 80% und zunehmend bevorzugt zu mindestens 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% und ganz besonders bevorzugt zu 100% identisch ist in Kombination mit 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM);
  • Lipase M-AP10Ā® in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP) oder AminotrimethylenphosphonsƤure (ATMP) oder NitrilotrimethylenphosphonsƤure (NTMP) oder DiethylentriaminpentamethylenphosphonsƤure (DTPMP) oder EthylendiamintetramethylenphosphonsƤure (EDTMP) oder 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM);
  • Lipase LEĀ® in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP) oder AminotrimethylenphosphonsƤure (ATMP) oder NitrilotrimethylenphosphonsƤure (NTMP) oder DiethylentriaminpentamethylenphosphonsƤure (DTPMP) oder EthylendiamintetramethylenphosphonsƤure (EDTMP) oder 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM);
  • Lipase FĀ® in Kombination mit 1-Hydroxyethan-1,1-diphosphonsƤure (HEDP) oder AminotrimethylenphosphonsƤure (ATMP) oder NitrilotrimethylenphosphonsƤure (NTMP) oder DiethylentriaminpentamethylenphosphonsƤure (DTPMP) oder EthylendiamintetramethylenphosphonsƤure (EDTMP) oder 2-Phosphonobutan-1,2,4-tricarbonsƤure (PBS-AM).
Particularly preferred combinations of lipase and phosphonate in surfactant preparations according to the invention are:
  • Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP);
  • Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with aminotrimethylene phosphonic acid (ATMP);
  • Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99% and most preferably 100% identical in combination with nitrilotrimethylene phosphonic acid (NTMP);
  • Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with diethylenetriaminepentamethylenephosphonic acid (DTPMP);
  • Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99% and most preferably 100% identical in combination with ethylenediamine tetramethylene phosphonic acid (EDTMP);
  • Lipase having an amino acid sequence corresponding to that shown in SEQ ID NO. At least 80% and more preferably at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96%, 97%, 98%, 99%, and most preferably 100% identical in combination with 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM);
  • Lipase M-AP10Ā® in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP) or aminotrimethylenephosphonic acid (ATMP) or nitrilotrimethylenephosphonic acid (NTMP) or diethylenetriaminepentamethylenephosphonic acid (DTPMP) or ethylenediamine tetramethylene phosphonic acid (EDTMP) or 2-phosphonobutane-1,2,4 tricarboxylic acid (PBS-AM);
  • Lipase LEĀ® in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP) or aminotrimethylenephosphonic acid (ATMP) or nitrilotrimethylenephosphonic acid (NTMP) or diethylenetriaminepentamethylenephosphonic acid (DTPMP) or ethylenediamine tetramethylenephosphonic acid (EDTMP) or 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM);
  • Lipase FĀ® in combination with 1-hydroxyethane-1,1-diphosphonic acid (HEDP) or aminotrimethylenephosphonic acid (ATMP) or nitrilotrimethylenephosphonic acid (NTMP) or Diethylenetriaminepentamethylenephosphonic acid (DTPMP) or ethylenediamine tetramethylene phosphonic acid (EDTMP) or 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM).

Die Bestimmung der IdentitƤt von NukleinsƤure- oder AminosƤuresequenzen erfolgt durch einen Sequenzvergleich. Solch ein Vergleich erfolgt dadurch, dass Ƥhnliche Abfolgen in den Nukleotidsequenzen oder AminosƤuresequenzen einander zugeordnet werden. Dieser Sequenzvergleich erfolgt vorzugsweise basierend auf dem im Stand der Technik etablierten und Ć¼blicherweise genutzten BLAST-Algorithmus (vgl. beispielsweise Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. (1990) "Basic local alignment search tool." J. Mol. Biol. 215:403-410 , und Altschul, Stephan F.,Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J. Lipman (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs"; Nucleic Acids Res., 25, S.3389-3402 ) und geschieht prinzipiell dadurch, dass Ƥhnliche Abfolgen von Nukleotiden oder AminosƤuren in den NukleinsƤure- bzw. AminosƤuresequenzen einander zugeordnet werden. Eine tabellarische Zuordnung der betreffenden Positionen wird als Alignment bezeichnet. Ein weiterer im Stand der Technik verfĆ¼gbarer Algorithmus ist der FASTA-Algorithmus. Sequenzvergleiche (Alignments), insbesondere multiple Sequenzvergleiche, werden Ć¼blicherweise mit Computerprogrammen erstellt. HƤufig genutzt werden beispielsweise die Clustal-Serie (vgl. beispielsweise Chenna et al. (2003): Multiple sequence alignment with the Clustal series of programs. Nucleic Acid Research 31, 3497-3500 ), T-Coffee (vgl. beispielsweise Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217 ) oder Programme, die auf diesen Programmen bzw. Algorithmen basieren. HƤufig genutzt werden beispielsweise Clustal (vgl. beispielsweise Chenna et al. (2003): Multiple sequence alignment with the Clustal series of programs. Nucleic Acid Research 31, 3497-3500 ) oder T-Coffee (vgl. beispielsweise Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217 ) sowie BLAST oder FASTA fĆ¼r die Datenbanksuche, beziehungsweise Programme, die auf diesen Programmen bzw. Algorithmen basieren. Im Rahmen der vorliegenden Erfindung werden Sequenzvergleiche und Alignments bevorzugt mit dem Computer-Programm Vector NTIĀ® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, Kalifornien, USA) mit den vorgegebenen Default-Parametern erstellt.The identity of nucleic acid or amino acid sequences is determined by a sequence comparison. Such a comparison is made by assigning similar sequences in the nucleotide sequences or amino acid sequences to each other. This sequence comparison is preferably carried out based on the BLAST algorithm established and commonly used in the prior art (cf., for example, US Pat Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ (1990) "Basic local alignment search tool." J. Mol. Biol. 215: 403-410 , and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J. Lipman (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs "; Nucleic Acids Res., 25, pp.3389-3402 ) and in principle takes place in that similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences are assigned to one another. A tabular assignment of the respective positions is referred to as alignment. Another algorithm available in the prior art is the FASTA algorithm. Sequence comparisons (alignments), in particular multiple sequence comparisons, are usually created using computer programs. Frequently used, for example, the Clustal series (see, for example Chenna et al. (2003): Multiple sequence alignment with the Clustal series of programs. Nucleic Acid Research 31, 3497-3500 ), T-Coffee (cf., for example Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217 ) or programs based on these programs or algorithms. For example, Clustal (cf., for example, Chenna et al. (2003): Multiple sequence alignment with the Clustal series of programs. Nucleic Acid Research 31, 3497-3500 ) or T-Coffee (cf., for example Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217 ) as well as BLAST or FASTA for the database search, or programs based on these programs or algorithms. In the context of the present invention, sequence comparisons and alignments are preferably created with the computer program Vector NTIĀ® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the default parameters specified.

Solch ein Vergleich erlaubt eine Aussage Ć¼ber die Ƅhnlichkeit der verglichenen Sequenzen zueinander. Sie wird Ć¼blicherweise in Prozent IdentitƤt, das heiƟt dem Anteil der identischen Nukleotide oder AminosƤurereste an denselben bzw. in einem Alignment einander entsprechenden Positionen angegeben. Der weiter gefasste Begriff der Homologie bezieht bei AminosƤuresequenzen konservierte AminosƤure-Austausche in die Betrachtung mit ein, also AminosƤuren mit Ƥhnlicher chemischer AktivitƤt, da diese innerhalb des Proteins meist Ƥhnliche chemische AktivitƤten ausĆ¼ben. Daher kann die Ƅhnlichkeit der verglichenen Sequenzen auch Prozent Homologie oder Prozent Ƅhnlichkeit angegeben sein. IdentitƤts- und/oder Homologieangaben kƶnnen Ć¼ber ganze Polypeptide oder Gene oder nur Ć¼ber einzelne Bereiche getroffen werden. Homologe bzw. identische Bereiche von verschiedenen NukleinsƤure- oder AminosƤuresequenzen sind daher durch Ɯbereinstimmungen in den Sequenzen definiert. Solche Bereiche weisen oftmals identische Funktionen auf. Sie kƶnnen klein sein und nur wenige Nukleotide bzw. AminosƤuren umfassen. Oftmals Ć¼ben solche kleinen Bereiche fĆ¼r die GesamtaktivitƤt des Proteins essentielle Funktionen aus. Es kann daher sinnvoll sein, SequenzĆ¼bereinstimmungen nur auf einzelne, gegebenenfalls kleine Bereiche zu beziehen. Soweit nicht anders angegeben beziehen sich IdentitƤts- bzw. Homologieangaben in der vorliegenden Anmeldung aber auf die GesamtlƤnge der jeweils angegebenen NukleinsƤure- oder AminosƤuresƤuresequenz.Such a comparison allows a statement about the similarity of the compared sequences to each other. It is usually given in percent identity, that is, the proportion of identical nucleotides or amino acid residues at the same or in an alignment corresponding positions. The broader concept of homology involves conserved amino acid substitutions in amino acids, such as amino acids similar chemical activity, as they usually carry out similar chemical activities within the protein. Therefore, the similarity of the sequences compared may also be stated as percent homology or percent similarity. Identity and / or homology information can be made about whole polypeptides or genes or only over individual regions. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences. Such areas often have identical functions. They can be small and comprise only a few nucleotides or amino acids. Often, such small regions exert essential functions for the overall activity of the protein. It may therefore be useful to relate sequence matches only to individual, possibly small areas. Unless stated otherwise, identity or homology information in the present application, however, refers to the total length of the respectively indicated nucleic acid or amino acid sequence.

In einerweiteren AusfĆ¼hrungsform der Erfindung ist eine erfindungsgemƤƟe Tensidzubereitung ferner dadurch gekennzeichnet, dass ihre Reinigungsleistung mindestens derjenigen einer Tensidzubereitung entspricht, die eine Lipase beinhaltet, die eine AminosƤuresequenz gemƤƟ SEQ ID NO. 1 aufweist, wobei die Reinigungsleistung in einem Waschsystem bestimmt wird, das ein Waschmittel in einer Dosierung zwischen 2,0 und 9,0 Gramm pro Liter Waschflotte sowie die Lipase enthƤlt, wobei die zu vergleichenden Lipasen aktivitƤtsgleich eingesetzt sind und die Reinigungsleistung gegenĆ¼ber einer oder mehrerer der Anschmutzungen RuƟ/Mineralƶl auf Baumwolle, RuƟ/Olivenƶl auf Baumwolle, Pigment/ƖI auf Baumwolle oder Hautfett (Sebum)/Kohlenschwarz,auf Baumwolle, insbesondere gegenĆ¼ber einer oder mehrerer der Anschmutzungen

  • RuƟ/Mineralƶl auf Baumwolle: Produkt Nr. C-01 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande
  • RuƟ/Olivenƶl auf Baumwolle: Produkt Nr. C-02 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande
  • Pigment/Ɩl auf Baumwolle: Produkt Nr. C-09 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande
  • Hautfett (Sebum)/Kohlenschwarz,auf Baumwolle: Produkt Nr. C-S-32 erhƤltlich von CFT (Center For Testmaterials) B.V. Vlaardingen, Niederlande,
bestimmt wird durch Messung des WeiƟheitsgrades der gewaschenen Textilien, der Waschvorgang fĆ¼r mindestens 30 Minuten, optional 60 Minuten, bei einer Temperatur von 40Ā°C erfolgt und das Wasser eine WasserhƤrte zwischen 15,5 und 16,5Ā° (deutsche HƤrte) aufweist.In a further embodiment of the invention, a surfactant preparation according to the invention is further characterized in that its cleaning performance corresponds at least to that of a surfactant preparation which comprises a lipase which has an amino acid sequence according to SEQ ID NO. 1, wherein the cleaning performance is determined in a washing system containing a detergent in a dosage between 2.0 and 9.0 grams per liter of wash liquor and the lipase, wherein the lipases to be compared are used in the same activity and the cleaning performance against one or more soiling of soot / mineral oil on cotton, soot / olive oil on cotton, pigment / oil on cotton or skin fat (sebum) / carbon black, on cotton, especially against one or more of the soiling
  • Carbon black / mineral oil on cotton: Product No. C-01 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands
  • Carbon black / olive oil on cotton: Product No. C-02 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands
  • Pigment / Oil on cotton: Product No. C-09 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands
  • Skin fat (sebum) / carbon black, on cotton: Product No. CS-32 available from CFT (Center For Test Materials) BV Vlaardingen, The Netherlands,
is determined by measuring the whiteness of the washed textiles, the washing process for at least 30 minutes, optionally 60 minutes, at a temperature of 40 Ā° C and the water has a water hardness between 15.5 and 16.5 Ā° (German hardness).

Das Waschmittel fĆ¼r das Waschsystem ist ein flĆ¼ssiges Waschmittel, das wie folgt zusammengesetzt (alle Angaben in Gewichts-Prozent): 0,3-0,5% Xanthan, 0,2-0,4% AntiSchaummittel, 6-7% Glycerin, 0,3-0,5% Ethanol, 4-7% FAEOS (Fettalkoholethersulfat), 24-28% nichtionische Tenside, 1% BorsƤure, 1-2% Natriumcitrat (Dihydrat), 2-4% Soda, 14-16% Kokosnuss-FettsƤuren, 0,5% HEDP (1-Hydroxyethan-1,1-diphosphonsƤure), 0-0,4% PVP (Polyvinylpyrrolidon), 0-0,05% optischer Aufheller, 0-0,001% Farbstoff, Rest demineralisiertes Wasser. Die Lipase wird diesbezĆ¼glich in einer Konzentration von 0,0001-0,06 Gew.-%, vorzugsweise von 0,001 bis 0,006 Gew.-%, in dem Waschmittel eingesetzt, bezogen auf aktives Protein. Die Dosierung des flĆ¼ssigen Waschmittels betrƤgt zwischen 2,0 und 9,0, vorzugsweise zwischen 2,5 und 8,0, zwischen 3,0 und 7,0 und besonders bevorzugt 3,5 Gramm pro Liter Waschflotte. Gewaschen wird in einem pH-Wertebereich zwischen pH 8 und pH 10,5, bevorzugt zwischen pH 8 und pH 9. Die LipaseaktivitƤt in der Waschflotte ist zu Waschbeginn nicht gleich Null.The detergent for the washing system is a liquid detergent composed as follows (all figures in weight percent): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0.3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda , 14-16% coconut fatty acids, 0.5% HEDP (1-hydroxyethane-1,1-diphosphonic acid), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% Dye, remainder demineralized water. The lipase is used in this regard in a concentration of 0.0001-0.06 wt .-%, preferably from 0.001 to 0.006 wt .-%, in the detergent, based on active protein. The dosage of the liquid detergent is between 2.0 and 9.0, preferably between 2.5 and 8.0, between 3.0 and 7.0 and more preferably 3.5 grams per liter of wash liquor. Washing takes place in a pH range between pH 8 and pH 10.5, preferably between pH 8 and pH 9. The lipase activity in the wash liquor is not equal to zero at the start of washing.

Der WeiƟheitsgrad, d.h. die Aufhellung der Anschmutzungen, als MaƟ fĆ¼r die Reinigungsleistung wird mit optischen Messverfahren bestimmt, bevorzugt photometrisch. Ein hierfĆ¼r geeignetes GerƤt ist beispielsweise das Spektrometer Minolta CM508d. Ɯblicherweise werden die fĆ¼r die Messung eingesetzten GerƤte zuvor mit einem WeiƟstandard, bevorzugt einem mitgelieferten WeiƟstandard, kalibriert.The degree of whiteness, i. the brightening of the stains, as a measure of the cleaning performance is determined by optical measurement methods, preferably photometrically. A suitable device for this purpose is for example the spectrometer Minolta CM508d. Usually, the devices used for the measurement are previously calibrated with a white standard, preferably a supplied white standard.

Durch den aktivitƤtsgleichen Einsatz der jeweiligen Lipase wird sichergestellt, dass auch bei einem etwaigen Auseinanderklaffen des VerhƤltnisses von Aktivsubstanz zu Gesamtprotein (die Werte der spezifischen AktivitƤt) die jeweiligen enzymatischen Eigenschaften, also beispielsweise die Reinigungsleistung an bestimmten Anschmutzungen, verglichen werden. Generell gilt, dass eine niedrige spezifische AktivitƤt durch Zugabe einer grĆ¶ĆŸeren Proteinmenge ausgeglichen werden kann.The activity-like use of the respective lipase ensures that even if the ratio of active substance to total protein (the values of the specific activity) diverge, the respective enzymatic properties, for example the cleaning performance of certain soils, are compared. In general, a low specific activity can be compensated by adding a larger amount of protein.

Die LipaseaktivitƤt wird in fachĆ¼blicher Weise bestimmt, und zwar vorzugsweise wie beschrieben in Bruno Stellmach, "Bestimmungsmethoden Enzyme fĆ¼r Pharmazie, Lebensmittelchemie, Technik, Biochemie, Biologie, Medizin" (Steinkopff Verlag Darmstadt, 1988, S. 172ff). Hierbei werden Lipase-haltige Proben zu einer Olivenƶlemulsion in emulgatorhaltigem Wasser gegeben und bei 30Ā°C und pH 9,0 inkubiert. Dabei werden FettsƤuren freigesetzt. Diese werden mit einem Autotitrator Ć¼ber 20min. laufend mit 0,01 N Natronlauge titriert, so dass der pH-Wert konstant bleibt ("pH-stat-Titration"). Anhand des Natronlauge-Verbrauchs erfolgt mittels Bezug auf eine Referenzlipaseprobe die Bestimmung der LipaseaktivitƤt.The lipase activity is determined in a customary manner, preferably as described in Bruno Stellmach, "Methods of determination enzymes for pharmacy, food chemistry, engineering, biochemistry, biology, medicine" (Steinkopff Verlag Darmstadt, 1988, p 172ff). In this case, lipase-containing samples are added to an olive oil emulsion in emulsifier-containing water and incubated at 30 Ā° C and pH 9.0. This fatty acids are released. These will be with an autotitrator over 20min. titrated continuously with 0.01 N sodium hydroxide solution so that the pH remains constant ("pH-stat titration"). Based on the sodium hydroxide consumption, the determination of the lipase activity takes place by reference to a reference lipase sample.

Zahlreiche Lipasen werden als sogenannte PrƤproteine, also zusammen mit einem Propeptid und/oder einem Signalpeptid gebildet. HƤufig handelt es sich bei Pro- und/oder Signalpeptid um N-terminale Sequenzen. Im Zuge des Faltungs- und/oder Sekretionsprozesses des Proteins werden Signal- und/oder Propeptid abgespalten, so dass nach der Abspaltung des Pro- und /oder Signalpeptids die dann reife (mature) Lipase ihre katalytische AktivitƤt ohne die ursprĆ¼nglich vorhandenen N-terminalen AminosƤuren ausĆ¼bt. FĆ¼r technische Anwendungen allgemein und insbesondere im Rahmen der Erfindung sind die reifen (maturen) Lipasen, d.h. die nach ihrer Herstellung prozessierten Enzyme, gegenĆ¼ber den PrƤproteinen bevorzugt. Die Lipasen kƶnnen ferner von den sie produzierenden Zellen nach der Herstellung der Polypeptidkette modifiziert werden, beispielsweise durch AnknĆ¼pfung von ZuckermolekĆ¼len, Formylierungen, Aminierungen, usw. Solche Modifikationen sind posttranslationale Modifikationen und kƶnnen, mĆ¼ssen jedoch nicht einen Einfluss auf die Funktion der Lipase ausĆ¼ben.Numerous lipases are formed as so-called pre-proteins, ie together with a propeptide and / or a signal peptide. Often the prodrug and / or signal peptide are N-terminal sequences. In the course of the folding and / or secretion process of the protein Cleaved signal and / or propeptide, so that after the cleavage of the pro- and / or signal peptide, the then mature lipase exerts its catalytic activity without the originally present N-terminal amino acids. For technical applications in general, and in particular in the context of the invention, the mature (mature) lipases, ie the enzymes processed after their preparation, are preferred over the preproteins. The lipases may also be modified by the cells producing them after production of the polypeptide chain, for example, by attachment of sugar molecules, formylations, aminations, etc. Such modifications are post-translational modifications and may, but do not, have an effect on the function of the lipase.

Ferner kann die in einer erfindungsgemƤƟen Tensidzubereitung enthaltene Lipase an TrƤgerstoffe adsorbiert und/oder in HĆ¼llsubstanzen eingebettet sein, um sie gegen vorzeitige Inaktivierung zu schĆ¼tzen. In der Wasch- bzw. Reinigungsflotte, also unter Anwendungsbedingungen, wird die Lipase dann freigesetzt und kann ihre lipolytische Wirkung entfalten.Furthermore, the lipase contained in a surfactant preparation according to the invention may be adsorbed to carriers and / or embedded in encapsulating substances in order to protect them against premature inactivation. In the washing or cleaning liquor, ie under conditions of use, the lipase is then released and can develop their lipolytic action.

In einer bevorzugten AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass das Phosphonat in einer Menge von 0,01 bis 4 Gew.-% enthalten ist. Weitere bevorzugte Mengen des in der Tensidzubereitung enthaltenen Phosphonats sind von 0,01 bis 3 Gew.-%, von 0,01 bis 2,5 Gew.-%, von 0,02 bis 2,4 Gew.-%, von 0,02 bis 2 Gew.-%, von 0,03 bis 1,5 Gew.-% oder von 0,05 bis 1 Gew.-%.In a preferred embodiment of the invention, the surfactant preparation is characterized in that the phosphonate is contained in an amount of 0.01 to 4 wt .-%. Further preferred amounts of the phosphonate contained in the surfactant preparation are from 0.01 to 3% by weight, from 0.01 to 2.5% by weight, from 0.02 to 2.4% by weight, from 0, 02 to 2 wt .-%, from 0.03 to 1.5 wt .-% or from 0.05 to 1 wt .-%.

Die Lipase ist in einer erfindungsgemƤƟen Tensidzubereitung vorzugsweise jeweils in einer Menge von 1 x 10-8 bis 5 Gew.-% bezogen auf aktives Protein enthalten. Zunehmend bevorzugt ist die Lipase in einer Menge von 1 x 10-7 -3 Gew.-%, von 0,00001-1 Gew.-%, von 0,0002-0,8% Gew.-% und besonders bevorzugt von 0,0008-0,4% Gew.-% in einer erfindungsgemƤƟen Tensidzubereitungen enthalten, bezogen auf aktives Protein. Die Proteinkonzentration kann mit Hilfe bekannter Methoden, zum Beispiel dem BCA-Verfahren (BicinchoninsƤure; 2,2'-Bichinolyl-4,4'-dicarbonsƤure) oder dem Biuret-Verfahren ( A. G. Gornall, C. S. Bardawill und M.M. David, J. Biol. Chem., 177 (1948), S. 751-766 ) bestimmt werden. Der Aktivenzymproteingehalt kann mittels "Active-Site"-Titration der LipaseprƤparation gemƤƟ Rotticci et al.: "An active-site titration method for lipases" (Biochim. Biophys. Acta 1483(1), Seite 132-140 ) bestimmt werden. Hierbei werden verschiedene Konzentrationen des Enzyms in einem entsprechenden Puffersystem mit einem Ɯberschuss an Inhibitor (Methyl-p-nitrophenyl-n-hexylphosphonat) versehen und die freiwerdende Menge an p-Nitrophenolat mittels Spektrophotometrie bei 400 nm bestimmt.The lipase is preferably contained in a surfactant preparation according to the invention in each case in an amount of from 1 Ɨ 10 -8 to 5% by weight, based on active protein. More preferably, the lipase is in an amount of 1 x 10 -7 -3 wt .-%, from 0.00001 to 1 wt .-%, from 0.0002 to 0.8% wt .-% and particularly preferably from 0 , 0008-0.4% wt .-% in a surfactant preparations according to the invention, based on active protein. The protein concentration can be determined by known methods, for example the BCA method (bicinchoninic acid, 2,2'-biquinolyl-4,4'-dicarboxylic acid) or the biuret method ( Gornall AG, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766 ). The Aktivenzymproteinehalt can by means of "Active Site" titration of the lipase preparation according to Rotticci et al .: "An active-site titration method for lipases" (Biochim Biophys Acta 1483 (1), pages 132-140 ). Here, various concentrations of the enzyme in an appropriate buffer system with an excess of inhibitor (methyl p-nitrophenyl-n-hexylphosphonat) provided and the liberated amount of p-nitrophenolate determined by spectrophotometry at 400 nm.

Unter einer Tensidzubereitung ist im Rahmen der vorliegenden Erfindung jegliche Art von Zusammensetzung zu verstehen, die mindestens ein Tensid enthƤlt. Vorzugsweise enthƤlt eine derartige Zusammensetzung ein Tensid wie weiter unten beschrieben.For the purposes of the present invention, a surfactant preparation is to be understood as meaning any type of composition which comprises at least one surfactant. Preferably, such a composition contains a surfactant as described below.

Als flĆ¼ssige Tensidzubereitungen kƶnnen hierbei alle flĆ¼ssigen bzw. flieƟfƤhigen Darreichungsformen dienen. "FlieƟfƤhig" im Sinne der vorliegenden Anmeldung sind dabei Zubereitungen, welche gieƟbar sind und ViskositƤten bis hin zu mehreren 10.000 mPas aufweisen kƶnnen. Die ViskositƤt kann mit Ć¼blichen Standardmethoden (beispielsweise Brookfield-Viskosimeter LVT-II bei 20 U/min und 20Ā°C, Spindel 3) gemessen werden und liegt vorzugsweise im Bereich von 5 bis 10000 mPas. Bevorzugte Tensidzubereitungen haben ViskositƤten von 10 bis 8000 mPas, wobei Werte zwischen 120 bis 3000 mPas besonders bevorzugt sind. Eine flĆ¼ssige Tensidzubereitung im Rahmen der vorliegenden Erfindung kann daher auch gelfƶrmig oder pastenfƶrmig sein, sie kann als homogene Lƶsung oder Suspension vorliegen, sowie beispielsweise versprĆ¼hbar oder in sonstigen Ć¼blichen Darreichungsformen konfektioniert sein.In this case, all liquid or flowable administration forms can serve as liquid surfactant preparations. "Flowable" in the context of the present application are preparations which are pourable and can have viscosities of up to several tens of thousands of mPas. The viscosity can be measured by conventional standard methods (for example, Brookfield LVT-II viscosimeter at 20 rpm and 20 Ā° C., spindle 3) and is preferably in the range from 5 to 10,000 mPas. Preferred surfactant formulations have viscosities of 10 to 8000 mPas, with values between 120 to 3000 mPas being particularly preferred. A liquid surfactant preparation in the context of the present invention can therefore also be gelatinous or paste-like, it can be in the form of a homogeneous solution or suspension, and can be sprayed or packaged in other conventional dosage forms, for example.

Eine erfindungsgemƤƟe flĆ¼ssige Tensidzubereitung kann als solche oder nach VerdĆ¼nnen mit Wasser eingesetzt werden, insbesondere zur Reinigung von Textilien und/oder harten OberflƤchen. Eine solche VerdĆ¼nnung kann leicht hergestellt werden, indem eine abgemessene Menge der Tensidzubereitung in einer weiteren Menge Wasser verdĆ¼nnt wird in bestimmten GewichtsverhƤltnissen von Tensidzubereitung : Wasser und optional diese VerdĆ¼nnung geschĆ¼ttelt wird, um eine gleichmƤƟige Verteilung der Tensidzubereitung im Wasser sicherzustellen. Mƶgliche Gewichts- oder VolumenverhƤltnisse der VerdĆ¼nnungen sind von 1:0 Tensidzubereitung : Wasser bis 1:10000 oder 1:20000 Tensidzubereitung : Wasser, vorzugsweise von 1:10 bis 1:2000 Tensidzubereitung : Wasser.A liquid surfactant preparation according to the invention can be used as such or after dilution with water, in particular for the cleaning of textiles and / or hard surfaces. Such dilution can be readily made by diluting a measured amount of the surfactant preparation in a further amount of water in certain weight ratios of surfactant preparation: water and optionally shaking this dilution to ensure uniform distribution of the surfactant formulation in the water. Possible weight or volume ratios of the dilutions are from 1: 0 surfactant preparation: water to 1: 10,000 or 1: 20000 surfactant preparation: water, preferably from 1:10 to 1: 2000 surfactant preparation: water.

Eine Tensidzubereitung im Sinne der vorliegenden Erfindung kann daher auch die Wasch- bzw. Reinigungsflotte selbst sein.A surfactant preparation in the sense of the present invention can therefore also be the washing or cleaning liquor itself.

In einer bevorzugten AusfĆ¼hrungsform ist die Tensidzubereitung ein Wasch-, Reinigungs- oder Desinfektionsmittel. Zu den Waschmitteln zƤhlen alle denkbaren Waschmittelarten, insbesondere Waschmittel fĆ¼r Textilien, Teppiche oder Naturfasern. Sie kƶnnen fĆ¼r die manuelle und/oder auch die maschinelle Anwendung vorgesehen sein. Zu den Waschmitteln zƤhlen ferner Waschhilfsmittel, die bei der manuellen oder maschinellen TextilwƤsche zum eigentlichen Waschmittel hinzudosiert werden, um eine weitere Wirkung zu erzielen. Zu den Reinigungsmitteln werden alle, ebenfalls in sƤmtlichen genannten Darreichungsformen vorkommenden Mittel zur Reinigung und/oder Desinfektion harter OberflƤchen, manuelle und maschinelle GeschirrspĆ¼lmittel, Teppichreiniger, Scheuermittel, Glasreiniger, WC-DuftspĆ¼ler, usw. gezƤhlt. Textilvor- und Nachbehandlungsmittel sind schlieƟlich auf der einen Seite solche Mittel, mit denen das WƤschestĆ¼ck vor der eigentlichen WƤsche in Kontakt gebracht wird, beispielsweise zum Anlƶsen hartnƤckiger Verschmutzungen, auf der anderen Seite solche, die in einem der eigentlichen TextilwƤsche nachgeschalteten Schritt dem Waschgut weitere wĆ¼nschenswerte Eigenschaften wie angenehmen Griff, Knitterfreiheit oder geringe statische Aufladung verleihen. Zu letztgenannten Mittel werden u.a. die WeichspĆ¼ler gerechnet. Desinfektionsmittel sind beispielsweise HƤndedesinfektionsmittel, FlƤchendesinfektionsmittel und Instrumentendesinfektionsmittel, die ebenfalls in den genannten Darreichungsformen vorkommen kƶnnen. Ein Desinfektionsmittel bewirkt vorzugsweise eine Keimreduktion um einen Faktor von mindestens 104, das heiƟt dass von ursprĆ¼nglich 10.000 vermehrungsfƤhigen Keimen (so genannte koloniebildende Einheiten - KBE) nicht mehr als ein Einziger Ć¼berlebt, wobei Viren diesbezĆ¼glich nicht als Keime gelten, da sie kein Zytoplasma und keinen eigenen Stoffwechsel aufweisen. Bevorzugte Desinfektionsmittel bewirken eine Keimreduktion um einen Faktor von mindestens 105.In a preferred embodiment, the surfactant preparation is a washing, cleaning or disinfecting agent. The detergents include all conceivable types of detergents, in particular detergents for textiles, carpets or natural fibers. They can be provided for manual and / or machine application. The detergents also include washing aids, which are added to the actual detergent in the manual or machine textile washing, in order to achieve a further effect. Detergents include all agents for cleaning and / or disinfecting hard surfaces also found in all of the above dosage forms, manual and automatic dishwashing detergents, carpet cleaners, abrasives, glass cleaners, toilet scavengers, etc. Textile pre- and post-treatment agent Finally, on the one hand are such means with which the laundry is brought into contact before the actual laundry, for example, for solving stubborn dirt, on the other hand, those in one of the actual textile laundry downstream step the laundry further desirable properties such as pleasant handle , Give crease-free or low static charge. Amongst others, the fabric softeners are calculated. Disinfectants are, for example, hand disinfectants, surface disinfectants and instrument disinfectants, which may also occur in the mentioned dosage forms. A disinfectant preferably causes a germ reduction by a factor of at least 10 4 , that is to say that of originally 10,000 proliferating germs (so-called colony-forming units - CFU) survived no more than a single, with viruses in this regard are not considered as germs, since they have no cytoplasm and have no own metabolism. Preferred disinfectants cause a germ reduction by a factor of at least 10 5 .

Als Tensid(e) kƶnnen anionische, nichtionische, zwitterionische und/oder amphotere Tenside eingesetzt werden. Bevorzugt sind aus anwendungstechnischer Sicht Mischungen aus anionischen und nichtionischen Tensiden. Der Gesamttensidgehalt der flĆ¼ssigen Tensidzubereitung liegt vorzugsweise unterhalb von 60 Gew.-% und besonders bevorzugt unterhalb von 45 Gew.-%, bezogen auf die gesamte flĆ¼ssige Tensidzubereitung.As surfactant (s) it is possible to use anionic, nonionic, zwitterionic and / or amphoteric surfactants. From an application point of view, preference is given to mixtures of anionic and nonionic surfactants. The total surfactant content of the liquid surfactant preparation is preferably below 60% by weight, and more preferably below 45% by weight, based on the total liquid surfactant formulation.

Geeignete nichtionische Tenside umfassen alkoxylierte Fettalkohole, alkoxylierte FettsƤurealkylester, FettsƤureamide, alkoxylierte FettsƤureamide, PolyhydroxyfettsƤureamide, Alkylphenolpolyglycolether, Aminoxide, Alkylpolyglucoside und Mischungen daraus.Suitable nonionic surfactants include alkoxylated fatty alcohols, alkoxylated fatty acid alkyl esters, fatty acid amides, alkoxylated fatty acid amides, polyhydroxy fatty acid amides, alkylphenol polyglycol ethers, amine oxides, alkyl polyglucosides, and mixtures thereof.

Als nichtionische Tenside werden vorzugsweise alkoxylierte, vorteilhafterweise ethoxylierte, insbesondere primƤre Alkohole mit vorzugsweise 8 bis 18 C-Atomen und durchschnittlich 1 bis 12 Mol Ethylenoxid (EO) pro Mol Alkohol eingesetzt, in denen der Alkoholrest linear oder bevorzugt in 2-Stellung methylverzweigt sein kann bzw. lineare und methylverzweigte Reste im Gemisch enthalten kann, so wie sie Ć¼blicherweise in Oxoalkoholresten vorliegen. Insbesondere sind jedoch Alkoholethoxylate mit linearen Resten aus Alkoholen nativen Ursprungs mit 12 bis 18 C-Atomen, zum Beispiel aus Kokos-, Palm-, Talgfett- oder Oleylalkohol, und durchschnittlich 2 bis 8 EO pro Mol Alkohol bevorzugt. Zu den bevorzugten ethoxylierten Alkoholen gehƶren beispielsweise C12-14-Alkohole mit 3 EO, 4 EO oder 7 EO, C9-11-Alkohol mit 7 EO, C13-5-Alkohole mit 3 EO, 5 EO, 7 EO oder 8 EO, C12-18-Alkohole mit 3 EO, 5 EO oder 7 EO und Mischungen aus diesen, wie Mischungen aus C12-14-Alkohol mit 3 EO und C12-18-Alkohol mit 7 EO. Die angegebenen Ethoxylierungsgrade stellen statistische Mittelwerte dar, die fĆ¼r ein spezielles Produkt eine ganze oder eine gebrochene Zahl sein kƶnnen. Bevorzugte Alkoholethoxylate weisen eine eingeengte Homologenverteilung auf (narrow range ethoxylates, NRE). ZusƤtzlich zu diesen nichtionischen Tensiden kƶnnen auch Fettalkohole mit mehr als 12 EO eingesetzt werden. Beispiele hierfĆ¼r sind Talgfettalkohol mit 14 EO, 25 EO, 30 EO oder 40 EO. Auch nichtionische Tenside, die EO- und PO-Gruppen zusammen im MolekĆ¼l enthalten, sind erfindungsgemƤƟ einsetzbar. Geeignet sind ferner auch eine Mischung aus einem (stƤrker) verzweigten ethoxylierten Fettalkohol und einem unverzweigten ethoxylierten Fettalkohol, wie beispielsweise eine Mischung aus einem C16-18-Fettalkohol mit 7 EO und 2-Propylheptanol mit 7 EO. Insbesondere bevorzugt enthƤlt die Tensidzubereitung einen C12-18-Fettalkohol mit 7 EO oder einen C13-15-Oxoalkohol mit 7 EO als nichtionisches Tensid.The nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary, alcohols having preferably 8 to 18 carbon atoms and on average 1 to 12 moles of ethylene oxide (EO) per mole of alcohol, in which the alcohol radical can be linear or preferably methyl-branched in the 2-position or linear and methyl-branched radicals in the mixture can contain, as they are usually present in Oxoalkoholresten. In particular, however, alcohol ethoxylates with linear radicals of alcohols of native origin having 12 to 18 carbon atoms, for example of coconut, palm, tallow or oleyl alcohol, and on average 2 to 8 EO per mole of alcohol are preferred. Preferred ethoxylated alcohols include, for example, C12-14 alcohols containing 3 EO, 7 EO or 4 EO, C9-11 alcohol containing 7 EO, C 13-5 alcohols containing 3 EO, 5 EO, 7 EO or 8 EO, C 12-18 -alcohols with 3 EO, 5 EO or 7 EO and mixtures of these, such as mixtures of C 12-14 -alcohol with 3 EO and C 12-18 -alcohol with 7 EO. The degrees of ethoxylation given represent statistical means which, for a particular product, may be an integer or a fractional number. Preferred alcohol ethoxylates have a narrowed Homolog distribution (narrow range ethoxylates, NRE). In addition to these nonionic surfactants, fatty alcohols with more than 12 EO can also be used. Examples include tallow fatty alcohol with 14 EO, 25 EO, 30 EO or 40 EO. Nonionic surfactants containing EO and PO groups together in the molecule can also be used according to the invention. Also suitable are also a mixture of a (more) branched ethoxylated fatty alcohol and an unbranched ethoxylated fatty alcohol, such as a mixture of a C 16-18 fatty alcohol with 7 EO and 2-propylheptanol with 7 EO. Particularly preferably, the surfactant preparation contains a C 12-18 fatty alcohol with 7 EO or a C 13-15 oxo alcohol with 7 EO as nonionic surfactant.

Der Gehalt an nichtionischen Tensiden betrƤgt bevorzugt 3 bis 40 Gew.-%, vorzugsweise 5 bis 30 Gew.-% und insbesondere 7 bis 20 Gew.-%, jeweils bezogen auf die gesamte Tensidzubereitung.The content of nonionic surfactants is preferably 3 to 40 wt .-%, preferably 5 to 30 wt .-% and in particular 7 to 20 wt .-%, each based on the total surfactant.

Neben den nichtionischen Tensiden kann die Tensidzubereitung auch anionische Tenside enthalten. Als anionisches Tensid werden vorzugsweise Sulfonate, Sulfate, Seifen, Alkylphosphate, anionische Silikontenside und Mischungen daraus eingesetzt.In addition to the nonionic surfactants, the surfactant preparation may also contain anionic surfactants. The anionic surfactant used is preferably sulfonates, sulfates, soaps, alkyl phosphates, anionic silicone surfactants and mixtures thereof.

Als Tenside vom Sulfonat-Typ kommen dabei vorzugsweise C9-13-Alkylbenzolsulfonate, Olefinsulfonate, d.h. Gemische aus Alken- und Hydroxyalkansulfonaten sowie Disulfonaten, wie man sie beispielsweise aus C12-18-Monoolefinen mit end- oder innenstƤndiger Doppelbindung durch Sulfonieren mit gasfƶrmigem Schwefeltrioxid und anschlieƟende alkalische oder saure Hydrolyse der Sulfonierungsprodukte erhƤlt, in Betracht. Geeignet sind auch C12-18-Alkansulfonate und die Ester von Ī±-SulfofettsƤuren (Estersulfonate), zum Beispiel die Ī±-sulfonierten Methylester der hydrierten Kokos-, Palmkern- oder TalgfettsƤuren.The surfactants of the sulfonate type are preferably C 9-13 -alkylbenzenesulfonates, olefinsulfonates, ie mixtures of alkene and hydroxyalkanesulfonates and disulfonates, as are obtained, for example, from C 12-18 -monoolefins having terminal or internal double bonds by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acid hydrolysis of the sulfonation products into consideration. Also suitable are C 12-18 alkanesulfonates and the esters of Ī±-sulfo fatty acids (ester sulfonates), for example the Ī±-sulfonated methyl esters of hydrogenated coconut, palm kernel or tallow fatty acids.

Als Alk(en)ylsulfate werden die Alkali- und insbesondere die Natriumsalze der SchwefelsƤurehalbester der C12-C18-Fettalkohole, beispielsweise aus Kokosfettalkohol, Talgfettalkohol, Lauryl-, Myristyl-, Cetyl- oder Stearylalkohol oder der C10-C20-Oxoalkohole und diejenigen Halbester sekundƤrer Alkohole dieser KettenlƤngen bevorzugt. Aus waschtechnischem Interesse sind die C12-C16-Alkylsulfate und C12-C15-Alkylsulfate sowie C14-C15-Alkylsulfate bevorzugt. Auch 2,3-Alkylsulfate sind geeignete anionische Tenside.Alk (en) ylsulfates are the alkali metal salts and in particular the sodium salts of the sulfuric monoesters of C 12 -C 18 fatty alcohols, for example coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl or stearyl alcohol or the C 10 -C 20 oxo alcohols and those half-esters of secondary alcohols of these chain lengths are preferred. Of washing technology interest, the C 12 -C 16 alkyl sulfates and C 12 -C 15 alkyl sulfates and C 14 -C 15 alkyl sulfates are preferred. 2,3-alkyl sulfates are also suitable anionic surfactants.

Auch die SchwefelsƤuremonoester der mit 1 bis 6 Mol Ethylenoxid ethoxylierten geradkettigen oder verzweigten C7-21-Alkohole, wie 2-Methyl-verzweigte C9-11-Alkohole mit im Durchschnitt 3,5 Mol Ethylenoxid (EO) oder C12-18-Fettalkohole mit 1 bis 4 EO, sind geeignet.The sulfuric acid monoesters of straight-chain or branched C 7-21 -alcohols ethoxylated with from 1 to 6 mol of ethylene oxide, such as 2-methyl-branched C 9-11- alcohols having on average 3.5 mol of ethylene oxide (EO) or C 12-18 . Fatty alcohols with 1 to 4 EO are suitable.

Auch bevorzugte anionische Tenside sind Seifen. Geeignet sind gesƤttigte und ungesƤttigte FettsƤureseifen, wie die Salze der LaurinsƤure, MyristinsƤure, PalmitinsƤure, StearinsƤure, (hydrierten) ErucasƤure und BehensƤure sowie insbesondere aus natĆ¼rlichen FettsƤuren, zum Beispiel Kokos-, Palmkern-, Olivenƶl- oder TalgfettsƤuren, abgeleitete Seifengemische.Also preferred anionic surfactants are soaps. Suitable are saturated and unsaturated fatty acid soaps, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid and, in particular, soap mixtures derived from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acids.

Die anionischen Tenside einschlieƟlich der Seifen kƶnnen in Form ihrer Natrium-, Kalium- oder Magnesium- oder Ammoniumsalze vorliegen. Vorzugsweise liegen die anionischen Tenside in Form ihrer Natriumsalze vor. Weitere bevorzugte Gegenionen fĆ¼r die anionischen Tenside sind auch die protonierten Formen von Cholin, Triethylamin oder Methylethylamin.The anionic surfactants including the soaps may be in the form of their sodium, potassium or magnesium or ammonium salts. Preferably, the anionic surfactants are in the form of their sodium salts. Further preferred counterions for the anionic surfactants are also the protonated forms of choline, triethylamine or methylethylamine.

Der Gehalt einer Tensidzubereitung an anionischen Tensiden kann 1 bis 40 Gew.-%, vorzugsweise 5 bis 30 Gew.-% und ganz besonders bevorzugt 10 bis 25 Gew.-%, jeweils bezogen auf die gesamte Tensidzubereitung, betragen.The content of a surfactant preparation of anionic surfactants can be from 1 to 40% by weight, preferably from 5 to 30% by weight and very particularly preferably from 10 to 25% by weight, based in each case on the total surfactant preparation.

In einerweiteren AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass sie ferner eine Komponente umfasst, die ausgewƤhlt ist aus i

  1. i. anionische und/oder polyanionische Substanz, und/oder
  2. ii. kationische und/oder polykationische Substanz, und/oder
  3. iii. Hydroxyl- und/oder Polyhydroxyl-Gruppe(n) aufweisende Substanz.
In a further embodiment of the invention, the surfactant preparation is characterized by further comprising a component selected from i
  1. i. anionic and / or polyanionic substance, and / or
  2. ii. cationic and / or polycationic substance, and / or
  3. iii. Hydroxyl and / or polyhydroxyl group (s) having substance.

Es wurde festgestellt, dass der Zusatz solcher Substanzen die Reinigungsleistung von Tensidzubereitungen, insbesondere von flĆ¼ssigen Wasch- oder Reinigungsmitteln, welche eine Lipase enthalten, insbesondere eine solche wie vorstehend beschrieben, weiter verbessert, insbesondere bei einer Temperatur zwischen 10Ā°C und 80Ā°C und vorzugsweise bei vergleichsweise niedrigen Temperaturen, insbesondere zwischen 10Ā°C und 50Ā°C, zwischen 10Ā°C und 40Ā°C, zwischen 10Ā°C und 30Ā°C und/oder zwischen 20Ā°C und 40Ā°C.It has been found that the addition of such substances further improves the cleaning performance of surfactant preparations, in particular of liquid detergents or cleaners containing a lipase, in particular such as described above, in particular at a temperature between 10 Ā° C and 80 Ā° C and preferably at comparatively low temperatures, in particular between 10 Ā° C and 50 Ā° C, between 10 Ā° C and 40 Ā° C, between 10 Ā° C and 30 Ā° C and / or between 20 Ā° C and 40 Ā° C.

Bei den vorstehend unter i. angegebenen Substanzen handelt es sich um anionische oder polyanionische Substanzen, d.h. diese Substanzen tragen mindestens eine und bevorzugt mehrere negative Ladungen. Bevorzugt handelt es sich um ein Polymer mit mindestens einem negativ gelandenen Monomer, bevorzugt mit mehreren negativ geladenen Monomeren. ErfindungsgemƤƟ bevorzugt ist dieses Polymer daher ein negativ geladenes Polymer. Bevorzugt sind beispielsweise Polymere organischer SƤuren bzw. deren Salze, insbesondere Polyacrylate und/oder Poly-ZuckersƤuren und/oder Polyarcylat-copolymere und/oder Poly-zucker-copolymere. DiesbezĆ¼glich weitere bevorzugte Verbindungen sind Polyacrylsulfonate oder Polycarboxylate und deren Salze, Copolymere oder Salze der Coploymere.In the case under i. The substances indicated are anionic or polyanionic substances, ie these substances carry at least one and preferably several negative charges. It is preferably a polymer having at least one negatively charged monomer, preferably having a plurality of negatively charged monomers. According to the invention, this polymer is therefore a negatively charged polymer. For example, polymers of organic acids or their salts, in particular polyacrylates and / or poly-sugar acids and / or polyarcylate copolymers and / or poly-sugar copolymers, are preferred. In this regard, further preferred compounds are polyacrylic sulfonates or polycarboxylates and their salts, copolymers or salts of the copolymers.

Beispiele fĆ¼r besonders bevorzugt einzusetzende Substanzen sind Acusol 587D (Polyacrylsulfonat; Unternehmen Rohm & Haas/Dow Chemical), Acusol 445N (Polycarboxylat Natriumsalz; Unternehmen Rohm & Haas/Dow Chemical), Acusol 590 (Polyarcrylat-copolymer; Unternehmen Rohm & Haas/Dow Chemical), Acusol 916 (Polyarcrylat Natriumsalz; Unternehmen Rohm & Haas/Dow Chemical), Sokalan CP42 (modifiziertes Polycarboxylat Natriumsalz; Unternehmen BASF), Sokalan PA 30CL (Polycarboxylat Natriumsalz; Unternehmen BASF), Dequest P 9000 (PolymaleinsƤure; Unternehmen Thermphos), AlginsƤure, Poly-2-acrylamido-2-methyl-1-propan-sulfonsƤure, Poly-4-styrol sulfonsƤure -co-maleinsƤure Natriumsalz, Poly-acrylamido-co-acrylsƤure Natriumsalz, Poly-methacrylsƤure Natriumsalz, Poly-methyl vinyl ether-alt maleinsƤure oder PolyvinylsulfonsƤure Natriumsalz.Examples of particularly preferable substances to be used are Acusol 587D (polyacrylic sulfonate, Rohm & Haas / Dow Chemical Company), Acusol 445N (polycarboxylate sodium salt, Rohm & Haas / Dow Chemical Company), Acusol 590 (polyacrylate copolymer; Rohm & Haas / Dow Chemical ), Acusol 916 (polyarcrylate sodium salt, Rohm & Haas / Dow Chemical Company), Sokalan CP42 (modified polycarboxylate sodium salt, BASF Company), Sokalan PA 30CL (polycarboxylate sodium salt, BASF Company), Dequest P 9000 (polymaleic acid, Thermphos Company), alginic acid , Poly-2-acrylamido-2-methyl-1-propane-sulfonic acid, poly-4-styrene sulfonic acid-co-maleic acid sodium salt, poly-acrylamido-co-acrylic acid sodium salt, poly-methacrylic acid sodium salt, poly-methyl vinyl ether-alt maleic acid or polyvinyl sulfonic acid sodium salt.

Bei den unter ii. angegebenen Substanzen handelt es sich kationische oder polykationische Substanzen, d.h. diese Substanzen tragen mindestens eine und bevorzugt mehrere positive Ladungen. Bevorzugt handelt es sich um ein Polymer mit mindestens einem positiv gelandenen Monomer, bevorzugt mit mehreren positiv geladenen Monomeren. ErfindungsgemƤƟ bevorzugt ist dieses Polymer daher ein positiv geladenes Polymer. Beispiele fĆ¼r diesbezĆ¼glich bevorzugte Verbindungen sind Salze der Polyamine, Polyethyleneimine bzw. deren Copolymere, Salze der Polyallylamine, Salze der Polydiallyldimethylammonium-verbindungen oder Poly(acrylamide-co-diallyldimethylammonium-verbindungen.In the under ii. The substances indicated are cationic or polycationic substances, i. these substances carry at least one and preferably several positive charges. It is preferably a polymer having at least one positively charged monomer, preferably having a plurality of positively charged monomers. According to the invention, this polymer is therefore a positively charged polymer. Examples of preferred compounds in this regard are salts of polyamines, polyethylene imines or their copolymers, salts of polyallylamines, salts of Polydiallyldimethylammonium compounds or poly (acrylamide-co-diallyldimethylammonium compounds.

Bei den unter iii. angegebenen Substanzen handelt es sich um Substanzen, die mindestens eine Hydroxyl- und/oder Polyhydroxyl-Gruppe und bevorzugt mehrere Hydroxyl- und/oder Polyhydroxyl-Gruppen aufweisen. Bevorzugt sind diesbezĆ¼glich beispielsweise Polyvinylalkohole, beispielsweise solche, die unter dem Handelsnamen Mowiol verfĆ¼gbar sind (Unternehmen Kremer Pigmente GmbH & Co. KG).In the under iii. specified substances are substances which have at least one hydroxyl and / or polyhydroxyl group and preferably more hydroxyl and / or polyhydroxyl groups. Preferred in this regard are, for example, polyvinyl alcohols, for example those which are available under the trade name Mowiol (Kremer Pigmente GmbH & Co. KG).

Es wird an dieser Stelle ausdrĆ¼cklich darauf hingewiesen, dass eine konkrete Substanz zu einer oder mehreren der vorstehend genannten Gruppen i. bis iii. zugehƶrig sein kann. Beispielsweise kann es sich um ein anionisches Polymer handeln, welches eine oder mehrere Hydroxyl- und/oder Polyhydroxyl-Gruppe(n) aufweist. Eine solche Substanz ist dann zugehƶrig zu den Gruppen i. und iii. Ebenso ist ein kationisches Polymer, welches eine oder mehrere Hydroxyl- und/oder Polyhydroxyl-Gruppe(n) aufweist, zugehƶrig zu den Gruppen ii. und iii.It is expressly noted at this point that a specific substance to one or more of the above groups i. to iii. may be associated. For example, it may be an anionic polymer having one or more hydroxyl and / or polyhydroxyl group (s). Such a substance is then associated with the groups i. and iii. Likewise, a cationic polymer having one or more hydroxyl and / or polyhydroxyl group (s) belonging to the groups ii. and iii.

Im Rahmen der vorliegenden Erfindung ebenfalls einsetzbar sind Derivate der vorstehend als zugehƶrig zu i., ii. oder iii. genannten Substanzen. Unter einem Derivat wird im Sinne der vorliegenden Anmeldung eine solche Substanz verstanden, die ausgehend von einer der vorstehend genannten Substanzen chemisch modifiziert ist, beispielsweise durch die Umwandlung einer Seitenkette oder durch kovalente Bindung einer anderen Verbindung an die Substanz. Bei solch einer Verbindung kann es sich beispielsweise um niedrigmolekulare Verbindungen wie Lipide oder Mono-, Oligo- oder Polysaccharide oder Amine bzw. Aminverbindungen handeln. Ferner kann die Substanz glykosyliert, hydrolysiert, oxidiert, N-methyliert, N-formyliert, N-acetyliert sein oder Methyl, Formyl, Ethyl, Acetyl, t-Butyl, Anisyl, Benzyl, Trifluroacetyl, N-hydroxysuccinimide, t-Butyloxycarbonyl, Benzoyl, 4-Methylbenzyl, Thioanizyl, Thiocresyl, Benzyloxymethyl, 4-Nitrophenyl, Benzyloxycarbonyl, 2-Nitrobenzoyl, 2-Nitrophenylsulphenyl, 4-Toluenesulphonyl, Pentafluorophenyl, Diphenylmethyl, 2-Chlorobenzyloxycarbonyl, 2,4,5-trichlorophenyl, 2-bromobenzyloxycarbonyl, 9-Fluorenylmethyloxycarbonyl, Tripheylmethyl, 2,2,5,7,8-pentamethyl-chroman-6-sulphonyl enthalten. Ebenso ist unter einem Derivat die kovalente oder nichtkovalente Bindung der Substanz an einen makromolekularen TrƤger zu verstehen, genauso wie auch ein nichtkovalenter Einschluss in geeignete makromolekulare KƤfigstrukturen. Auch Kopplungen mit sonstigen makromolekularen Verbindungen, wie etwa Polyethylenglykol, kƶnnen vorgenommen sein. Weitere bevorzugte chemische Modifikationen sind die Modifikation von einer oder mehreren der chemischen Gruppen -COOH, -OH, =NH, -NH2 -SH zu -COOR, -OR, -NHR, -NR2, -NHR, -NR, -SR; wobei:

  • R ist-CH=CH-R2, -Cā‰”C-R2, -C(R2)=CH2, -C(R2)=C(R3), -CH=NR2, -C(R2)=N-R3, ein 4-7 C-Ring System mit oder ohne Substitution, ein 4-7 Stickstoffheterozyklus mit oder ohne Substitution, oder eine C2 bis C8 Kette mit 1 bis 5 Doppel- oder Dreifachbindungen mit Substitutionen ausgewƤhlt aus R1, R2, oder R3, wobei
  • -R1 ist H, -R, -NO2, -CN, Halogenidsubstituent, -N3, -C1-8 alkyl, -(CH2)nCO2R2, -C2-8 alkenyl-CO2R2, -O(CH2)nCO2R2, -C(O)NR2R3, -P(O)(OR2)2, alkyl substituiertes tetrazol-5-yl, -(CH2)nO(CH2)n aryl, -NR2R3, -(CH2)n OR2, -(CH2)n SR2, -N(R2)C(O)R3, -S(O2)NR2R3, -N(R2)S(O2)R3, -(CHR2)n NR2R3, -C(O)R3, (CH2)n N(R3)C(O)R3, -N(R2)CR2R3, substituiertes oder nicht substituiertes (CH2)n-zykloalkyl, substituiertes oder nicht substituiertes (CH2)n-phenyl, oder-zyklus; wobei n eine Zahl grĆ¶ĆŸer als 1 ist;
  • -R2 ist H, Halogenidsubstituent, -alkyl, -halogenalkyl, -(CH2)n-phenyl, -(CH2)1-3-biphenyl, -(CH2)1-4-Ph-N(SO2-C1-2-alkyl)2, -CO(CHR1)n-OR1, -(CHR1)n-Heterozyklus, -(CHR1)n-NH-CO-R1, -(CHR1)n-NH-SO2R1, -(CHR1)n-Ph-N(SO2-C1-2-alkyl)2, -(CHR1)n-C(O)(CHR1)-NHR1, -(CHR1)n-C(S)(CHR1)-NHR1, -(CH2)nO(CH2)nCH3, -CF3, -C2-C5 acyl, -(CHR1)nOH, -(CHR1)nCO2R1, -(CHR1)n-O-alkyl, -(CHR1)n-O-(CH2)n-O-alkyl, -(CHR1)n-S-alkyl, -(CHR1)n-S(O)-alkyl, -(CHR1)n-S(O2)-alkyl, -(CHR1)n-S(O2)-NHR3, -(CHR3)n-N3, -(CHR3)nNHR4, eine C2 bis C8 Kette Alken-Kette mit 1 bis 5 Doppelbindungen, eine C2 bis C8 Kette Alkin-Kette mit 1 bis 5 Dreifachbindungen, substituierter oder nicht substituierter -(CHR3)n Heterozyklus, substituiertes oder nicht substituiertes gesƤttigtes oder nicht gesƤttigtes -(CHR3)n Zykloalkyl; wobei n eine Zahl grĆ¶ĆŸer als 1 ist und R1 und R3 gleich oder unterschiedlich sein kƶnnen;
  • -R3 ist H, -OH, -CN, substituiertes Alkyl, - C2 bis C8 Alkenyl, substituiertes oder nicht substituiertes Zykloalkyl, -N(R1)R2, gesƤttigter oder nicht gesƤttigter C5 bis C7 Heterozyklus oder Heterobizyklus von 4 bis 7 C-Atomen, -NR1, -NR2, -NR1R2 bestehend aus einem gesƤttigten oder nicht gesƤttigten Heterozyklus oder einem Heterobizyklus von 4 bis 7 C-Atomen;
  • -R4 ist H, -(CH2)nOH, -C(O)ORS, -C(O)SR5, -(CH2)n C(O)NR6R7, -O-C(O)-O-R6, eine AminosƤure oder ein Peptid; wobei n eine Zahl zwischen 0 und 4 ist;
  • -R5 ist H,
  • -R6 ist -C(R7)-(CH2)n-O-C(O)-R8, -(CH2)n-C(R7)-O-C(O)R8, -(CH2)n-C(R7)-O-C(O)-O-R8, oder-C(R7)-(CH2)n-O-C(O)-O-R8; wobei n eine Zahl zwischen 0 und 4 ist; und
  • -R7 und R8 sind jeweils H, Alkyl, substituiertes Alkyl, Aryl, substituiertes Aryl, Alkenyl, substituiertes Alkenyl, Alkinyl, substituiertes Alkinyl, Heterozyklus, substituierter Heterozyklus, Alkylaryl, substituiertes Alkylaryl, Zykloalkyl, substituiertes Zykloalkyl, oder CH2CO2alkyl, wobei R7 und R8 gleich oder unterschiedlich sein kƶnnen.
Also usable in the context of the present invention are derivatives of those mentioned above as belonging to i., Ii. or iii. mentioned substances. For the purposes of the present application, a derivative is understood as meaning a substance which is chemically modified starting from one of the abovementioned substances, for example by the conversion a side chain or by covalent attachment of another compound to the substance. Such a compound may be, for example, low molecular weight compounds such as lipids or mono-, oligo- or polysaccharides or amines or amine compounds. Further, the substance may be glycosylated, hydrolyzed, oxidized, N-methylated, N-formylated, N-acetylated or methyl, formyl, ethyl, acetyl, t-butyl, anisyl, benzyl, trifluoroacetyl, N-hydroxysuccinimides, t-butyloxycarbonyl, benzoyl , 4-methylbenzyl, thioanizyl, thiocresyl, benzyloxymethyl, 4-nitrophenyl, benzyloxycarbonyl, 2-nitrobenzoyl, 2-nitrophenylsulphenyl, 4-toluenesulphonyl, pentafluorophenyl, diphenylmethyl, 2-chlorobenzyloxycarbonyl, 2,4,5-trichlorophenyl, 2-bromobenzyloxycarbonyl, 9 Fluoroenylmethyloxycarbonyl, tripheylmethyl, 2,2,5,7,8-pentamethylchroman-6-sulphonyl. Likewise, a derivative is to be understood as meaning the covalent or noncovalent binding of the substance to a macromolecular carrier, as well as noncovalent inclusion in suitable macromolecular cage structures. Also, couplings with other macromolecular compounds, such as polyethylene glycol, may be made. Further preferred chemical modifications are the modification of one or more of the chemical groups -COOH, -OH, = NH, -NH 2 -SH to -COOR, -OR, -NHR, -NR 2, -NHR, -NR, -SR; in which:
  • R is -CH = CH-R2, -Cā‰”C-R2, -C (R 2 ) = CH 2 , -C (R 2 ) = C (R 3), -CH = NR 2 , -C (R 2 ) = N-R 3 , a 4-7 C-ring system with or without substitution, a 4-7 nitrogen heterocycle with or without substitution, or a C 2 to C 8 chain with 1 to 5 double or triple bonds with substitutions selected from R1, R2, or R3 , in which
  • -R 1 is H, -R, -NO 2, -CN, halide substituent, -N 3, -C1-8 alkyl, - (CH 2) n CO 2 R 2, -C2-8 alkenyl-CO 2 R 2, -O (CH 2 ) nCO 2 R 2 , -C (O) NR 2 R 3, -P (O) (OR 2 ) 2 , alkyl substituted tetrazol-5-yl, - (CH 2 ) n O (CH 2 ) n aryl, -NR 2 R 3, - (CH 2) n OR 2, - (CH 2) n SR2, -N (R2) C (O) R3, -S (O 2) NR2R3, -N (R2) S (O 2) R 3, - (CHR 2) n NR2R3 , -C (O) R 3, (CH 2 ) n, N (R 3) C (O) R 3, -N (R 2 ) CR 2 R 3, substituted or unsubstituted (CH 2 ) n -cycloalkyl, substituted or unsubstituted (CH 2 ) n-phenyl, or -cycle; where n is a number greater than 1;
  • -R2 is H, halide substituent, alkyl, haloalkyl, - (CH 2) n-phenyl, - (CH2) 1-3-biphenyl, - (CH 2) 1-4-Ph-N (SO 2 -C 1 -2-alkyl) 2, -CO (CHR1) n OR1, - (CHR1) n-heterocycle, - (CHR1) n-NH-CO-R1, - (CHR1) n-NH-SO 2 R1, - ( CHR1) n-Ph-N (SO2 -C1-2 alkyl) 2, - (CHR1) n C (O) (CHR1) -NHR1, - (CHR1) n C (S) (CHR1) -NHR1, - (CH 2 ) nO (CH 2 ) n CH 3 , -CF 3 , -C 2 -C 5 acyl, - (CHR 1) n OH, - (CHR 1) n CO 2 R 1 , - (CHR 1) nO-alkyl, - (CHR 1) nO- (CH 2 ) nO-alkyl, - (CHR 1) n -S -alkyl, - (CHR 1) nS (O) -alkyl, - (CHR 1) nS (O 2 ) -alkyl, - (CHR 1) nS (O 2 ) -NHR 3 , - (CHR 3 ) n N 3 , - (CHR 3) n NHR 4, a C 2 to C 8 chain alkene chain having 1 to 5 double bonds, a C 2 to C 8 chain alkyne chain having 1 to 5 triple bonds, substituted or unsubstituted - (CHR3) n heterocycle, substituted or unsubstituted saturated or unsaturated - (CHR3) n cycloalkyl; where n is a number greater than 1 and R1 and R3 may be the same or different;
  • -R3 is H, -OH, -CN, substituted alkyl, - C 2 to C 8 alkenyl, substituted or unsubstituted cycloalkyl, -N (R 1) R 2, saturated or unsaturated C 5 to C 7 heterocycle or heterobicycycle of 4 to 7 C atoms, -NR1, -NR2, -NR1R2 consisting of a saturated or unsaturated heterocycle or a heterocycle of 4 to 7 C atoms;
  • -R 4 is H, - (CH 2) n OH, -C (O) ORS, -C (O) SR5, - (CH 2) n C (O) NR6R7, -OC (O) -O-R6, an amino acid or a peptide; where n is a number between 0 and 4;
  • -R5 is H,
  • -R6 is -C (R7) - (CH2) nOC (O) -R 8, - (CH 2) n C (R7) -OC (O) R8, - (CH 2) n C (R7) -OC (O) -O-R8, or-C (R7) - (CH2) nOC (O) -O-R8; where n is a number between 0 and 4; and
  • R 7 and R 8 are each H, alkyl, substituted alkyl, aryl, substituted aryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, heterocycle, substituted heterocycle, alkylaryl, substituted alkylaryl, cycloalkyl, substituted cycloalkyl, or CH 2 CO 2 alkyl, where R7 and R8 may be the same or different.

ErfindungsgemƤƟ ist es weiter mƶglich, alle mƶglichen Kombinationen der vorstehend als zugehƶrig zu i., ii. oder iii. genannten Substanzen und/oder deren Derivate einzusetzen.According to the invention, it is further possible to use all possible combinations of those mentioned above as belonging to i., Ii. or iii. to use said substances and / or derivatives thereof.

In einerweiteren AusfĆ¼hrungsform der Erfindung ist die Tensidzubereitung dadurch gekennzeichnet, dass sie ferner mindestens einen weiteren Inhaltsstoff umfasst, der ausgewƤhlt ist aus der Gruppe bestehend aus GerĆ¼ststoff (Builder), Persauerstoffverbindung, Bleichaktivator, nichtwƤssriges Lƶsungsmittel, SƤure, wasserlƶsliches Salz, Verdickungsmittel, desinfizierender Inhaltsstoff sowie Kombinationen hiervon.In another embodiment of the invention, the surfactant preparation is characterized by further comprising at least one other ingredient selected from the group consisting of builder, peroxygen compound, bleach activator, nonaqueous solvent, acid, water soluble salt, thickener, disinfecting ingredient, and the like Combinations thereof.

Das HinzufĆ¼gen von einem oder mehreren der weiteren Inhaltsstoff(e) erweist sich als vorteilhaft, da hierdurch eine weiter verbesserte Reinigungsleistung und/oder Desinfektion erreicht wird. Vorzugsweise beruht die verbesserte Reinigungsleistung und/oder Desinfektion auf einem synergistischen Zusammenwirken von mindestens zwei Inhaltsstoffen. Insbesondere durch die Kombination der enthaltenen Lipase und/oder des enthaltenen Phosphonats mit einem der nachstehend beschriebenen GerĆ¼ststoffe (Builder) und/oder mit einer der nachstehend beschriebenen Persauerstoffverbindungen und/oder mit einem der nachstehend beschriebenen Bleichaktivatoren und/oder mit einem der nachfolgend beschriebenen nichtwƤssrigen Lƶsungsmittel und/oder mit einer der nachfolgend beschriebenen SƤuren und/oder mit einem der nachstehend beschriebenen wasserlƶslichen Salze und/oder mit einem der nachfolgend beschriebenen Verdickungsmittel und/oder mit einem der nachfolgend beschriebenen desinfizierenden Inhaltsstoffe kann eine solche Synergie erreicht werden.The addition of one or more of the further ingredient (s) proves to be advantageous, as this further improved cleaning performance and / or disinfection is achieved. Preferably, the improved cleaning performance and / or disinfection is based on a synergistic interaction of at least two ingredients. In particular, by the combination of the lipase and / or phosphonate contained therein with one of the builders described below and / or with one of the peroxygen compounds described below and / or with one of the bleach activators described below and / or with one of the nonaqueous solvents described below and / or with one of the acids described below and / or with one of the water-soluble salts described below and / or with one of the thickening agents described below and / or with one of the disinfecting ingredients described below, such a synergy can be achieved.

Als GerĆ¼ststoffe (Builder), die in der Tensidzubereitung enthalten sein kƶnnen, sind insbesondere Silikate, Aluminiumsilikate (insbesondere Zeolithe), Carbonate, Salze organischer Di- und PolycarbonsƤuren sowie Mischungen dieser Stoffe zu nennen.Builders which may be present in the surfactant preparation include, in particular, silicates, aluminum silicates (in particular zeolites), carbonates, salts of organic di- and polycarboxylic acids and mixtures of these substances.

Organische GerĆ¼ststoffe, welche in der Tensidzubereitung vorhanden sein kƶnnen, sind beispielsweise die in Form ihrer Natriumsalze einsetzbaren PolycarbonsƤuren, wobei unter PolycarbonsƤuren solche CarbonsƤuren verstanden werden, die mehr als eine SƤurefunktion tragen. Beispielsweise sind dies CitronensƤure, AdipinsƤure, BernsteinsƤure, GlutarsƤure, ƄpfelsƤure, WeinsƤure, MaleinsƤure, FumarsƤure, ZuckersƤuren, AminocarbonsƤuren, NitrilotriessigsƤure (NTA), MethylglycindiessigsƤure (MGDA) und deren Abkƶmmlinge sowie Mischungen aus diesen. Bevorzugte Salze sind die Salze der PolycarbonsƤuren wie CitronensƤure, AdipinsƤure, BernsteinsƤure, GlutarsƤure, WeinsƤure, ZuckersƤuren und Mischungen aus diesen.Organic builders which may be present in the surfactant preparation are, for example, the polycarboxylic acids which can be used in the form of their sodium salts, polycarboxylic acids meaning those carboxylic acids which carry more than one acid function. These are, for example, citric acid, adipic acid, succinic acid, glutaric acid, malic acid, tartaric acid, maleic acid, fumaric acid, sugar acids, aminocarboxylic acids, nitrilotriacetic acid (NTA), methylglycine diacetic acid (MGDA) and derivatives thereof and mixtures thereof. Preferred salts are the salts of polycarboxylic acids such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof.

Als GerĆ¼ststoffe sind weiter polymere Polycarboxylate geeignet. Dies sind beispielsweise die Alkalimetallsalze der PolyacrylsƤure oder der PolymethacrylsƤure, zum Beispiel solche mit einer relativen MolekĆ¼lmasse von 600 bis 750.000 g / mol.As builders further polymeric polycarboxylates are suitable. These are, for example, the alkali metal salts of polyacrylic acid or polymethacrylic acid, for example, those having a molecular weight of 600 to 750,000 g / mol.

Geeignete Polymere sind insbesondere Polyacrylate, die bevorzugt eine MolekĆ¼lmasse von 1.000 bis 15.000 g / mol aufweisen. Aufgrund ihrer Ć¼berlegenen Lƶslichkeit kƶnnen aus dieser Gruppe wiederum die kurzkettigen Polyacrylate, die Molmassen von 1.000 bis 10.000 g / mol, und besonders bevorzugt von 1.000 bis 5.000 g / mol, aufweisen, bevorzugt sein.Suitable polymers are in particular polyacrylates, which preferably have a molecular weight of from 1,000 to 15,000 g / mol. Because of their superior solubility, the short-chain polyacrylates, which have molecular weights of from 1,000 to 10,000 g / mol, and particularly preferably from 1,000 to 5,000 g / mol, may again be preferred from this group.

Geeignet sind weiterhin copolymere Polycarboxylate, insbesondere solche der AcrylsƤure mit MethacrylsƤure und der AcrylsƤure oder MethacrylsƤure mit MaleinsƤure. Zur Verbesserung der Wasserlƶslichkeit kƶnnen die Polymere auch AllylsulfonsƤuren, wie AllyloxybenzolsulfonsƤure und MethallylsulfonsƤure, als Monomer enthalten.Also suitable are copolymeric polycarboxylates, in particular those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid. To improve the water solubility, the polymers may also contain allylsulfonic acids, such as allyloxybenzenesulfonic acid and methallylsulfonic acid, as a monomer.

Bevorzugt werden allerdings lƶsliche GerĆ¼ststoffe, wie beispielsweise CitronensƤure, oder Acrylpolymere mit einer Molmassen von 1.000 bis 5.000 g / mol bevorzugt in der flĆ¼ssigen Tensidzubereitung eingesetzt.However, preference is given to using soluble builders, such as, for example, citric acid, or acrylic polymers having a molar mass of from 1,000 to 5,000 g / mol, preferably in the liquid surfactant preparation.

Bei den fĆ¼r polymere Polycarboxylate angegebenen Molmassen handelt es sich im Sinne dieser Schrift um gewichtsmittlere Molmassen Mw der jeweiligen SƤureform, die grundsƤtzlich mittels Gelpermeationschromatographie (GPC) bestimmt wurden, wobei ein UV-Detektor eingesetzt wurde. Die Messung erfolgte dabei gegen einen externen PolyacrylsƤure-Standard, der aufgrund seiner strukturellen Verwandtschaft mit den untersuchten Polymeren realistische Molgewichtswerte liefert. Diese Angaben weichen deutlich von den Molgewichtsangaben ab, bei denen PolystyrolsulfonsƤuren als Standard eingesetzt werden. Die gegen PolystyrolsulfonsƤuren gemessenen Molmassen sind in der Regel deutlich hƶher als die in dieser Schrift angegebenen Molmassen.For the purposes of this document, the molecular weights stated for polymeric polycarboxylates are weight-average molecular weights M w of the particular acid form, which were determined in principle by means of gel permeation chromatography (GPC), a UV detector being used. The measurement was carried out against an external polyacrylic acid standard, which provides realistic molecular weight values due to its structural relationship with the polymers investigated. These data differ significantly from the molecular weight data in which Polystyrene sulfonic acids are used as standard. The molar masses measured against polystyrenesulfonic acids are generally significantly higher than the molecular weights specified in this document.

Derartige organische Buildersubstanzen kƶnnen gewĆ¼nschtenfalls in Mengen bis zu 40 Gew.-%, insbesondere bis zu 25 Gew.-% und vorzugsweise von 1 Gew.-% bis 8 Gew.-% enthalten sein. Mengen nahe der genannten Obergrenze werden vorzugsweise in pastenfƶrmigen oder flĆ¼ssigen, insbesondere wasserhaltigen, Tensidzubereitungen eingesetzt.If desired, such organic builder substances may be present in amounts of up to 40% by weight, in particular up to 25% by weight and preferably from 1% by weight to 8% by weight. Amounts close to the stated upper limit are preferably used in paste-form or liquid, in particular water-containing, surfactant preparations.

Als fĆ¼r den Einsatz in erfindungsgemƤƟen Tensidzubereitungen geeignete Persauerstoffverbindungen kommen insbesondere organische PersƤuren beziehungsweise persaure Salze organischer SƤuren, wie PhthalimidopercapronsƤure, PerbenzoesƤure oder Salze der DiperdodecandisƤure, Wasserstoffperoxid und unter den Waschbedingungen Wasserstoffperoxid abgebende anorganische Salze, zu denen Perborat, Percarbonat, Persilikat und/oder Persulfat wie Caroat gehƶren, in Betracht. Falls eine Zubereitung Persauerstoffverbindungen enthƤlt, sind diese in Mengen von vorzugsweise bis zu 50 Gew.-%, insbesondere von 5 Gew.-% bis 30 Gew.-%, vorhanden. Der Zusatz geringer Mengen bekannter Bleichmittelstabilisatoren wie beispielsweise von Phosphonaten, Boraten beziehungsweise Metaboraten und Metasilikaten sowie Magnesiumsalzen wie Magnesiumsulfat kann zweckdienlich sein.Peroxygen compounds which are suitable for use in surfactant preparations according to the invention are, in particular, organic peracids or persalts of organic acids, such as phthalimidopercaproic acid, perbenzoic acid or salts of diperdodecanedioic acid, hydrogen peroxide and inorganic salts which release hydrogen peroxide under the washing conditions, such as perborate, percarbonate, persilicate and / or persulphate Caroat belong into consideration. If a preparation contains peroxygen compounds, they are present in amounts of preferably up to 50% by weight, especially from 5% to 30% by weight. The addition of small amounts of known bleach stabilizers such as phosphonates, borates or metaborates and metasilicates and magnesium salts such as magnesium sulfate may be useful.

Als Bleichaktivatoren kƶnnen Verbindungen, die unter Perhydrolysebedingungen aliphatische PeroxocarbonsƤuren mit vorzugsweise 1 bis 10 C-Atomen, insbesondere 2 bis 4 C-Atomen, und/oder gegebenenfalls substituierte PerbenzoesƤure ergeben, eingesetzt werden. Geeignet sind Substanzen, die O- und/oder N-Acylgruppen der genannten C-Atomzahl und/oder gegebenenfalls substituierte Benzoylgruppen tragen. Bevorzugt sind mehrfach acylierte Alkylendiamine, insbesondere Tetraacetylethylendiamin (TAED), acylierte Triazinderivate, insbesondere 1,5-Diacetyl-2,4-dioxohexahydro-1,3,5-triazin (DADHT), acylierte Glykolurile, insbesondere Tetraacetylglykoluril (TAGU), N-Acylimide, insbesondere N-Nonanoylsuccinimid (NOSI), acylierte Phenolsulfonate, insbesondere n-Nonanoyl- oder Isononanoyloxybenzolsulfonat (n- bzw. iso-NOBS), CarbonsƤureanhydride, insbesondere PhthalsƤureanhydrid, acylierte mehrwertige Alkohole, insbesondere Triacetin, Ethylenglykoldiacetat, 2,5-Diacetoxy-2,5-dihydrofuran und Enolester sowie acetyliertes Sorbitol und Mannitol beziehungsweise deren beschriebene Mischungen (SORMAN), acylierte Zuckerderivate, insbesondere Pentaacetylglukose (PAG), Pentaacetylfruktose, Tetraacetylxylose und Octaacetyllactose sowie acetyliertes, gegebenenfalls N-alkyliertes Glucamin und Gluconolacton, und/oder N-acylierte Lactame, beispielsweise N-Benzoylcaprolactam. Die hydrophil substituierten Acylacetale und die Acyllactame werden ebenfalls bevorzugt eingesetzt. Auch Kombinationen konventioneller Bleichaktivatoren kƶnnen eingesetzt werden. Derartige Bleichaktivatoren kƶnnen, insbesondere bei Anwesenheit obengenannter Wasserstoffperoxid-liefernder Bleichmittel, im Ć¼blichen Mengenbereich, vorzugsweise in Mengen von 0,5 Gew.-% bis 10 Gew.-%, insbesondere 1 Gew.-% bis 8 Gew.-%, bezogen auf die gesamte Tensidzubereitung, enthalten sein, fehlen bei Einsatz von PercarbonsƤure als alleinigem Bleichmittel jedoch vorzugsweise ganz.As bleach activators, it is possible to use compounds which, under perhydrolysis conditions, give aliphatic peroxycarboxylic acids having preferably 1 to 10 C atoms, in particular 2 to 4 C atoms, and / or optionally substituted perbenzoic acid. Suitable substances are those which carry O- and / or N-acyl groups of the stated C atom number and / or optionally substituted benzoyl groups. Preference is given to polyacylated alkylenediamines, in particular tetraacetylethylenediamine (TAED), acylated triazine derivatives, in particular 1,5-diacetyl-2,4-dioxohexahydro-1,3,5-triazine (DADHT), acylated glycolurils, in particular tetraacetylglycoluril (TAGU), N- Acylimides, in particular N-nonanoylsuccinimide (NOSI), acylated phenolsulfonates, in particular n-nonanoyl or isononanoyloxybenzenesulfonate (n- or iso-NOBS), carboxylic anhydrides, in particular phthalic anhydride, acylated polyhydric alcohols, in particular triacetin, ethylene glycol diacetate, 2,5-diacetoxy- 2,5-dihydrofuran and enol esters and also acetylated sorbitol and mannitol or mixtures thereof (SORMAN), acylated sugar derivatives, in particular pentaacetylglucose (PAG), pentaacetylfruktose, tetraacetylxylose and octaacetyllactose as well as acetylated, optionally N-alkylated glucamine and gluconolactone, and / or N- acylated lactams, for example N-benzoyl-caprolactam. The hydrophilic substituted acyl acetals and the acyl lactams are also preferably used. Also combinations of conventional bleach activators can be used. Such bleach activators can, in particular in the presence of the abovementioned hydrogen peroxide-producing bleach, in the usual amount range, preferably in amounts of from 0.5 wt .-% to 10 wt .-%, in particular 1 wt .-% to 8 wt .-%, based on However, the total surfactant preparation, be contained when using percarboxylic acid as the sole bleach, but preferably completely.

ZusƤtzlich zu den konventionellen Bleichaktivatoren oder an deren Stelle kƶnnen auch Sulfonimine und/oder bleichverstƤrkende Ɯbergangsmetallsalze beziehungsweise Ɯbergangsmetallkomplexe als sogenannte Bleichkatalysatoren enthalten sein.In addition to the conventional bleach activators or in their place, sulfone imines and / or bleach-enhancing transition metal salts or transition metal complexes may also be present as so-called bleach catalysts.

Die erfindungsgemƤƟen Tensidzubereitungen sind flĆ¼ssig und enthalten vorzugsweise Wasser als Hauptlƶsungsmittel. Daneben oder alternativ kƶnnen der Tensidzubereitung nichtwƤssrige Lƶsungsmittel zugesetzt werden. Geeignete nichtwƤssrige Lƶsungsmittel umfassen ein- oder mehrwertige Alkohole, Alkanolamine oder Glykolether, sofern sie im angegebenen Konzentrationsbereich mit Wasser mischbar sind. Vorzugsweise werden die Lƶsungsmittel ausgewƤhlt aus Ethanol, n-Propanol, i-Propanol, Butanolen, Glykol, Propandiol, Butandiol, Glycerin, Diglykol, Propyldiglycol, Butyldiglykol, Hexylenglycol, Ethylenglykolmethylether, Ethylenglykolethylether, Ethylenglykolpropylether, Ethylenglykolmono-n-butylether, Diethylenglykolmethylether, Diethylenglykolethylether, Propylenglykolmethylether, Propylenglykolethylether, Propylenglykolpropylether, Dipropylenglykolmonomethylether, Dipropylenglykolmonoethylether, Diisopropylenglykolmonomethylether, Di-isopropylenglykolmonoethylether, Methoxytriglykol, Ethoxytriglykol, Butoxytriglykol, 1-Butoxyethoxy-2-propanol, 3-Methyl-3-methoxybutanol, Propylenglykol-t-butylether, Di-n-octylether sowie Mischungen dieser Lƶsungsmittel. Es ist allerdings bevorzugt, dass die Tensidzubereitung ein Polyol als nicht-wƤssriges Lƶsungsmittel enthƤlt. Das Polyol kann insbesondere Glycerin, 1,2-Propandiol, 1,3-Propandiol, Ethylenglycol, Diethylenglycol und/oder Dipropylenglycol umfassen. Insbesondere bevorzugt enthƤlt die Tensidzubereitung eine Mischung aus einem Polyol und einem einwertigen Alkohol. NichtwƤssrige Lƶsungsmittel kƶnnen in der Tensidzubereitung in Mengen zwischen 0,5 und 15 Gew.-%, bevorzugt aber unter 12 Gew.-% und eingesetzt werden.The surfactant preparations according to the invention are liquid and preferably contain water as the main solvent. In addition or alternatively, non-aqueous solvents may be added to the surfactant preparation. Suitable non-aqueous solvents include mono- or polyhydric alcohols, alkanolamines or glycol ethers, provided that they are miscible with water in the specified concentration range. Preferably, the solvents are selected from ethanol, n-propanol, i-propanol, butanols, glycol, propanediol, butanediol, glycerol, diglycol, propyldiglycol, butyldiglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, ethylene glycol mono-n-butyl ether, diethylene glycol methyl ether, diethylene glycol ethyl ether, Propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, diisopropylene glycol monomethyl ether, di-isopropylene glycol monoethyl ether, methoxytriglycol, ethoxytriglycol, butoxytriglycol, 1-butoxyethoxy-2-propanol, 3-methyl-3-methoxybutanol, propylene glycol t-butyl ether, di-n-octyl ether, and the like Mixtures of these solvents. However, it is preferred that the surfactant formulation contain a polyol as a nonaqueous solvent. The polyol may in particular comprise glycerol, 1,2-propanediol, 1,3-propanediol, ethylene glycol, diethylene glycol and / or dipropylene glycol. Most preferably, the surfactant formulation contains a mixture of a polyol and a monohydric alcohol. Non-aqueous solvents may be used in the surfactant preparation in amounts of between 0.5 and 15% by weight, but preferably below 12% by weight.

Zur Einstellung eines gewĆ¼nschten, sich durch die Mischung der Ć¼brigen Komponenten nicht von selbst ergebenden pH-Werts kƶnnen die Tensidzubereitungen system- und umweltvertrƤgliche SƤuren, insbesondere CitronensƤure, EssigsƤure, WeinsƤure, ƄpfelsƤure, MilchsƤure, GlykolsƤure, BernsteinsƤure, GlutarsƤure und/oder AdipinsƤure, aber auch MineralsƤuren, insbesondere SchwefelsƤure, oder Basen, insbesondere Ammonium- oder Alkalihydroxide, enthalten. Derartige pH-Regulatoren sind in den Tensidzubereitungen in Mengen von vorzugsweise nicht Ć¼ber 20 Gew.-%, insbesondere von 1,2 Gew.-% bis 17 Gew.-%, enthalten.To set a desired, not by the mixture of the other components resulting in self-added pH, the surfactant formulations systemic and environmentally acceptable acids, especially citric acid, acetic acid, tartaric acid, malic acid, lactic acid, glycolic acid, succinic acid, glutaric acid and / or adipic acid, but Also, mineral acids, in particular sulfuric acid, or bases, in particular ammonium or alkali metal hydroxides. Such pH regulators are present in the surfactant preparations in amounts of preferably not more than 20% by weight, in particular from 1.2% by weight to 17% by weight.

Eine Tensidzubereitung im Sinne der Erfindung kann weiterhin ein oder mehrere wasserlƶsliche Salze enthalten, die beispielsweise zur ViskositƤtseinstellung dienen. Es kann sich dabei um anorganische und/oder organische Salze handeln. Einsetzbare anorganische Salze sind dabei vorzugsweise ausgewƤhlt aus der Gruppe umfassend farblose wasserlƶsliche Halogenide, Sulfate, Sulfite, Carbonate, Hydrogencarbonate, Nitrate, Nitrite, Phosphate und/oder Oxide der Alkalimetalle, der Erdalkalimetalle, des Aluminiums und/oder der Ɯbergangsmetalle; weiterhin sind Ammoniumsalze einsetzbar. Besonders bevorzugt sind dabei Halogenide und Sulfate der Alkalimetalle; vorzugsweise ist das anorganische Salz daher ausgewƤhlt aus der Gruppe umfassend Natriumchlorid, Kaliumchlorid, Natriumsulfat, Kaliumsulfat sowie Gemische derselben. Einsetzbare organische Salze sind beispielsweise farblose wasserlƶsliche Alkalimetall-, Erdalkalimetall-, Ammonium-, Aluminium- und/oder Ɯbergangsmetallsalze der CarbonsƤuren. Vorzugsweise sind die Salze ausgewƤhlt aus der Gruppe umfassend Formiat, Acetat, Propionat, Citrat, Malat, Tartrat, Succinat, Malonat, Oxalat, Lactat sowie Gemische derselben.A surfactant preparation according to the invention may further contain one or more water-soluble salts which serve, for example, for adjusting the viscosity. These may be inorganic and / or organic salts. Useful inorganic salts are preferably selected from the group consisting of colorless water-soluble halides, sulfates, sulfites, carbonates, bicarbonates, nitrates, nitrites, phosphates and / or oxides of the alkali metals, alkaline earth metals, aluminum and / or transition metals; Furthermore, ammonium salts can be used. Particularly preferred are halides and sulfates of the alkali metals; Preferably, therefore, the inorganic salt is selected from the group comprising sodium chloride, potassium chloride, sodium sulfate, potassium sulfate and mixtures thereof. Useful organic salts are, for example, colorless water-soluble alkali metal, alkaline earth metal, ammonium, aluminum and / or transition metal salts of the carboxylic acids. Preferably, the salts are selected from the group comprising formate, acetate, propionate, citrate, malate, tartrate, succinate, malonate, oxalate, lactate and mixtures thereof.

Zur Verdickung kann eine erfindungsgemƤƟe Tensidzubereitung ein oder mehrere Verdickungsmittel enthalten. Bevorzugt ist das Verdickungsmittel ausgewƤhlt aus der Gruppe umfassend Xanthan, Guar, Carrageenan, Agar-Agar, Gellan, Pektin, Johannisbrotkernmehl und Mischungen daraus. Diese Verbindungen sind auch in Gegenwart von anorganischen Salzen effektive Verdickungsmittel. In einer besonders bevorzugten AusfĆ¼hrungsform enthƤlt die Tensidzubereitung Xanthan als Verdickungsmittel, da Xanthan auch in Gegenwart von hohen Salzkonzentrationen effektiv verdickt und eine makroskopische Auftrennung der kontinuierlichen Phase verhindert. ZusƤtzlich stabilisiert das Verdickungsmittel die kontinuierliche, tensidarme Phase und verhindert eine makroskopische Phasenseparation.For thickening, a surfactant preparation according to the invention may contain one or more thickeners. Preferably, the thickener is selected from the group comprising xanthan, guar, carrageenan, agar-agar, gellan, pectin, locust bean gum and mixtures thereof. These compounds are effective thickeners even in the presence of inorganic salts. In a particularly preferred embodiment, the surfactant formulation contains xanthan gum as a thickener because xanthan effectively thickened even in the presence of high salt concentrations and prevents macroscopic separation of the continuous phase. In addition, the thickener stabilizes the continuous, low surfactant phase and prevents macroscopic phase separation.

Alternativ oder ergƤnzend kƶnnen auch (Meth)AcrylsƤure(co)polymere als Verdickungsmittel eingesetzt werden. Geeignete Acryl- und Methacryl(co)polymere umfassen beispielsweise die hochmolekularen mit einem Polyalkenylpolyether, insbesondere einem Allylether von Saccharose, Pentaerythrit oder Propylen, vernetzten Homopolymere der AcrylsƤure (INCI-Bezeichnung gemƤƟ "International Dictionary of Cosmetic Ingredients" der "The Cosmetic, Toiletry and Fragrance Association (CTFA)": Carbomer), die auch als Carboxyvinylpolymere bezeichnet werden. Solche PolyacrylsƤuren sind unter anderem unter den Handelsnamen PolygelĀ® und CarbopolĀ® erhƤltlich. Weiterhin sind beispielsweise folgende AcrylsƤure-Copolymere geeignet: (i) Copolymere von zwei oder mehr Monomeren aus der Gruppe der AcrylsƤure, MethacrylsƤure und ihrer einfachen, vorzugsweise mit C1-4-Alkanolen gebildeten, Ester (INCI Acrylates Copolymer), die beispielsweise unter den Handelsnamen AculynĀ®, AcusolĀ® oder TegoĀ® Polymer erhƤltlich sind; (ii) vernetzte hochmolekulare AcrylsƤure-Copolymere, zu denen etwa die mit einem Allylether der Saccharose oder des Pentaerythrits vernetzten Copolymere von C10-30-Alkylacrylaten mit einem oder mehreren Monomeren aus der Gruppe der AcrylsƤure, MethacrylsƤure und ihrer einfachen, vorzugsweise mit C1-4-Alkanolen gebildeten, Ester (INCI Acrylates/C10-30 Alkyl Acrylate Crosspolymer) gehƶren und die beispielsweise unter dem Handelsnamen CarbopolĀ® erhƤltlich sind. Weitere geeignete Polymere sind (Meth)AcrylsƤure(co)polymere des Typs SokalanĀ®.Alternatively or additionally, it is also possible to use (meth) acrylic acid (co) polymers as thickeners. Suitable acrylic and methacrylic (co) polymers include, for example, the high molecular weight homopolymers of acrylic acid crosslinked with a polyalkenyl polyether, in particular an allyl ether of sucrose, pentaerythritol or propylene (INCI name according to "International Dictionary of Cosmetic Ingredients" of "The Cosmetic, Toiletry and Fragrance Association (CTFA) ": carbomer), also referred to as carboxyvinyl polymers. Such polyacrylic acids are available, inter alia, under the trade names PolygelĀ® and CarbopolĀ®. Furthermore, for example, the following acrylic acid copolymers are suitable: (i) copolymers of two or more monomers from the group of acrylic acid, methacrylic acid and their simple, preferably formed with C 1-4 alkanols, esters (INCI acrylates copolymer), for example, among the Trade names AculynĀ®, AcusolĀ® or TegoĀ® Polymer are available; (ii) crosslinked high molecular weight acrylic acid copolymers, such as those crosslinked with an allyl ether of sucrose or pentaerythritol copolymers of C 10-30 alkyl acrylates with one or more Monomers from the group of acrylic acid, methacrylic acid and their simple, preferably with C 1-4 alkanols formed ester (INCI acrylates / C 10-30 alkyl acrylate crosspolymer) include and are available, for example, under the trade name CarbopolĀ®. Other suitable polymers are (meth) acrylic acid (co) polymers of the SokalanĀ® type.

Es kann bevorzugt sein, dass die erfindungsgemƤƟe Tensidzubereitung ein (Meth)AcrylsƤure(co)polymer in Kombination mit einem weiteren Verdickungsmittel, vorzugsweise Xanthan, enthƤlt. Die Tensidzubereitung kann 0,05 bis 1,5 Gew.-% und vorzugsweise 0,1 bis 1 Gew.-%, jeweils bezogen auf die gesamte Tensidzubereitung, Verdickungsmittel enthalten. Die Menge an eingesetztem Verdickungsmittel ist dabei abhƤngig von der Art des Verdickungsmittels und dem gewĆ¼nschten Grad der Verdickung.It may be preferred that the surfactant preparation according to the invention contains a (meth) acrylic acid (co) polymer in combination with a further thickener, preferably xanthan. The surfactant preparation can contain from 0.05 to 1.5% by weight and preferably from 0.1 to 1% by weight, based in each case on the total surfactant preparation, of thickening agent. The amount of thickener used depends on the type of thickener and the desired degree of thickening.

Unter einem desinfizierenden Inhaltsstoff werden insbesondere Inhaltsstoffe verstanden, die eine antimikrobielle oder antivirale Wirksamkeit besitzen, also Keime abtƶten. Die keimabtƶtende Wirkung ist dabei abhƤngig von dem Gehalt des desinfizierenden Inhaltsstoffes in der Tensidzubereitung, wobei die keimabtƶtende Wirkung mit abnehmendem Gehalt an desinfizierendem Inhaltsstoff bzw. zunehmender VerdĆ¼nnung der Tensidzubereitung abnimmt.In particular, ingredients which have an antimicrobial or antiviral activity, ie kill germs, are understood to be a disinfectant ingredient. The germicidal effect is dependent on the content of the disinfecting ingredient in the surfactant preparation, wherein the germicidal effect decreases with decreasing content of disinfecting ingredient or increasing dilution of the surfactant preparation.

Ein bevorzugter desinfizierender Inhaltsstoff ist Ethanol oder Propanol. Diese einwertigen Alkohole werden aufgrund ihrer Lƶsemitteleigenschaften und ihrer keimtƶtenden Wirkung hƤufig in Desinfektionsmitteln und auch in Reinigungsmitteln allgemein eingesetzt. Dabei umfasst der Begriff "Propanol" sowohl das 1-Propanol (n-Propanol) als auch das 2-Propanol ("Isopropanol"). Ethanol und/oder Propanol ist beispielsweise in einer Menge von insgesamt 10 bis 65 Gew.-%, vorzugsweise 25 bis 55 Gew.-% in der Tensidzubereitung enthalten. Ein weiterer bevorzugter desinfizierender Inhaltsstoff ist Teebaumƶl. Hierbei handelt es sich um das Ƥtherische Ɩl des Australischen Teebaums (Melaleuca alternifolia), einem in New South Wales und Queensland beheimateten immergrĆ¼nen Strauch aus der Gattung Myrtenheiden (Melaleuca), sowie weiterer Teebaum-Arten aus verschiedenen Gattungen (z.B. Baeckea, Kunzea und Leptospermum) in der Familie der MyrtengewƤchse (Myrtaceae). Das Teebaumƶl wird durch Wasserdampfdestillation aus den BlƤttern und Zweigspitzen dieser BƤume gewonnen und ist ein Gemisch aus ca. 100 Substanzen; zu den Hauptbestandteilen zƤhlen (+)-Terpinen-4-ol, Ī±-Terpinen, Terpinolen, Terpineol, Pinen, Myrcen, Phellandren, p-Cymen, Limonen und 1,8-Cineol. Teebaumƶl ist beispielsweise in einer Menge von 0,05 bis 10 Gew.-%, vorzugsweise 0,1 bis 5,0 Gew.-%, in der viruziden Behandlungslƶsung enthalten. Ein weiterer bevorzugter desinfizierender Inhaltsstoff ist MilchsƤure. Die MilchsƤure oder 2-HydroxypropionsƤure ist ein GƤrungsprodukt, das von verschiedenen Mikroorganismen erzeugt wird. Sie ist schwach antibiotisch aktiv. MilchsƤure ist beispielsweise in Mengen von bis zu 10 Gew.-%, vorzugsweise 0,2 bis 5,0 Gew.-% in der Tensidzubereitung enthalten.A preferred disinfecting ingredient is ethanol or propanol. These monohydric alcohols are commonly used in disinfectants and detergents because of their solvent properties and their germicidal activity. The term "propanol" includes both the 1-propanol (n-propanol) and the 2-propanol ("isopropanol"). Ethanol and / or propanol, for example, in an amount of from 10 to 65 wt .-%, preferably 25 to 55 wt .-% in the surfactant preparation. Another preferred disinfecting ingredient is tea tree oil. These are the essential oil of the Australian Tea Tree (Melaleuca alternifolia), a native of New South Wales and Queensland evergreen shrub of the genus Myrtenheiden (Melaleuca), and other tea tree species from different genera (eg Baeckea, Kunzea and Leptospermum) in the family of myrtle family (Myrtaceae). The tea tree oil is obtained by steam distillation from the leaves and branch tips of these trees and is a mixture of about 100 substances; its main constituents include (+) - terpinene-4-ol, Ī±-terpinene, terpinolene, terpineol, pinene, myrcene, phellandrene, p-cymene, limonene and 1,8-cineole. Tea tree oil is contained, for example, in an amount of 0.05 to 10% by weight, preferably 0.1 to 5.0% by weight, in the virucidal treatment solution. Another preferred disinfecting ingredient is lactic acid. The lactic acid or 2-hydroxypropionic acid is a fermentation product produced by various microorganisms. She is weakly active in antibiotics. Lactic acid is for example, in amounts of up to 10 wt .-%, preferably 0.2 to 5.0 wt .-% in the surfactant preparation.

Weitere desinfizierende Inhaltsstoffe sind beispielsweise Wirkstoffe aus den Gruppen der Alkohole, Aldehyde, antimikrobiellen SƤuren bzw. deren Salze, CarbonsƤureester, SƤureamide, Phenole, Phenolderivate, Diphenyle, Diphenylalkane, Harnstoffderivate, Sauerstoff-, Stickstoff-Acetale sowie Formale, Benzamidine, Isothiazole und deren Derivate wie Isothiazoline und Isothiazolinone, Phthalimidderivate, Pyridinderivate, antimikrobiellen oberflƤchenaktiven Verbindungen, Guanidine, antimikrobiellen amphoteren Verbindungen, Chinoline, 1,2-Dibrom-2,4-dicyanobutan, lodo-2-propynyl-butyl-carbamat, lod, lodophore und Peroxide. Hierunter bevorzugte Wirkstoffe werden vorzugsweise ausgewƤhlt aus der Gruppe umfassend 1,3-Butandiol, Phenoxyethanol, 1,2-Propylenglykol, Glycerin, UndecylensƤure, ZitronensƤure, MilchsƤure, BenzoeesƤure, SalicylsƤure, Thymol, 2-Benzyl-4-chlorphenol, 2,2'-Methylen-bis-(6-brom-4-chlorphenol), 2,4,4'-Trichlor-2'-hydroxydiphenylether, N-(4-Chlorphenyl)-N-(3,4-dichlorphenyl)-harnstoff, N,N'-(1,10-decandiyldi-1-pyridinyl-4-yliden)-bis-(1-octanamin)-dihydrochlorid, N,N'-Bis-(4-Chlorphenyl)-3,12-diimino-2,4,11,13-tetraazatetradecandiimidamid, quaternƤre oberflƤchenaktive Verbindungen, Guanidine. Bevorzugte oberflƤchenaktive quaternƤre Verbindungen enthalten eine Ammonium-, Sulfonium-, Phosphonium-, Jodonium- oder Arsoniumgruppe. Weiterhin kƶnnen auch desinfizierende Ƥtherische Ɩle eingesetzt werden, die gleichzeitig fĆ¼ eine Beduftung der viruziden Behandlungslƶsung sorgen. Besonders bevorzugte Wirkstoffe sind jedoch ausgewƤhlt aus der Gruppe umfassend SalicylsƤure, quaternƤre Tenside, insbesondere Benzalkoniumchlorid, PeroxoVerbindungen, insbesondere Wasserstoffperoxid, Alkalimetallhypochlorit sowie Gemische derselben. Ein solcher weiterer desinfizierender Inhaltsstoff ist beispielsweise in einer Menge von 0,01 bis 1 Gew.-%, vorzugsweise 0,02 bis 0,8 Gew.-%, insbesondere 0,05 bis 0,5 Gew.-%, besonders bevorzugt 0,1 bis 0,3 Gew.-%, ƤuƟerst bevorzugt 0,2 Gew.-% in der Tensidzubereitung enthalten.Further disinfectant ingredients are, for example, active compounds from the groups of alcohols, aldehydes, antimicrobial acids or their salts, carboxylic esters, acid amides, phenols, phenol derivatives, diphenyls, diphenylalkanes, urea derivatives, oxygen, nitrogen acetals and formals, benzamidines, isothiazoles and derivatives thereof such as isothiazolines and isothiazolinones, phthalimide derivatives, pyridine derivatives, antimicrobial surface active compounds, guanidines, antimicrobial amphoteric compounds, quinolines, 1,2-dibromo-2,4-dicyanobutane, iodo-2-propynyl-butyl-carbamate, iodine, iodophores and peroxides. Among these, preferred active ingredients are selected from the group comprising 1,3-butanediol, phenoxyethanol, 1,2-propylene glycol, glycerol, undecylenic acid, citric acid, lactic acid, benzoic acid, salicylic acid, thymol, 2-benzyl-4-chlorophenol, 2,2 '. -Methylene bis (6-bromo-4-chlorophenol), 2,4,4'-trichloro-2'-hydroxydiphenyl ether, N- (4-chlorophenyl) -N- (3,4-dichlorophenyl) -urea, N , N '- (1,10-decanediyldi-1-pyridinyl-4-ylidene) bis (1-octanamine) dihydrochloride, N, N'-bis (4-chlorophenyl) -3,12-diimino-2 , 4,11,13-tetraazatetradecandiimidamide, quaternary surface active compounds, guanidines. Preferred quaternary surface active compounds contain an ammonium, sulfonium, phosphonium, iodonium or arsonium group. Furthermore, disinfectant essential oils can be used, which at the same time provide for a scenting of the virucidal treatment solution. However, particularly preferred active compounds are selected from the group comprising salicylic acid, quaternary surfactants, in particular benzalkonium chloride, peroxo compounds, in particular hydrogen peroxide, alkali metal hypochlorite and mixtures thereof. Such another disinfecting ingredient is, for example, in an amount of 0.01 to 1 wt .-%, preferably 0.02 to 0.8 wt .-%, in particular 0.05 to 0.5 wt .-%, particularly preferably 0 , 1 to 0.3 wt .-%, most preferably 0.2 wt .-% in the surfactant preparation.

FlĆ¼ssige erfindungsgemƤƟe Tensidzubereitungen in Form von Ć¼bliche Lƶsungsmittel enthaltenden Lƶsungen werden in der Regel durch einfaches Mischen der Inhaltsstoffe, die in Substanz oder als Lƶsung in einen automatischen Mischer gegeben werden kƶnnen, hergestellt.Liquid surfactant preparations according to the invention in the form of customary solvent-containing solutions are generally prepared by simply mixing the ingredients, which can be added in bulk or as a solution in an automatic mixer.

ErfindungsgemƤƟe Tensidzubereitungen kƶnnen als enzymatische Bestandteile ausschlieƟlich eine Lipase enthalten wie beschrieben. Alternativ kƶnnen sie auch weitere hydrolytische Enzyme oder andere Enzyme in einer fĆ¼r die Wirksamkeit der Tensidzubereitung zweckmƤƟigen Konzentration enthalten. In einer weiteren AusfĆ¼hrungsform der Erfindung umfasst die Tensidzubereitung daher mindestens ein weiteres Enzym. Prinzipiell sind diesbezĆ¼glich alle im Stand der Technik fĆ¼r diese Zwecke etablierten Enzyme einsetzbar. Als weitere Enzyme bevorzugt einsetzbar sind alle Enzyme, die in einer erfindungsgemƤƟen Tensidzubereitung eine katalytische AktivitƤt entfalten kƶnnen, insbesondere eine Protease, Amylase, Cellulase, Hemicellulase, Mannanase, Pektinase, Tannase, Xylanase, Xanthanase, Ɵ-Glucosidase, Carrageenase, Perhydrolase, Oxidase, Oxidoreduktase oder eine weitere Lipase, sowie deren Gemische. Weitere Enzyme sind in der Tensidzubereitung vorteilhafterweise jeweils in einer Gesamtmenge von 1 x 10-8 bis 5 Gew.-% bezogen auf aktives Protein enthalten. Zunehmend bevorzugt ist jedes weitere Enzym in einer Menge von 1 x 10-7 -3 Gew.-%, von 0,00001-1 Gew.-%, von 0,00005-0,5 Gew.-%, von 0,0001 bis 0,1 Gew.-% und besonders bevorzugt von 0,0001 bis 0,05 Gew.-% in erfindungsgemƤƟen Tensidzubereitungen enthalten, bezogen auf aktives Protein. Besonders bevorzugt zeigen die Enzyme synergistische Reinigungsleistungen gegenĆ¼ber bestimmten Anschmutzungen oder Flecken, d.h. die in der Tensidzubereitung enthaltenen Enzyme unterstĆ¼tzen sich in ihrer Reinigungsleistung gegenseitig. Ganz besonders bevorzugt liegt ein solcher Synergismus vor zwischen der enthaltenen Lipase und einem weiteren Enzym der erfindungsgemƤƟen Tensidzubereitung, darunter insbesondere zwischen der Lipase und einer Protease und/oder einer Amylase und/oder einer Mannanase und/oder einer Cellulase und/oder einer Pektinase. Synergistische Effekte kƶnnen nicht nur zwischen verschiedenen Enzymen, sondern auch zwischen einem oder mehreren Enzymen und weiteren Inhaltsstoffen der erfindungsgemƤƟen Tensidzubereitung auftreten.Surfactant preparations according to the invention may contain as enzymatic constituents exclusively a lipase as described. Alternatively, they may also contain other hydrolytic enzymes or other enzymes in a concentration useful for the effectiveness of the surfactant formulation. In a further embodiment of the invention, therefore, the surfactant preparation comprises at least one further enzyme. In principle, all the enzymes established in the prior art for this purpose can be used in this regard. Preferred as further enzymes all enzymes which can develop a catalytic activity in a surfactant preparation according to the invention can be used, in particular a protease, amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, .beta.-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreductase or another Lipase, as well as their mixtures. Further enzymes are advantageously contained in the surfactant preparation, in each case in a total amount of from 1 Ɨ 10 -8 to 5% by weight, based on active protein. More preferably, each further enzyme is in an amount of 1 x 10 -7 -3 wt%, from 0.00001 to 1 wt%, from 0.00005 to 0.5 wt%, from 0.0001 to 0.1 wt .-% and particularly preferably from 0.0001 to 0.05 wt .-% in inventive surfactant preparations, based on active protein. Particularly preferably, the enzymes show synergistic cleaning performance against certain stains or stains, ie the enzymes contained in the surfactant preparation support each other in their cleaning performance. Very particular preference is given to such synergism between the lipase contained and another enzyme of the surfactant preparation according to the invention, including in particular between the lipase and a protease and / or an amylase and / or a mannanase and / or a cellulase and / or a pectinase. Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the surfactant preparation according to the invention.

Unter den Proteasen sind solche vom Subtilisin-Typ bevorzugt. Beispiele hierfĆ¼r sind die Subtilisine BPN' und Carlsberg, die Protease PB92, die Subtilisine 147 und 309, die Alkalische Protease aus Bacillus lentus, Subtilisin DY und die den Subtilasen, nicht mehr jedoch den Subtilisinen im engeren Sinne zuzuordnenden Enzyme Thermitase, Proteinase K und die Proteasen TW3 und TW7. Subtilisin Carlsberg ist in weiterentwickelter Form unter dem Handelsnamen AlcalaseĀ® von der Firma Novozymes A/S, Bagsvaard, DƤnemark, erhƤltlich. Die Subtilisine 147 und 309 werden unter den Handelsnamen EsperaseĀ®, beziehungsweise SavinaseĀ® von der Firma Novozymes vertrieben. Von der Protease aus Bacillus lentus DSM 5483 leiten sich die unter der Bezeichnung BLAPĀ® gefĆ¼hrten Protease-Varianten ab. Weitere brauchbare Proteasen sind beispielsweise die unter den Handelsnamen DurazymĀ®, RelaseĀ®, EverlaseĀ®, NafizymĀ®, NatalaseĀ®, KannaseĀ® und OvozymeĀ® von der Firma Novozymes, die unter den Handelsnamen, PurafectĀ®, PurafectĀ® OxP, PurafectĀ® Prime, ExcellaseĀ® und ProperaseĀ® von der Firma Genencor, das unter dem Handelsnamen ProtosolĀ® von der Firma Advanced Biochemicals Ltd., Thane, Indien, das unter dem Handelsnamen WuxiĀ® von der Firma Wuxi Snyder Bioproducts Ltd., China, die unter den Handelsnamen ProleatherĀ® und Protease PĀ® von der Firma Amano Pharmaceuticals Ltd., Nagoya, Japan, und das unter der Bezeichnung Proteinase K-16 von der Firma Kao Corp., Tokyo, Japan, erhƤltlichen Enzyme. Besonders bevorzugt eingesetzt werden auch die Proteasen aus Bacillus gibsonii und Bacillus pumilus, die offenbart sind in den internationalen Patentanmeldungen WO2008/086916 und WO2007/131656 .Among the proteases, those of the subtilisin type are preferable. Examples thereof are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the alkaline protease from Bacillus lentus, subtilisin DY and the enzymes thermitase, proteinase K and the subtilases, but not the subtilisins in the narrower sense Proteases TW3 and TW7. Subtilisin Carlsberg is available in a further developed form under the trade name AlcalaseĀ® from Novozymes A / S, Bagsvaard, Denmark. The subtilisins 147 and 309 are sold under the trade names EsperaseĀ®, and SavinaseĀ® by the company Novozymes. From the protease from Bacillus lentus DSM 5483 derived under the name BLAPĀ® protease variants derived. Further useful proteases are, for example, those under the trade names DurazymĀ®, RelaseĀ®, EverlaseĀ®, NafizymĀ®, NatalaseĀ®, KannaseĀ® and OvozymeĀ® from Novozymes, which are available under the trade names, PurafectĀ®, PurafectĀ® OxP, PurafectĀ® Prime, ExcellaseĀ® and ProperaseĀ® from Genencor, sold under the trade name ProtosolĀ® by Advanced Biochemicals Ltd., Thane, India, under the trade name WuxiĀ® by Wuxi Snyder Bioproducts Ltd., China, under the trade names Proleather Ā® and Protease PĀ® from Amano Pharmaceuticals Ltd., Nagoya, Japan, and the enzyme available under the name Proteinase K-16 from Kao Corp., Tokyo, Japan. The proteases are also used with particular preference Bacillus gibsonii and Bacillus pumilus disclosed in international patent applications WO2008 / 086916 and WO2007 / 131656 ,

ErfindungsgemƤƟ konfektionierbare Amylasen sind beispielsweise die Ī±-Amylasen aus Bacillus licheniformis, aus Bacillus amyloliquefaciens oder aus Bacillus stearothermophilus sowie insbesondere auch deren fĆ¼r den Einsatz in Wasch- oder Reinigungsmitteln verbesserte Weiterentwicklungen. Das Enzym aus Bacillus licheniformis ist von dem Unternehmen Novozymes unter dem Namen TermamylĀ® und von dem Unternehmen Danisco/Genencor unter dem Namen PurastarĀ®ST erhƤltlich. Weiterentwicklungsprodukte dieser Ī±-Amylase sind von dem Unternehmen Novozymes unter den Handelsnamen DuramylĀ® und TermamylĀ®ultra, von dem Unternehmen Danisco/Genencor unter dem Namen PurastarĀ®OxAm und von dem Unternehmen Daiwa Seiko Inc., Tokyo, Japan, als KeistaseĀ® erhƤltlich. Die Ī±-Amylase von Bacillus amyloliquefaciens wird von dem Unternehmen Novozymes unter dem Namen BANĀ® vertrieben, und abgeleitete Varianten von der Ī±-Amylase aus Bacillus stearothermophilus unter den Namen BSGĀ® und NovamylĀ®, ebenfalls von dem Unternehmen Novozymes. Desweiteren sind fĆ¼r diesen Zweck die Ī±-Amylase aus Bacillus sp. A 7-7 (DSM 12368) und die Cyclodextrin-Glucanotransferase (CGTase) aus Bacillus agaradherens (DSM 9948) hervorzuheben. Ebenso sind Fusionsprodukte aller genannten MolekĆ¼le einsetzbar. DarĆ¼ber hinaus sind die unter den Handelsnamen FungamylĀ® von dem Unternehmen Novozymes erhƤltlichen Weiterentwicklungen der Ī±-Amylase aus Aspergillus niger und A. oryzae geeignet. Weitere vorteilhaft einsetzbare Handelsprodukte sind beispielsweise die Amylase-LTĀ® und StainzymeĀ® oder Stainzyme ultraĀ® bzw. Stainzyme plusĀ®, letztere ebenfalls von dem Unternehmen Novozymes. Auch durch Punktmutationen erhƤltliche Varianten dieser Enzyme kƶnnen erfindungsgemƤƟ eingesetzt werden. Besonders bevorzugte Amylasen sind offenbart in den internationalen Offenlegungsschriften WO 00/60060 , WO 03/002711 , WO 03/054177 und WO07/079938 , auf deren Offenbarung daher ausdrĆ¼cklich verwiesen wird bzw. deren diesbezĆ¼glicher Offenbarungsgehalt daher ausdrĆ¼cklich in die vorliegende Patentanmeldung mit einbezogen wird. ErfindungsgemƤƟ konfektionierbare Amylasen sind ferner vorzugsweise Ī±-Amylasen.Amylases which can be synthesized according to the invention are, for example, the Ī±-amylases from Bacillus licheniformis, from Bacillus amyloliquefaciens or from Bacillus stearothermophilus, and in particular also their further developments improved for use in detergents or cleaners. The enzyme from Bacillus licheniformis is available from the company Novozymes under the name TermamylĀ® and from the company Danisco / Genencor under the name PurastarĀ®ST. Further development products of this Ī±-amylase are available from the company Novozymes under the trade name DuramylĀ® and TermamylĀ®ultra, from the company Danisco / Genencor under the name PurastarĀ®OxAm and from the company Daiwa Seiko Inc., Tokyo, Japan, as KeistaseĀ®. The Bacillus amyloliquefaciens Ī±-amylase is sold by the company Novozymes under the name BANĀ®, and variants derived from the Bacillus stearothermophilus Ī±-amylase under the names BSGĀ® and NovamylĀ®, also from the company Novozymes. Furthermore, for this purpose, the Ī±-amylase from Bacillus sp. A 7-7 (DSM 12368) and cyclodextrin glucanotransferase (CGTase) from Bacillus agaradherens (DSM 9948). Likewise, fusion products of all the molecules mentioned can be used. In addition, the further developments of the Ī±-amylase from Aspergillus niger and A. oryzae available under the trade name FungamylĀ® from the company Novozymes are suitable. Further advantageously usable commercial products are, for example, the amylase-LTĀ® and StainzymeĀ® or Stainzyme ultraĀ® or Stainzyme plusĀ®, the latter also from the company Novozymes. Also variants of these enzymes obtainable by point mutations can be used according to the invention. Particularly preferred amylases are disclosed in International Publications WO 00/60060 . WO 03/002711 . WO 03/054177 and WO07 / 079938 , whose disclosure is therefore expressly referred to, or whose disclosure in this regard is therefore expressly incorporated into the present patent application. Further, amylases which can be synthesized according to the invention are preferably .alpha.-amylases.

Beispiele fĆ¼r zusƤtzliche erfindungsgemƤƟ konfektionierbare Lipasen oder Cutinasen, die insbesondere wegen ihrer Triglycerid-spaltenden AktivitƤten enthalten sind, aber auch, um aus geeigneten Vorstufen in situ PersƤuren zu erzeugen, sind die ursprĆ¼nglich aus Humicola lanuginosa (Thermomyces lanuginosus) erhƤltlichen, beziehungsweise weiterentwickelten Lipasen, insbesondere solche mit dem AminosƤureaustausch D96L. Sie werden beispielsweise von der Firma Novozymes unter den Handelsnamen LipolaseĀ®, LipolaseĀ®Ultra, LipoPrimeĀ®, LipozymeĀ® und LipexĀ® vertrieben. Desweiteren sind beispielsweise die Cutinasen einsetzbar, die ursprĆ¼nglich aus Fusarium solani pisi und Humicola insolens isoliert worden sind. Von der Firma Genencor sind beispielsweise die Lipasen beziehungsweise Cutinasen einsetzbar, deren Ausgangsenzyme ursprĆ¼nglich aus Pseudomonas mendocina und Fusarium solanii isoliert worden sind. Als weitere wichtige Handelsprodukte sind die ursprĆ¼nglich von der Firma Gist-Brocades vertriebenen PrƤparationen M1 LipaseĀ® und LipomaxĀ® und die von der Firma Meito Sangyo KK, Japan, unter den Namen Lipase MY-30Ā®, Lipase OFĀ® und Lipase PLĀ® vertriebenen Enzyme zu erwƤhnen, ferner das Produkt LumafastĀ® von der Firma Genencor.Examples of additional lipases or cutinases which can be synthesized according to the invention, which are contained in particular because of their triglyceride-cleaving activities, but also in order to generate in situ peracids from suitable precursors, are the lipases which are originally obtainable from Humicola lanuginosa (Thermomyces lanuginosus) or further developed, in particular those with the amino acid exchange D96L. They are sold for example by the company Novozymes under the trade names LipolaseĀ®, LipolaseĀ®Ultra, LipoPrimeĀ®, LipozymeĀ® and LipexĀ®. Furthermore, for example, the cutinases can be used, which were originally isolated from Fusarium solani pisi and Humicola insolens. From the company Genencor are For example, the lipases or cutinases can be used whose initial enzymes were originally isolated from Pseudomonas mendocina and Fusarium solanii. Other important commercial products are the preparations M1 Lipase.RTM. And Lipomax.RTM. Originally sold by Gist-Brocades and the enzymes marketed by Meito Sangyo KK, Japan, under the name Lipase MY-30Ā®, Lipase OFĀ® and Lipase PLĀ® to mention also the product LumafastĀ® from the company Genencor.

ErfindungsgemƤƟe Wasch- oder Reinigungsmittel kƶnnen ferner Cellulasen enthalten, je nach Zweck als reine Enzyme, als EnzymprƤparationen oder in Form von Mischungen, in denen sich die einzelnen Komponenten vorteilhafterweise hinsichtlich ihrer verschiedenen Leistungsaspekte ergƤnzen. Zu diesen Leistungsaspekten zƤhlen insbesondere BeitrƤge zur PrimƤrwaschleistung, zur SekundƤrwaschleistung des Mittels (Antiredepositionswirkung oder Vergrauungsinhibition) und Avivage (Gewebewirkung), bis hin zum AusĆ¼ben eines "stone washed"-Effekts.Detergents or cleaning agents according to the invention may also contain cellulases, depending on the purpose, as pure enzymes, as enzyme preparations or in the form of mixtures in which the individual components advantageously supplement each other in terms of their various performance aspects. These performance aspects include, in particular, contributions to the primary washing performance, the secondary washing performance of the composition (anti-redeposition effect or graying inhibition) and softening (fabric effect), up to the exercise of a "stone washed" effect.

ErfindungsgemƤƟ konfektionierbare Cellulasen (Endoglucanasen, EG) umfassen beispielsweise die pilzliche, Endoglucanase(EG)-reiche Cellulase-PrƤparation beziehungsweise deren Weiterentwicklungen, die von dem Unternehmen Novozymes unter dem Handelsnamen CelluzymeĀ® angeboten wird. Die ebenfalls von dem Unternehmen Novozymes erhƤltlichen Produkte EndolaseĀ® und CarezymeĀ® basieren auf der 50 kD-EG, beziehungsweise der 43 kD-EG aus Humicola insolens DSM 1800. Weitere einsetzbare Handelsprodukte dieses Unternehmens sind CellusoftĀ®, RenozymeĀ® und CellucleanĀ®. Weiterhin einsetzbar sind beispielsweise Cellulasen, die von dem Unternehmen AB Enzymes, Finnland, unter den Handelsnamen EcostoneĀ® und BiotouchĀ® erhƤltlich sind, und die zumindest zum Teil auf der 20 kD-EG aus Melanocarpus basieren. Weitere Cellulasen von dem Unternehmen AB Enzymes sind EconaseĀ® und EcopulpĀ®. Weitere geeignete Cellulasen sind aus Bacillus sp. CBS 670.93 und CBS 669.93, wobei die aus Bacillus sp. CBS 670.93 von dem Unternehmen Danisco/Genencor unter dem Handelsnamen PuradaxĀ® erhƤltlich ist. Weitere verwendbare Handelsprodukte des Unternehmens Danisco/Genencor sind "Genencor detergent cellulase L" und IndiAgeĀ®Neutra. Auch durch Punktmutationen erhƤltliche Varianten dieser Enzyme kƶnnen erfindungsgemƤƟ eingesetzt werden. Besonders bevorzugte Cellulasen sind Thielavia terrestris Cellulasevarianten, die in der internationalen Offenlegungsschrift WO 98/12307 offenbart sind, Cellulasen aus Melanocarpus, insbesondere Melanocarpus albomyces, die in der internationalen Offenlegungsschrift WO 97/14804 offenbart sind, Cellulasen vom EGIII-Typ aus Trichoderma reesei, die in der europƤischen Patentanmeldung EP 1 305 432 offenbart sind bzw. hieraus erhƤltliche Varianten, insbesondere diejenigen, die offenbart sind in den europƤischen Patentanmeldungen EP 1240525 und EP 1305432 , sowie Cellulasen, die offenbart sind in den internationalen Offenlegungsschriften WO 1992006165 , WO 96/29397 und WO 02/099091 . Auf deren jeweilige Offenbarung wird daher ausdrĆ¼cklich verwiesen bzw. deren diesbezĆ¼glicher Offenbarungsgehalt wird daher ausdrĆ¼cklich in die vorliegende Patentanmeldung mit einbezogen.Cellulases (endoglucanases, EG) which can be synthesized according to the invention comprise, for example, the fungal cellulase preparation rich in endoglucanase (EG) or its further developments, which is offered by the company Novozymes under the trade name CelluzymeĀ®. EndolaseĀ® and CarezymeĀ®, also available from Novozymes, are based on the 50 kD EG or 43 kD EG from Humicola insolens DSM 1800. Further commercial products of this company are CellusoftĀ®, RenozymeĀ® and CellucleanĀ®. Further usable are, for example, cellulases available from the company AB Enzymes, Finland, under the trade names EcostoneĀ® and BiotouchĀ®, which are based, at least in part, on the 20 kD-EG of melanocarpus. Other cellulases from AB Enzymes are EconaseĀ® and EcopulpĀ®. Other suitable cellulases are from Bacillus sp. CBS 670.93 and CBS 669.93, those derived from Bacillus sp. CBS 670.93 is available from the company Danisco / Genencor under the trade name PuradaxĀ®. Other usable commercial products of the company Danisco / Genencor are "Genencor detergent cellulase L" and IndiAgeĀ®Neutra. Also variants of these enzymes obtainable by point mutations can be used according to the invention. Particularly preferred cellulases are Thielavia terrestris cellulase variants described in International Publication WO 98/12307 Cellulases from Melanocarpus, in particular Melanocarpus albomyces, disclosed in the international publication WO 97/14804 Cellulases of the EGIII type from Trichoderma reesei disclosed in the European patent application EP 1 305 432 and variations obtainable therefrom, in particular those disclosed in the European patent applications EP 1240525 and EP 1305432 , as well as cellulases, which are disclosed in international publications WO 1992006165 . WO 96/29397 and WO 02/099091 , On their respective disclosure is therefore expressly referenced or their disclosure in this regard is therefore expressly included in the present patent application.

Ferner kƶnnen insbesondere zur Entfernung bestimmter Problemanschmutzungen weitere Enzyme eingesetzt sein, die unter dem Begriff Hemicellulasen zusammengefasst werden. Hierzu gehƶren beispielsweise Mannanasen, Xanthanlyasen, Xanthanasen, Pektinlyasen (=Pektinasen), Pektinesterasen, Pektatlyasen, Xyloglucanasen, Xylanasen, Pullulanasen und Ī²-Glucanasen. DiesbezĆ¼glich geeignete Enzyme sind beispielsweise unter den Namen GamanaseĀ® und Pektinex ARĀ® von der Firma Novozymes, unter dem Namen RohapecĀ® B1L von der Firma AB Enzymes und unter dem Namen PyrolaseĀ® von der Firma Diversa Corp., San Diego, CA, USA erhƤltlich. Die aus Bacillus subtilis gewonnene Ī²-Glucanase ist unter dem Namen CerefloĀ® von der Firma Novozymes erhƤltlich. ErfindungsgemƤƟ besonders bevorzugte Hemicellulasen sind Mannanasen, welche beispielsweise unter den Handelsnamen MannawayĀ® von dem Unternehmen Novozymes oder PurabriteĀ® von dem Unternehmen Genencor vertrieben werden.Furthermore, in particular for the removal of certain problem soiling, further enzymes can be used, which are summarized by the term hemicellulases. These include, for example, mannanases, xanthan lyases, xanthanases, pectin lyases (= pectinases), pectin esterases, pectate lyases, xyloglucanases, xylanases, pullulanases and Ī²-glucanases. Suitable enzymes for this purpose are available, for example, under the name GamanaseĀ® and Pektinex ARĀ® from Novozymes, under the name RohapecĀ® B1L from AB Enzymes and under the name PyrolaseĀ® from Diversa Corp., San Diego, CA, USA , The Ī²-glucanase obtained from Bacillus subtilis is available under the name CerefloĀ® from Novozymes. Hemicellulases which are particularly preferred according to the invention are mannanases which are sold, for example, under the trade names MannawayĀ® by the company Novozymes or PurabriteĀ® by the company Genencor.

Zur Erhƶhung der bleichenden Wirkung kann eine erfindungsgemƤƟe Tensidzubereitung auch Oxidoreduktasen, beispielsweise Oxidasen, Oxygenasen, Katalasen (die bei niedrigen H2O2-Konzentrationen als Peroxidase reagieren), Peroxidasen, wie Halo-, Chloro-, Bromo-, Lignin-, Glucose- oder Manganperoxidasen, Dioxygenasen oder Laccasen (Phenoloxidasen, Polyphenoloxidasen) enthalten. Als geeignete Handelsprodukte sind DeniliteĀ® 1 und 2 der Firma Novozymes zu nennen. Als vorteilhaft einsetzbare Beispielsysteme fĆ¼r eine enzymatische Perhydrolyse wird auf die Anmeldungen WO 98/45398 A1 , WO 2005/056782 A2 sowie WO 2004/058961 A1 verwiesen. Ein kombiniertes enzymatisches Bleichsystem, umfassend eine Oxidase und eine Perhydrolase beschreibt die Anmeldung WO 2005/124012 . Vorteilhafterweise werden zusƤtzlich vorzugsweise organische, besonders bevorzugt aromatische, mit den Enzymen wechselwirkende Verbindungen zugegeben, um die AktivitƤt der betreffenden Oxidoreduktasen zu verstƤrken (Enhancer) oder um bei stark unterschiedlichen Redoxpotentialen zwischen den oxidierenden Enzymen und den Anschmutzungen den ElektronenfluƟ zu gewƤhrleisten (Mediatoren).To increase the bleaching effect, a surfactant preparation according to the invention may also contain oxidoreductases, for example oxidases, oxygenases, catalases (which react as peroxidase at low H 2 O 2 concentrations), peroxidases, such as halo-, chloro-, bromo-, lignin-, glucose- or manganese peroxidases, dioxygenases or laccases (phenol oxidases, polyphenol oxidases). Suitable commercial products are DeniliteĀ® 1 and 2 from Novozymes. As an example of advantageous systems for enzymatic perhydrolysis can be applied to the applications WO 98/45398 A1 . WO 2005/056782 A2 such as WO 2004/058961 A1 directed. A combined enzymatic bleaching system comprising an oxidase and a perhydrolase describes the application WO 2005/124012 , Advantageously, it is additionally preferred to add organic, particularly preferably aromatic, compounds which interact with the enzymes in order to enhance the activity of the relevant oxidoreductases (enhancers) or to ensure the flow of electrons (mediators) at greatly varying redox potentials between the oxidizing enzymes and the soils.

Die erfindungsgemƤƟ einzusetzenden Enzyme kƶnnen ferner zusammen mit Begleitstoffen, etwa aus der Fermentation, oder mit Stabilisatoren konfektioniert sein und in einer derartigen Konfektionierungsform in eine erfindungsgemƤƟe Tensidzubereitung eingearbeitet werden.The enzymes to be used according to the invention may also be formulated together with accompanying substances, for example from the fermentation, or with stabilizers and incorporated in such a formulation in a surfactant preparation according to the invention.

Einen weiteren Erfindungsgegenstand stellt die Verwendung einer erfindungsgemƤƟen Tensidzubereitung zur Entfernung von Anschmutzungen, insbesondere von lipase-sensitiven Anschmutzungen, auf Textilien oder harten OberflƤchen, d.h. zur Reinigung von Textilien oder von harten OberflƤchen, dar. Denn erfindungsgemƤƟe Tensidzubereitungen kƶnnen, insbesondere auf Grund der enthaltenen Kombination von Phosphonat und Lipase, vorteilhaft dazu verwendet werden, um von Textilien oder von harten OberflƤchen entsprechende Verunreinigungen zu beseitigen. AusfĆ¼hrungsformen dieses Erfindungsgegenstandes stellen beispielsweise die HandwƤsche, die manuelle Entfernung von Flecken von Textilien oder von harten OberflƤchen oder die Verwendung im Zusammenhang mit einem maschinellen Verfahren dar. Alle Sachverhalte, GegenstƤnde und AusfĆ¼hrungsformen, die fĆ¼r erfindungsgemƤƟe Tensidzubereitungen beschrieben sind, sind auch auf diesen Erfindungsgegenstand anwendbar. Daher wird an dieser Stelle ausdrĆ¼cklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch fĆ¼r die vorstehende erfindungsgemƤƟe Verwendung gilt. Entsprechendes gilt fĆ¼r die Verwendung einer erfindungsgemƤƟen Tensidzubereitung zur Desinfektion.A further subject of the invention is the use of a surfactant preparation according to the invention for the removal of stains, in particular of lipase-sensitive stains, on textiles or hard surfaces, ie for the cleaning of textiles or of hard surfaces. For example, surfactant preparations according to the invention may be used, in particular because of the combination of phosphonate and lipase, advantageously in order to remove impurities from textiles or from hard surfaces. Embodiments of this subject invention include, for example, hand washing, manual removal of stains from textiles or hard surfaces, or use in conjunction with a machine process. All aspects, articles, and embodiments described for surfactant formulations of the invention are also applicable to this subject of the invention , Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also applies to the above inventive use. The same applies to the use of a surfactant preparation according to the invention for disinfection.

Einen weiteren Erfindungsgegenstand stellt ein Verfahren zur Reinigung von Textilien oder harten OberflƤchen oder zur Desinfektion dar, wobei in mindestens einem Verfahrensschritt eine erfindungsgemƤƟe Tensidzubereitung angewendet wird.A further subject of the invention is a process for the cleaning of textiles or hard surfaces or for disinfection, wherein in at least one process step a surfactant preparation according to the invention is used.

Ein weiterer Gegenstand der Erfindung ist ein Verfahren, insbesondere eine Wasch-, Reinigungs-oder Desinfektionsverfahren, in dem eine Waschflotte, die ein Phosphonat und eine Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucorjavanicus ist, umfasst, mit einer lipase-sensitiven Anschmutzung oder einem Keim auf einem Textil oder einer harten OberflƤche in Kontakt gebracht wird.The invention furthermore relates to a process, in particular a washing, cleaning or disinfecting process, in which a wash liquor which comprises a phosphonate and a lipase which is naturally present in a microorganism, the microorganism being Rhizopus oryzae or Mucorjavanicus, is contacted with a lipase-sensitive soil or germ on a textile or hard surface.

Hierunter fallen sowohl manuelle als auch maschinelle Verfahren, wobei maschinelle Verfahren aufgrund ihrer prƤziseren Steuerbarkeit, was beispielsweise die eingesetzten Mengen und Einwirkzeiten angeht, bevorzugt sind. Verfahren zur Reinigung von Textilien zeichnen sich im Allgemeinen dadurch aus, dass eine oder mehrere reinigungsaktive Substanzen auf das Reinigungsgut aufgebracht und nach der Einwirkzeit abgewaschen werden. Insbesondere wird das Reinigungsgut mit der Tensidzubereitung oder der durch sie gebildeten Waschflotte behandelt, vorzugsweise fĆ¼r eine bestimmte Mindestdauer, beispielsweise 5, 10, 15, 20, 25, 30, 40, 50 oder 60 Minuten. Entsprechendes gilt fĆ¼r Verfahren zur Reinigung von allen anderen Materialien als Textilien, insbesondere von harten OberflƤchen. Bei Desinfektionsverfahren wird der abzutƶtende Keim mit der Tensidzubereitung bzw. der durch sie gebildeten Waschflotte in Kontakt gebracht, vorzugsweise fĆ¼r eine bestimmte Mindestdauer, beispielsweise 5, 10, 15, 20, 25, 30, 40, 50 oder 60 Minuten. Alle denkbaren Wasch-, Reinigungs- oder Desinfektionsverfahren kƶnnen in wenigstens einem der Verfahrensschritte um die Anwendung einer erfindungsgemƤƟen Tensidzubereitung beziehungsweise um die Anwendung einer erfindungsgemƤƟen Lipase in Kombination mit einem Phosphonat bereichert werden und stellen dann AusfĆ¼hrungsformen der vorliegenden Erfindung dar. Alle Sachverhalte, GegenstƤnde und AusfĆ¼hrungsformen, die fĆ¼r erfindungsgemƤƟe Tensidzubereitungen beschrieben sind, sind auch auf diese ErfindungsgegenstƤnde anwendbar. Daherwird an dieser Stelle ausdrĆ¼cklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch fĆ¼r die vorstehenden erfindungsgemƤƟen Verfahren gilt.This includes both manual and mechanical processes, with mechanical processes being preferred on account of their more precise controllability, for example with regard to the quantities and reaction times used. Processes for cleaning textiles are generally characterized in that one or more cleaning-active substances are applied to the items to be cleaned and washed off after the action time. In particular, the cleaning product is treated with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes. The same applies to processes for cleaning all other materials than textiles, especially hard surfaces. In disinfection process, the germ to be killed is brought into contact with the surfactant preparation or the wash liquor formed by it, preferably for a certain minimum duration, for example 5, 10, 15, 20, 25, 30, 40, 50 or 60 minutes. All conceivable washing, cleaning or disinfection methods can be enriched in at least one of the method steps to the application of a surfactant preparation according to the invention or to the application of a lipase according to the invention in combination with a phosphonate and then provide embodiments of All facts, objects and embodiments described for surfactant preparations according to the invention are also applicable to these subjects of the invention. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the note that this disclosure also applies to the above inventive method.

In einer bevorzugten AusfĆ¼hrungsform ist ein erfindungsgemƤƟes Verfahren dadurch gekennzeichnet, dass die Lipase in der Waschflotte in einer Konzentration von 0,0000003 bis 0,0004 Gew.-%, bevorzugt von 0,0000005 bis 0,0003 Gew.-% vorliegt, wobei die Angaben auf Aktivprotein in der Waschflotte bezogen sind. In einerweiteren bevorzugten AusfĆ¼hrungsform ist ein erfindungsgemƤƟes Verfahren dadurch gekennzeichnet, dass es bei einer Temperatur zwischen 10Ā°C und 80Ā°C, bevorzugt zwischen 10Ā°C und 70Ā°C und besonders bevorzugt zwischen 20Ā°C und 60Ā°C durchgefĆ¼hrt wird.In a preferred embodiment, a method according to the invention is characterized in that the lipase is present in the wash liquor in a concentration of 0.0000003 to 0.0004 wt .-%, preferably from 0.0000005 to 0.0003 wt .-%, wherein the Details are based on active protein in the wash liquor. In a further preferred embodiment, a method according to the invention is characterized in that it is carried out at a temperature between 10 Ā° C and 80 Ā° C, preferably between 10 Ā° C and 70 Ā° C and more preferably between 20 Ā° C and 60 Ā° C.

ErfindungsgemƤƟ vorgesehene Lipasen sind vorteilhaft in erfindungsgemƤƟen Tensidzubereitungen sowie Verfahren, insbesondere Wasch-, Reinigungs- oder Desinfektionsverfahren, einsetzbar. Sie kƶnnen also vorteilhaft dazu verwendet werden, um in entsprechenden Zubereitungen eine lipolytische AktivitƤt bereitzustellen.Lipases provided according to the invention are advantageously usable in surfactant preparations according to the invention and processes, in particular washing, cleaning or disinfection processes. They can therefore be used advantageously to provide lipolytic activity in corresponding preparations.

Einen weiteren Gegenstand der Erfindung stellt daher die Verwendung einer Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucorjavanicus ist, zur Bereitstellung einer lipolytischen AktivitƤt in einer flĆ¼ssigen Tensidzubereitung, welche ferner ein Phosphonat umfasst, dar.Another object of the invention, therefore, is the use of a lipase naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucorjavanicus, for providing a lipolytic activity in a liquid surfactant preparation further comprising a phosphonate.

Ein weiterer Gegenstand der Erfindung ist die Verwendung einer Lipase, die natĆ¼rlicherweise in einem Mikroorganismus vorhanden ist, wobei der Mikroorganismus Rhizopus oryzae oder Mucor javanicus ist, zur Entfernung von lipase-sensitiven Anschmutzungen auf Textilien oder harten OberflƤchen oder zur Desinfektion in einer Waschflotte, welche ferner ein Phosphonat umfasst.Another object of the invention is the use of a lipase, which is naturally present in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus, for the removal of lipase-sensitive stains on textiles or hard surfaces or for disinfection in a wash liquor, which further comprises a phosphonate.

Alle Sachverhalte, GegenstƤnde und AusfĆ¼hrungsformen, die fĆ¼r erfindungsgemƤƟe Tensidzubereitungen und/oder erfindungsgemƤƟe Verfahren beschrieben sind, sind auch auf die genannten Verwendungen anwendbar. Daherwird an dieser Stelle ausdrĆ¼cklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch fĆ¼r die vorstehenden erfindungsgemƤƟen Verwendungen gilt.All facts, subjects and embodiments described for surfactant preparations and / or methods according to the invention are also applicable to the mentioned uses. Therefore, reference is made at this point expressly to the disclosure in the appropriate place with the statement that this disclosure also applies to the above uses according to the invention.

Beispiel:Example: Ermittlung der Reinigungsleistung einer erfindungsgemƤƟen flĆ¼ssigen TensidzubereitungDetermination of the cleaning performance of a liquid surfactant preparation according to the invention

FĆ¼r dieses Beispiel wurden standardisiert verschmutze Textilien eingesetzt, die von dem Center For Testmaterials (CFT, Vlaardingen, Niederlande) bezogen worden waren. Dabei wurden folgende Anschmutzungen und Textilien verwendet:

  1. A: RuƟ/Mineralƶl auf Baumwolle: Produkt Nr. C-01 erhƤltlich von CFT;
  2. B: RuƟ/Olivenƶl auf Baumwolle: Produkt Nr. C-02 erhƤltlich von CFT;
  3. C: Pigment/ƖI auf Baumwolle: Produkt Nr. C-09 erhƤltlich von CFT ;
  4. D: Hautfett (Sebum)/Kohlenschwarz,auf Baumwolle: Produkt Nr. C-S-32 erhƤltlich von CFT.
For this example, standard contaminated fabrics obtained from the Center For Testmaterials (CFT, Vlaardingen, The Netherlands) were used. The following stains and textiles were used:
  1. A: carbon black / mineral oil on cotton: Product No. C-01 available from CFT;
  2. B: carbon black / olive oil on cotton: Product No. C-02 available from CFT;
  3. C: Pigment / oil on cotton: Product No. C-09 available from CFT;
  4. D: Skin fat (sebum) / carbon black, on cotton: Product No. CS-32 available from CFT.

Mit diesem Testmaterial wurden verschiedene Waschmittel auf ihre Reinigungsleistung hin untersucht. DafĆ¼r wurden die AnsƤtze fĆ¼r 30 Minuten bei Temperaturen von 40Ā°C gewaschen. Die Dosierung lag bei 3,5 Gramm des Waschmittels pro Liter Waschflotte. Es wurde mit Stadtwasser mit einer WasserhƤrte von etwa 16Ā° deutscher HƤrte gewaschen.With this test material, various detergents were examined for their cleaning performance. For this, the batches were washed for 30 minutes at temperatures of 40 Ā° C. The dosage was 3.5 grams of detergent per liter of wash liquor. It was washed with city water with a water hardness of about 16 Ā° German hardness.

Als Waschmittel-Basis-Rezeptur diente ein Phosphonat-haltiges FlĆ¼ssigwaschmittel folgender Zusammensetzung (alle Angaben in Gewichts-Prozent): 0,3-0,5% Xanthan, 0,2-0,4% AntiSchaummittel, 6-7% Glycerin, 0,3-0,5% Ethanol, 4-7% FAEOS (Fettalkoholethersulfat), 24-28% nichtionische Tenside, 1% BorsƤure, 1-2% Natriumcitrat (Dihydrat), 2-4% Soda, 14-16% Kokosnuss-FettsƤuren, 0,5% HEDP (1-Hydroxyethan-1,1-diphosphonsƤure), 0-0,4% PVP (Polyvinylpyrrolidon), 0-0,05% optischer Aufheller, 0-0,001% Farbstoff, Rest demineralisiertes Wasser.The detergent base formulation used was a phosphonate-containing liquid detergent of the following composition (all figures in percent by weight): 0.3-0.5% xanthan gum, 0.2-0.4% anti-foaming agent, 6-7% glycerol, 0 , 3-0.5% ethanol, 4-7% FAEOS (fatty alcohol ether sulfate), 24-28% nonionic surfactants, 1% boric acid, 1-2% sodium citrate (dihydrate), 2-4% soda, 14-16% coconut oil. Fatty acids, 0.5% HEDP (1-hydroxyethane-1,1-diphosphonic acid), 0-0.4% PVP (polyvinylpyrrolidone), 0-0.05% optical brightener, 0-0.001% dye, balance demineralized water.

Diese Waschmittel-Basis-Rezeptur wurde fĆ¼r die verschiedenen Versuchsreihen aktivitƤtsgleich zu 0,35 Gew.-% Lipex 100L (LipaseprƤparation des Unternehmens Novozymes (Ansatz 4 als Referenz) mit folgenden Lipasen versetzt: Lipase M-AP10Ā® (Ansatz 1), Lipase LEĀ® (Ansatz 2) und Lipase FĀ® (auch Lipase JVĀ®; Ansatz 3), alle erhƤltlich von dem Unternehmen Amano Pharmaceuticals.This detergent base formulation was added to the following series of lipases for the various series of experiments in an activity-identical manner to 0.35% by weight of Lipex 100L (lipase preparation from Novozymes (batch 4 as reference): Lipase M-AP10Ā® (batch 1), Lipase LE Ā® (batch 2) and Lipase FĀ® (also Lipase JVĀ®, batch 3), all available from Amano Pharmaceuticals.

Nach dem Waschen wurde der WeiƟheitsgrad der gewaschenen Textilien gemessen. Die Messung erfolgte an einem Spektrometer Minolta CM508d (Lichtart D65, 10Ā°). Das GerƤt wurde zuvor mit einem mitgelieferten WeiƟstandard kalibriert. Die erhaltenen Ergebnisse sind die Differenzremissionen zwischen einem Waschvorgang mit einem Waschmittel enthaltend die jeweilige Lipase und einem parallel durchgefĆ¼hrten Kontrollwaschgang mit einem Waschmittel ohne Lipase. Die Ergebnisse sind in der nachfolgenden Tabelle 1 zusammengestellt und erlauben einen unmittelbaren RĆ¼ckschluss auf den Beitrag des jeweils enthaltenen Enzyms zur Reinigungsleistung des verwendeten Mittels. Tabelle 1: Waschergebnisse mit einem flĆ¼ssigen Waschmittel bei 40Ā°C Anschmutzung Ansatz 1 Ansatz 2 Ansatz 3 Ansatz 4 A 32,6 32,2 33,3 29,7 B 32,1 31,9 32,1 27,1 C 63,2 61,9 62,1 61,2 D 31,6 31,8 32,8 30,8 After washing, the whiteness of the washed fabrics was measured. The measurement was carried out on a Minolta CM508d spectrometer (illuminant D65, 10 Ā°). The device was previously calibrated with a supplied white standard. The results obtained are the difference remissions between a washing process with a detergent containing the respective lipase and a parallel control wash with a detergent without lipase. The results are summarized in the following Table 1 and allow a direct conclusion on the contribution of each enzyme contained to the cleaning performance of the agent used. Table 1: Wash results with a liquid detergent at 40 Ā° C soiling Approach 1 Approach 2 Approach 3 Approach 4 A 32.6 32.2 33.3 29.7 B 32.1 31.9 32.1 27.1 C 63.2 61.9 62.1 61.2 D 31.6 31.8 32.8 30.8

Es wird deutlich, dass erfindungsgemƤƟe Tensidzubereitungen (AnsƤtze 1 bis 3) sehr gute Reinigungsleistungen zeigen, die gegenĆ¼ber der Referenz (Ansatz 4) verbessert sind.It is clear that surfactant preparations according to the invention (batches 1 to 3) show very good cleaning performances, which are improved over the reference (batch 4).

SEQUENCE LISTINGSEQUENCE LISTING

  • <110> Henkel AG & Co. KGaA<110> Henkel AG & Co. KGaA
  • <120> FlĆ¼ssige Tensidzubereitung enthaltend Lipase und Phosphonat<120> Liquid surfactant preparation containing lipase and phosphonate
  • <130> H 08918 (PT018327)<130> H 08918 (PT018327)
  • <150> DE 102010063743.2
    <151> 2010-12-21
    <150> DE 102010063743.2
    <151> 2010-12-21
  • <160> 1<160> 1
  • <170> PatentIn version 3.3<170> PatentIn version 3.3
  • <210> 1
    <211> 269
    <212> PRT
    <213> Rhizopus oryzae
    <210> 1
    <211> 269
    <212> PRT
    <213> Rhizopus oryzae
  • <400> 1
    Figure imgb0001
    Figure imgb0002
    <400> 1
    Figure imgb0001
    Figure imgb0002

Claims (10)

  1. A liquid surfactant preparation comprising a phosphonate and a lipase that exists naturally in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus.
  2. The surfactant preparation according to claim 1, characterized in that the phosphonate is selected from the group consisting of 1-hydroxyethane-1,1-diphosphonic acid (HEDP), aminotrimethylene phosphonic acid (ATMP), nitrilotrimethylene phosphonic acid (NTMP), diethylenetriaminepentamethylene phosphonic acid (DTPMP, DETPMP or DTPNT), ethylenediaminetetramethylene phosphonic acid (EDTMP), 2-phosphonobutane-1,2,4-tricarboxylic acid (PBS-AM) as well as combinations thereof.
  3. The surfactant preparation according to claim 1 or 2, characterized in that the lipase possesses an amino acid sequence that is at least 80 % identical to the amino acid sequence listed in SEQ ID NO. 1.
  4. The surfactant preparation according to one of claims 1 to 3, characterized in that the phosphonate is comprised in an amount of 0.01 to 4 wt %, and/or the lipase is comprised in an amount of 1 x 10-8 to 5 wt %, based on active protein.
  5. The surfactant preparation according to one of claims 1 to 4, characterized in that it is a washing agent, cleaning agent or disinfectant.
  6. The surfactant preparation according to one of claims 1 to 5, characterized in that it additionally comprises a component selected from
    i. an anionic and/or polyanionic substance, and/or
    ii. a cationic and/or polycationic substance, and/or
    iii. a substance that possesses hydroxyl and/or polyhydroxyl group(s).
  7. The surfactant preparation according to one of claims 1 to 6, characterized in that it additionally comprises at least one additional ingredient selected from the group consisting of builder, peroxygen compound, bleach activator, non-aqueous solvent, acid, water-soluble salt, thickener, disinfecting ingredient as well as combinations thereof, and/or that it contains at least one additional enzyme, in particular a protease, amylase, cellulase, hemicellulase, mannanase, pectinase, tannase, xylanase, xanthanase, Ī²-glucosidase, carrageenase, perhydrolase, oxidase, oxidoreductase or a lipase, and preferably their mixtures.
  8. A method for cleaning fabrics or hard surfaces or for disinfection, wherein a surfactant preparation according to one of claims 1 to 7 is used in at least one process step.
  9. A method, in particular a washing, cleaning or disinfection method, in which a washing liquor that contains a phosphonate and a lipase that exists naturally in a microorganism, is brought into contact with a lipase-sensitive soil or a germ on a fabric or on a hard surface, wherein said microorganism is Rhizopus oryzae or Mucor javanicus.
  10. Use of a lipase that exists naturally in a microorganism, wherein the microorganism is Rhizopus oryzae or Mucor javanicus, so as to provide a lipolytic activity in a liquid surfactant preparation that additionally comprises a phosphonate, or so as to remove lipase-sensitive soils on fabrics or hard surfaces or for disinfection in a washing liquor that additionally comprises a phosphonate.
EP11805804.9A 2010-12-21 2011-12-13 Liquid surfactant preparation containing lipase and phosphonate Active EP2655587B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL11805804T PL2655587T3 (en) 2010-12-21 2011-12-13 Liquid surfactant preparation containing lipase and phosphonate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010063743A DE102010063743A1 (en) 2010-12-21 2010-12-21 Liquid surfactant preparation containing lipase and phosphonate
PCT/EP2011/072513 WO2012084582A1 (en) 2010-12-21 2011-12-13 Liquid surfactant preparation containing lipase and phosphonate

Publications (2)

Publication Number Publication Date
EP2655587A1 EP2655587A1 (en) 2013-10-30
EP2655587B1 true EP2655587B1 (en) 2017-05-10

Family

ID=45464508

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11805804.9A Active EP2655587B1 (en) 2010-12-21 2011-12-13 Liquid surfactant preparation containing lipase and phosphonate

Country Status (9)

Country Link
US (1) US20130266552A1 (en)
EP (1) EP2655587B1 (en)
KR (1) KR101928587B1 (en)
DE (1) DE102010063743A1 (en)
ES (1) ES2634512T3 (en)
HU (1) HUE035746T2 (en)
MX (1) MX2013007116A (en)
PL (1) PL2655587T3 (en)
WO (1) WO2012084582A1 (en)

Families Citing this family (4)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
US10731110B2 (en) 2013-12-20 2020-08-04 Novozymes A/S Compositions and processes for treatment with lipases
CN105849121B (en) 2014-01-22 2020-12-29 čÆŗē»“äæ”公åø Polypeptides having lipase activity and polynucleotides encoding same
DE102017202034A1 (en) 2017-02-09 2018-08-09 Henkel Ag & Co. Kgaa Lipases with increased thermostability
EP3772540A1 (en) 2019-08-08 2021-02-10 Henkel AG & Co. KGaA Lipases with increased thermostability

Family Cites Families (23)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
JP2706778B2 (en) 1988-03-07 1998-01-28 å¤©é‡Žč£½č–¬ ę Ŗ式会ē¤¾ Oil and fat reforming method
EP0443063A1 (en) 1990-02-22 1991-08-28 Henkel Research Corporation Pseudomonas lipase gene, vectors for the expression thereof, production of the lipase by transformed microorganisms and uses of this enzyme
DE69133633D1 (en) 1991-06-11 2010-07-08 Genencor Int Cellulase compositions having a deficiency of type CBH I component-containing detergent compositions
CN101955921A (en) 1995-03-17 2011-01-26 čÆŗę²ƒå„‡ę¢…å…¹ęœ‰é™å…¬åø Novel endoglucanases
EP0857216B1 (en) 1995-10-17 2014-09-10 AB Enzymes Oy Cellulases, the genes encoding them and uses thereof
DE69735767T2 (en) 1996-09-17 2007-04-05 Novozymes A/S cellulase
AU734264B2 (en) 1996-11-15 2001-06-07 Ecolab Inc. Cleaning method for polyethylene terephthalate containers
DE19713852A1 (en) * 1997-04-04 1998-10-08 Henkel Kgaa Activators for peroxygen compounds in detergents and cleaning agents
US7312062B2 (en) 1998-11-27 2007-12-25 Novozymes A/S Lipolytic enzyme variants
MXPA01009706A (en) 1999-03-31 2002-05-14 Novozymes As Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same.
AU2452101A (en) 1999-12-23 2001-07-03 Pharmacia & Upjohn Company Assays and methods of diagnosis and treatment based on use of sodium channels astargets for amyloid beta or its aggregates
JP4907834B2 (en) 2000-08-04 2012-04-04 ćƒ€ćƒ‹ć‚¹ć‚³ćƒ»ćƒ¦ćƒ¼ć‚Øć‚¹ćƒ»ć‚¤ćƒ³ć‚³ćƒ¼ćƒćƒ¬ćƒ¼ćƒ†ćƒƒćƒ‰ Mutant EGIII cellulase, DNA encoding such EGIII composition and method for obtaining the same
US20030050211A1 (en) * 2000-12-14 2003-03-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Enzymatic detergent compositions
WO2002099091A2 (en) 2001-06-06 2002-12-12 Novozymes A/S Endo-beta-1,4-glucanase from bacillus
DE10131441A1 (en) 2001-06-29 2003-01-30 Henkel Kgaa A new group of alpha amylases and a method for identifying and obtaining new alpha amylases
DE10163748A1 (en) 2001-12-21 2003-07-17 Henkel Kgaa New glycosyl hydrolases
AU2003302905A1 (en) * 2002-12-11 2004-06-30 Novozymes A/S Detergent composition comprising endo-glucanase
DE10260903A1 (en) 2002-12-20 2004-07-08 Henkel Kgaa New perhydrolases
DK2664670T3 (en) 2003-12-03 2015-07-27 Danisco Us Inc perhydrolase
DE102004029475A1 (en) 2004-06-18 2006-01-26 Henkel Kgaa New enzymatic bleaching system
DE102006038448A1 (en) 2005-12-28 2008-02-21 Henkel Kgaa Enzyme-containing cleaning agent
DE102006022224A1 (en) 2006-05-11 2007-11-15 Henkel Kgaa Subtilisin from Bacillus pumilus and detergents and cleaners containing this new subtilisin
DE102007003143A1 (en) * 2007-01-16 2008-07-17 Henkel Kgaa New alkaline protease from Bacillus gibsonii and detergents and cleaners containing this novel alkaline protease

Non-Patent Citations (1)

* Cited by examiner, ā€  Cited by third party
Title
None *

Also Published As

Publication number Publication date
PL2655587T3 (en) 2017-10-31
EP2655587A1 (en) 2013-10-30
ES2634512T3 (en) 2017-09-28
WO2012084582A1 (en) 2012-06-28
KR20130135272A (en) 2013-12-10
US20130266552A1 (en) 2013-10-10
KR101928587B1 (en) 2018-12-12
DE102010063743A1 (en) 2012-06-21
MX2013007116A (en) 2013-08-27
HUE035746T2 (en) 2018-05-28

Similar Documents

Publication Publication Date Title
EP2478097B1 (en) Stable liquid washing or cleaning agent containing a protease
EP3260537B1 (en) Storage-stable liquid washing or cleaning agent containing protease and cellulase
EP2569409B1 (en) Storage-stable liquid detergent or cleaning agent containing protease and lipase
DE102014018149A1 (en) Solid washing and cleaning agent with amylase
EP2598624A2 (en) Stabilized liquid tenside preparation comprising enzymes
EP2652131A1 (en) Storage-stable liquid washing or cleaning agent containing protease and amylase
EP2756064A2 (en) Method for adapting a hydrolytic enzyme to a component that stabilizes the hydrolytic enzyme
DE102020205400A1 (en) Highly alkaline laundry detergent with protease
EP3230443B1 (en) Detergents and cleaning agents comprising a combination of amylase and protease
WO2011036198A1 (en) Stabilized enzymatic composition
EP2655587B1 (en) Liquid surfactant preparation containing lipase and phosphonate
EP2598626A2 (en) Stabilized liquid tenside preparation comprising enzymes
DE102020205381A1 (en) Highly alkaline laundry detergent with protease
DE102019210806A1 (en) Laundry detergent with a Bacillus gibsonii protease
EP2640818B1 (en) Stabilized liquid surfactant composition comprising enzym
WO2023232193A1 (en) Detergents and cleaning agents with an improved enzyme stability
WO2023232192A1 (en) Detergent and cleaning agent with improved enzyme stability
WO2023232194A1 (en) Detergents and cleaning agents with an improved enzyme stability
EP2598622A2 (en) Stabilized liquid tenside preparation comprising enzymes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130522

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140606

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: C11D 3/386 20060101AFI20170109BHEP

INTG Intention to grant announced

Effective date: 20170202

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 892339

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170515

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 502011012230

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170510

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2634512

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20170928

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170811

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170810

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170910

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170810

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20171212

Year of fee payment: 7

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 502011012230

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20180213

REG Reference to a national code

Ref country code: HU

Ref legal event code: AG4A

Ref document number: E035746

Country of ref document: HU

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: HU

Payment date: 20171218

Year of fee payment: 7

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171213

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20181211

Year of fee payment: 8

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 892339

Country of ref document: AT

Kind code of ref document: T

Effective date: 20171213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181214

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170510

Ref country code: CZ

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20191213

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20221202

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20230227

Year of fee payment: 12

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231220

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231228

Year of fee payment: 13

Ref country code: FR

Payment date: 20231221

Year of fee payment: 13

Ref country code: DE

Payment date: 20231214

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20231130

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240126

Year of fee payment: 13